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ABSTRACT
Numerous hormones and neurotransmitters have been reported to modulate steroid
secretion from the adrenal cortex. In particular, acetylcholine (ACh) and angiotensin II
(All) stimulate both aldosterone and Cortisol secredon from the adrenocortical zona
glomerulosa (zg) and zona fasciculata/reticularis (zfr) respectively. This study has
investigated the cellular mechanisms by which ACh and All stimulate Cortisol secretion
from bovine adrenal zfr cells maintained in primary culture.
The ability of ACh and All to stimulate Cortisol secretion from zfr cells was assessed over
experimental days 1 (initial isolation of cells) to 5. Freshly isolated cells secreted Cortisol
in response to ACh and AIL This steroidogenic response was significantly reduced or
absent on day 2, and recovered over days 3 and 4, at which time cells were maximally
responsive to these agents. The reduced secretory response on day 2 was accompanied by
a paradoxical increase in phospholipase C (PLC) activation, indicating that stimulation of
PLC by ACh and All becomes uncoupled from stimulation of steroidogenesis at this
time. In contrast, steroidogenic and second messenger responsiveness to
adrenocorticotropin (ACTH) and adrenaline, which activate adenylate cyclase, increased
over experimental days 1 to 4. This loss of steroidogenic responsiveness to ACh and All
was shown to occur through a defect in the protein kinase C-mediated stimulation of the
steroidogenic pathway.
The receptor subtype(s) mediating the steroidogenic responses to ACh and All were
characterised using selective antagonists. Hexahydro-sila-difenidol and p-fluoro-
hexahydro-sila-difenidol were potent competitive antagonists of ACh-stimulated Cortisol
secretion with pA2 values of 8.68 and 7.96 respectively. Pirenzepine (pA2= 6.95) and
methoctramine (pA2=6.06) were relatively weak competitive antagonists. These values
correlated closely with the established antagonist profile of the M3 muscarinic receptor.
In addition, a rapid desensitisation of this M3 receptor-mediated response was
demonstrated. All-stimulated Cortisol secretion and phosphoinositol production were
dose-dependently inhibited both by saralasin and by the AT,-selective antagonist
losartan. PD123177 (AT2-selective antagonist) was without effect, indicating the presence
of the AT, receptor. Schild analysis of the inhibition of All-stimulated Cortisol secretion
by saralasin and losartan produced pA2 values of 8.79 and 7.02 respectively. While the
pA2 for saralasin agreed closely with previous measurements in other systems, that for
losartan was significantly lower than the values previously reported in other systems,
possibly indicating heterogeneity of the ATI receptor. Indeed, isoelectric focusing of zfr
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cell membranes labelled with 125I-AII revealed the presence of two distinct losartan-
sensitive All binding proteins.
Previous studies have shown that in bovine zfr cells, ACh and All stimulate PLC without
affecting adenosine 3',5'-cyclic monophosphate (cAMP) levels. In order to ascertain
whether ACh and All stimulate a common pool of PLC, the effects of these agonists in
combination were studied. Partial additivity of response was observed with respect to
both Cortisol secretion and PLC activation, possibly indicative of heterologous
desensitisation. However, evidence was obtained to suggest that in [3H]inositol-
prelabelled cells, ACh and All stimulate incorporation of [3H]inositol into a common
hormone-sensitive pool of phosphoinositides, which was distinct from the non-hormone-
sensitive pool labelled in the presence of Mn2+.
Finally, changes in intracellular Ca2+ concentration ([Ca2+]j) in response to ACh and All
were measured in single fura-2 loaded cells by fluorescence microscopy. Both agonists
stimulated increases in [Ca2+]j. The Ca2+ signals observed in response to ACh were
heterogeneous, with 60% of cells showing an initial increase in [Ca2+]; followed by a
decline to a resting level, the magnitude of which was dose-dependent (type 1). The
remaining 40% of cells exhibited an initial increase, followed by oscillations in [Ca2+]l5
the frequency of which was dose-dependent (type 2). Intracellular Ca2+ responses to All
were more homogeneous, and of type 1 only.
These results extend knowledge of ACh and All effects in inner adrenocortical zone cells.
The role of these agonists in the normal and pathological control of adrenocortical
function in vivo merits further investigation.
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This chapter presents a general introduction to the adrenal cortex and to the steroidogenic
agonists acetylcholine and angiotensin II. The chapter is divided into eight sections: The
anatomy and physiology of the adrenal cortex, and the nature of the adrenocortical
hormones, are described in sections 1.1 and 1.2. Section 1.3 considers the mechanisms of
agonist-stimulated adrenocortical steroidogenesis with respect to the adenylate cyclase
and inositol phosphate/calcium signalling systems. The pathophysiology of the adrenal
cortex is described briefly in section 1.4. Sections 1.5 and 1.6 introduce the
neurotransmitter acetylcholine and the peptide hormone angiotensin II. Each agonist is
described in general terms before a more detailed review of their effects on adrenocortical
steroidogenesis and second messenger formation. Interactions between acetylcholine,
angiotensin II and other agonists are described in section 1.7, and the final section of this
introductory chapter describes the aims of this thesis.
1.1 THE ADRENAL GLAND - INTRODUCTION
1.1.1 Historical aspects
The first accurate description of the adrenal glands was by Eustachius in 1563, although
his illustrations remained unknown until the early eighteenth century. Thus the first
descriptions to receive significant attention were by Caspar Bartholinius the Elder in
1611. Little advancement was made for the next two hundred years, and it was not until
1845 that Huschke noted the distinction between the adrenal cortex and medulla
(Huschke, 1845). Ten years later, the critical importance of the gland was emphasised by
Addison, who provided detailed descriptions of the symptoms of adrenal insufficiency
(Addison, 1855). Brown-Sequard (1856) demonstrated that surgical removal of the
adrenals quickly resulted in death, although, as discussed by Neville and O'Hare (1982),
this was probably due more to shock and sepsis than to true adrenal insufficiency. Much
controversy followed these findings, and it was not until the early 1900s that proof for the
adrenal cortex, and not the medulla, being vital to life, was obtained (Wheller & Vincent,
1917; Houssay & Lewis, 1923). The race to isolate an active adrenocortical extract
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capable of sustaining adrenalectomised animals quickly followed, and was won by
Swingle and Pfiffner (1930). The 1930s also saw the preparation and identification of the
major adrenocortical steroids, and in 1948, cortisone was chemically synthesised (Sarett,
1948) and successfully used to treat rheumatoid arthritis the following year (Hench et al,
1949). During the next two decades, the relationships between mineralocorticoids and
glucocorticoids, their physiology and biochemistry, and the factors controlling their
release, were elucidated.
1.1.2 Embryology and development
The human adrenal glands are two ovoid glands bilaterally positioned on the superior
pole of each kidney, located in the retroperitoneum. The organs consist of two
morphologically and functionally distinct glands, the steroid secreting adrenal cortex, and
the inner catecholamine producing medulla, which are of different embryological origin
(Crowder, 1957). The cortical tissue is the first to appear, at about the fifth week of
gestation in humans, and arises from the mesoderm in the urogenital tract. During the
seventh week the mass of the presumptive cortical cells is invaded by cells migrating
from the neural crest of the ectoderm, which eventually become surrounded by the
mesodermal cells, and form the adrenal medulla. The circulation of the gland is
established early, and is continuous with the general circulation by sixty days. During the
first trimester, the gland enlarges rapidly such that by the second trimester, it weighs
around 4g/kg body weight (35 times the adult value). Most of the cortical volume
represents the foetal zone (see section 1.1.4), which rapidly degenerates after parturition,
and is completely lost by 1 year, at which time the gland weighs only 50% of the birth
weight. The gland enlarges slowly over the next ten years to reach 2g in weight, but
doubles in weight during puberty to reach the adult weight at age 18.
1.1.3 Anatomy and blood supply
The paired adult human adrenals weigh about 10 g, and measure approximately 5cm x
2cm. The left adrenal, situated at the tail of the spleen, is crescent shaped, while the more
pyramidal right adrenal lies close to the inferior vena cava. Three distinct regions of the
human gland are defined: the head, containing mostly medullary tissue, the tail containing
mostly cortical tissue and the body containing both tissue types. The cortical tissue
accounts for around 80% of the volume and weight of the gland.
The arterial blood supply is derived from three sources: the inferior phrenic artery, the









FIGURE 1.1 : Illustration of the human right adrenal gland showing the blood supply
and internal structure.
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arterial vessels bifurcate en route to the gland, and the adrenal capsule is thus penetrated
by up to 50 or 60 arterial twigs, which form the subcapsular plexus. Effluent blood is
collected into a single central vein emerging from the anterior surface of the gland. The
right adrenal vein passes directly into the superior vena cava while the left joins the
inferior phrenic vein, before entering the left renal vein.
The intra-adrenal vascular architecture has been described by Dobbie et al (1968).
Arterial blood flows from the subcapsular plexus into parallel capillaries which descend
through the zona fasciculata (see section 1.1.4) before reaching the zona reticularis,
where they form the plexus reticularis. Blood either drains from this plexus into the
sinusoids of the alar raphe, or, in regions of the gland containing medullary tissue,
continues towards the medulla. This cortico-medullary portal system is thought to be the
sole source of medullary blood in the rat and bovine adrenal (Vinson et al, 1985),
although the human medulla is also supplied directly by the arteria medullae (Flint,
1900). The deeper cortical layers thus have no direct arterial supply, but receive blood
which has already perfused the outer cell layers. This centripetal arrangement is
extremely well preserved between species, and is found even in the largest mammals such
as the elephant (Krumley & Buss, 1969) and whale (Race & Wu, 1961). Thus, in order
to maintain adequate perfusion of the deeper cortical layers in larger mammals, adrenal
bulk is increased by lateral expansion and convolution, rather than increases in
adrenocortical width. The centripetal blood supply has important implications in the
gradient theory of adrenocortical zonation (see section 1.1.4).
1.1.4 Adrenocortical histology and zonation
The adrenal gland is enclosed by several layers of elongated connective cells surrounded
by collagen fibres, which form the capsule. The remainder of the cortex consists of three
distinct cell types arranged in concentric zones, the zonae glomerulosa, fasciculata and
reticularis (Figure 1.2). Directly underneath the capsule, and forming the periphery of
the cortex, lies the zona glomerulosa (zg). Accounting for around 5% of the total mass of
the cortex, the relatively small cells of the zg are arranged in rounded clusters (glomus =
ball), with a high nuclear/cytoplasmic ratio. The cytoplasm contains comparatively little
lipid, and is extremely rich in elongated mitochondria. The majority of the mass of the
cortex (70%) is composed of the zona fasciculata (zf). The large zf cells are arranged in
columnar layers (fascis = bundle), and are characterised by their prominent plasma
membranes, low nuclear/cytoplasmic ratio, extensive lipid droplets and small, ovoid
mitochondria. The remaining 20% of cortical tissue comprises the innermost zona
















FIGURE 1.2 : Zonation of the mammalian adrenal cortex. Diagramatic representation of
the arrangement of cells in a cross-section of the adrenal gland.
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Exhibiting a network-like arrangement (rete = net), zr cells are usually described as
"compact". The cells of the zr are more pigmented than those of the other adrenocortical
zones, due to the presence of cytoplasmic lipofuscin granules.
The exact cellular arrangement of the cortex varies between species. In the human gland,
there is no sharp delineation between the zg and the zf, and the zones merge
imperceptibly, with zf cells often observed directly underneath the capsule. In contrast,
the zg of the bovine cortex is sharply demarked from the inner zones, while the zf and zr
form a single uniform layer. The three zones are clearly distinguishable in the rat,
guinea-pig and rabbit cortex, while the amphibian adrenal cortex (interrenal gland)
displays no significant zonation.
Further adrenocortical zones have been described, with species and developmental
variation. In the male mouse, the zr is replaced by the so-called X-zone (Dunn, 1970;
Shire, 1979), which disappears following sexual maturity. Rat, rabbit, cat and dog
adrenal cortices exhibit a fourth zone, situated between the zg and the zf, termed the zona
intermedia (zi) (Deane, 1962). The human and primate foetal adrenal cortex exhibits
only two zones, the outer definitive and the inner foetal zone. The foetal zone, first
described by Elliot and Armour (1911), enlarges rapidly during gestation, and represents
the bulk of the foetal cortical mass before its degeneration following parturition.
The division of the adrenal cortex into the zg, zf and zr was first proposed over one
hundred years ago (Arnold, 1866). Although this distinction was made on histological
and anatomical grounds, it is now clear that the adrenocortical zones are also functionally
distinct. Differences in the enzyme complement of the zones lead to differences in the
steroids secreted by them. Thus, aldosterone is secreted exclusively by the zg, while
Cortisol is produced solely by the inner zfr. Androgens are secreted principally by the zr
(see section 1.2).
It has been proposed that the functional zonation of the cortex arises as a result of the
blood supply to the organ. As discussed in the preceding section, the adrenocortical
blood supply is centripetal in nature, and the adrenocortical sinusoids are arranged so that
blood tends to pool in the innermost zone. As cells of the inner zones are exposed to the
secretory products of cells nearer the capsule, a steroid gradient is thought to exist
between the capsule and the medulla (reviewed in Hornsby, 1987). It is proposed that the
steroidogenic enzymes can be regulated by steroids, allowing the activation or inhibition
of a given cellular enzyme depending on its position in the steroid gradient. Thus, the
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dominant enzymatic activities of the steroidogenic ceil would be determined by its
position in the cortex.
Until relatively recently it was assumed that the anatomical separation of the adrenal
cortex and medulla, coupled with the centripetal blood supply to the gland, would
preclude any functional contact between medullary and cortical cells. However, in the rat
adrenal gland, projections of chromaffin cells from the medulla towards the outer
adrenocortical zones have been observed (Gallo-Payet et al, 1987). A similar invasion of
medullary tissue into cortical regions appears to exist in the porcine adrenal, which also
showed invasion of the medulla by cortical cells (Bornstein et al, 1991). This cortical
invasion of the medulla was also seen in the bovine adrenal. In porcine and rat adrenals,
chromaffin cells within the cortex appear to form intimate connections with cortical cells
(Bornstein etal, 1991).
1.1.5 Adrenocortical Innervation
It is well established that the adrenal medulla receives a rich preganglionic sympathetic
cholinergic innervation. Fibres arising from the splanchnic nerve appear to penetrate the
adrenal cortex without synapsing and terminate directly on the medullary chromaffin
cells (Symington, 1969). It has widely been assumed that in contrast to the medulla, the
adrenal cortex receives no innervation. However, recent studies have provided
conclusive evidence for the presence of adrenocortical nerve fibres in many species. The
subject of adrenocortical innervation is reviewed in detail in Charlton (1989), on which
the following brief discussion is mainly based.
Robinson (1977) described a complex innervation of the ovine adrenal cortex.
Acetylcholinesterase (AChE)-positive nerve fibres were distributed in the cortical tissue
and formed a distinct plexus in the zr. The outer zones of the cortex also exhibited
aminergic nerve fibres, as determined by catecholamine-fluorescence histochemistry. A
similar anatomical distribution of nerve fibres has been described in rat, pig and mouse
adrenal cortex (Unsicker, 1971; Migally, 1979). More recently, Charlton et al (1991)
have used AChE-histochemistry to demonstrate a complex cholinergic innervation,
possibly derived from the splanchnic nerve, in normal human adrenocortical tissue. A
subcapsular nerve plexus was evident in some specimens, and nerve trunks extended
through the zf before forming a second plexus in the zr. The distribution of fibres was
consistent with innervation of either cortical cells and/or blood vessels. The human
adrenal cortex has also been shown to contain noradrenergic (dopamine [3-hydroxylase-
positive) nerve fibres, showing a similar distribution to the cholinergic innervation
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(Gilchrist et al, 1993). With the exception of the innermost zr, noradrenergic neurones
were present throughout the cortex, and were found in juxtaposition to both blood vessels
and steroidogenic cells (Charlton et al, 1992).
Several studies have demonstrated increased steroidogenesis in response to electrical
stimulation of the splanchnic nerve (Charlton, 1989, and section 1.5.3), although it is
unclear whether this represents a direct effect on the steroidogenic cells themselves or an
indirect effect related to changes in adrenocortical blood flow. Although many putative
adrenocortical neurotransmitters directly stimulate steroid secretion from isolated
adrenocortical cells (see Tables 1.2 and 1.3), stimulation of the splanchnic nerve is known
to result in a decrease in adrenocortical vascular resistance (Engeland et al, 1985;
Edwards et al, 1986; Engeland & Gann, 1989). The resultant increase in adrenocortical
blood flow could stimulate steroidogenesis by increasing the delivery of humoral
stimulants such as ACTH, or steroid substrates to the gland. Furthermore, the rate of
steroid secretion by the isolated perfused rat adrenal gland can be markedly increased by
increasing the rate of delivery of perfusion medium to the gland (Hinson et al, 1986).
The relative importance of neural effects on adrenocortical blood vessels and direct
effects on adrenocortical cells remains to be established.
1.1.6 Experimental adrenocortical preparations
Many of the pioneering studies on adrenocortical function were performed using intact
animals in vivo. While it is clearly desirable to study the adrenal cortex in its natural
environment, the measurement of steroid hormones in body fluids gives little or no
information about the source of the measured hormones, or the extent to which they have
been metabolised. Furthermore, the concentration of adrenal hormones in plasma is
extremely low, and problems of assay sensitivity led to the development of in situ
methods of measuring secretion from the whole organ. This technique of catheterisation
of the adrenal vein allows the measurement of adrenal hormones in the effluent blood (at
much higher concentrations than in peripheral plasma) while maintaining the organ in its
natural environment.
These in vivo methods do not allow the contribution of each individual adrenal cell type
to be assessed, nor the effect of cortico-medullary interactions to be analysed. They are
also unsuitable preparations with which to investigate the cellular mechanisms of agonist-
stimulated steroidogenesis. Thus, the need for purified preparations was recognised, and
many workers used adrenal tissue slices incubated in simple salt solutions in vitro.
Although crude preparations of zg and zfr slices can be prepared in this way, tissue slices
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suffer from poor oxygenation and impaired delivery of test substances to inner cell layers,
resulting in reduced steroidogenic responsiveness compared to results of in vivo and in
situ studies.
These problems are overcome by the culture of adrenocortical cells. Following
enzymatic digestion of tissue slices, dispersed cells can be rigourously purified by density
gradient centrifugation or column filtration and maintained in chemically defined media.
Delivery of oxygen and test substances is enhanced, and secreted steroids can accumulate
at high concentration. Furthermore, the pooling of tissue from many different animals to
produce a composite cell preparation reduces the inherent biological variability associated
with whole animal studies. Purified cells from each zone can be further disrupted to
produce subcellular organelle fractions for enzymatic studies, or plasma membrane
fractions for hormone receptor studies.
1.2 THE ADRENOCORTICAL STEROIDS
Over 40 different steroids have been isolated from the adrenal cortex, although many of
these represent intermediates or precursors of the major secretory products. The main
adrenal steroids are those with mineralocorticoid or glucocorticoid activity, although
some sex steroids (androgens, estrogens and progestins) are also secreted. All steroids
have a common ring structure consisting of three six-membered rings and one five-
membered ring (Figure 1.3), and their biological activity is determined by the number and
structure of the functional groups attached to this ring nucleus.
Early studies using capsular (95% zg) and decapsulated (zfr) portions of rat and bovine
adrenal cortex established that aldosterone, the major mineralocorticoid in all species, is
produced exclusively in the zg, while Cortisol, the major glucocorticoid in human, bovine,
sheep and guinea-pig, is produced solely in the zfr. Corticosterone (the major secretory
product in rat, rabbit and mouse) is produced both by the zg and the zfr. Although the zf
and zr secrete the same steroids qualitatively, sex steroids such • as
dehydroepiandrosterone appear to be produced preferentially by the zr. The evidence
which established this functional zonation is reviewed in Tait et al (1980a).
1.2.1 Mineralocorticoids and glucocorticoids
The major endogenous mineralocorticoid is aldosterone, although corticosterone and 11-
deoxycorticosterone also exhibit weak mineralocorticoid activity (Table 1.1). The





FIGURE 1.3 : Structure of the adrenocortical steroids. The nomenclature of the ring
nuclei and numbering of the carbon atoms is shown in (a). Rings B:C and C:D are
invariably joined in the trans configuration, while rings A:B can be either trans or cis.
Thus A:B trans compounds exhibit a planar structure (b), while in A:B cis compounds,





























* relative to Cortisol
** relative to testosterone
TABLE 1.1 : Secretion rates and biological activities of the major steroids secreted by
the human adrenal cortex. Secretion rates are given relative to that of Cortisol (around 15
- 30 mg per day in humans), and biological activities expressed relative to Cortisol or
testosterone. For comparison, the activities of two synthetic (syn) steroids are given.
Abbreviations: DOC, deoxycorticosterone; DHEA(S), dehydroepiandrosterone(sulphate).
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and an aldehyde group at carbon-18. Released under conditions of sodium depletion,
decreased blood volume and blood pressure, the physiological function of aldosterone is
to conserve salt by directly stimulating the absorption of sodium in exchange for the
excretion of K+ or H+ by the renal distal tubules.
The mechanism by which aldosterone stimulates sodium absorption was originally
elucidated through studies on the isolated toad bladder, a convenient in vitro model for
measuring ion transport across epithelial cells (Fraser, 1971; Edelman & Fanestil, 1970).
More recent work has utilised cultured epithelial cells (Handler, 1983). The effect of
aldosterone on ion transport is characterised by a latent peroid of around 1 h, followed by
an early response during which sodium transport is stimulated and transepithelial
resistance is decreased. This is followed by a late response (after around six hours) in
which continued sodium transport is accompanied by a constant stable transepithelial
resistance (Garty, 1986). Aldosterone binds to a specific high affinity cytosolic receptor
(section 1.2.2) which translocates to the cell nucleus on agonist binding and activates or
represses specific genes by interacting with hormone-responsive elements in the DNA.
Protein synthesis is then stimulated, the importance of which is indicated by the
inhibitory effects of actinomycin D on aldosterone-stimulated ion transport in the
mammalian kidney (Horisberger & Diezi, 1984). A rapid increase in transcription of the
a and (3 subunit genes of the Na+/K+-ATPase has been observed in response to
aldosterone (Verry, 1990), although at present the identities of the other proteins involved
in the action of aldosterone are unknown. Possible candidates include citrate synthase,
sodium permease enzymes, or protein kinases/phosphatases which may modulate the
activity of membrane ion channels (Reviewed in Horisberger & Rossier, 1992).
Glucocorticoids are characterised by the presence or absence of hydroxyl groups at C-ll
and C-17. The main naturally-occurring glucocorticoids are Cortisol and corticosterone
(Table 1.1). In contrast to the relatively specific actions of aldosterone, the
glucocorticoids exert a wide variety of metabolic and non-metabolic effects (reviewed in
David et al, 1970). Glucocorticoid effects on metabolism are generally antagonistic to
those of insulin ie. mobilisation of lipid, deposition of glycogen, inhibition of protein
synthesis in peripheral tissues and stimulation of hepatic gluconeogenesis and protein
synthesis. In addition, glucocorticoids act to suppress allergic and inflammatory
reactions, decrease resistance to infection and suppress lymphoid function. The mode of
action of the glucocorticoids appears to be similar to that of other steroid hormones, ie.
induction of nuclear protein synthesis following interaction of glucocorticoids with
specific cytosolic receptors (O'Malley et al, 1991).
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1.2.2 Mineralocorticoid and glucocorticoid receptors
Corticosteroid receptors have been classsified according to the differential binding
affinity of aldosterone. Those receptors exhibiting high affinity for aldosterone (ca.109
M) are found in most aldosterone target tissues and designated type 1 receptors, while
lower affinity (ca. 5 x 10"8M) receptors are classed as type II. The type 1 receptor has
been cloned, and shown to be a 107 kD protein with a C-terminal steroid binding region
and a 70 amino acid section corresponding to the DNA binding region (Arriza et al, 1987;
Evans, 1988). Both type I and type II receptors show little selectivity between
aldosterone and Cortisol (Sheppard & Funder, 1987), and, since circulating levels of
Cortisol greatly exceed those of aldosterone, a great deal of research has focused on the
mechanism by which mineralcorticoids can exert their effects. It has recently been shown
that aldosterone target tissues contain higher levels of llp-hydroxy steroid
dehydrogenase (11P-HSD) activity than other tissues. llp-HSD converts Cortisol into
the relatively inactive compound cortisone, thus allowing intracellular steroid receptors to
bind aldosterone rather than be saturated with Cortisol (reviewed in Stewart et al, 1987;
Funder et al. 1988).
1.2.3 Adrenocortical steroid biosynthesis
The precursor of all adrenocortical steroids is cholesterol, stored in adrenocortical lipid
droplets as cholesterol ester. Human adrenocortical cells, although capable of de novo
cholesterol synthesis from acetate (Hechter et al, 1953) derive the majority of their
cholesterol from plasma low density lipoproteins (LDL) (Brown et al, 1979), which are
internalised by receptor-mediated endocytosis. In contrast, the major source of
cholesterol for rat adrenocortical cells is high density lipoproteins (HDL). Free
cholesterol is made available for steroidogenesis by the action of cholesterol esterase,
while cholesterol ester synthetase is responsible for the storage of cholesterol as
cholesterol ester.
The understanding of steroid synthetic mechanisms has changed markedly over the last
few years. It was previously assumed that a large number of separate enzymes with strict
substrate specificity were necessary for the various reactions and interconversions known
to occur in adrenocortical cells. However, as the steroidogenic enzymes were cloned, it
became clear that comparatively few enzymes, each capable of catalysing more than one
activity, are involved in the conversion of cholesterol to active steroid hormones. Most of
the steroidogenic enzymes are members of the cytochrome P450 family of oxidases,
which reduce atmospheric 02 with electrons from NADPH (reviewed in Miller, 1988):
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NADPH + H+ + 02 + RH > R-OH + H,0 + NADP
Four distinct P450 enzymes have been shown to be involved in adrenocortical
steroidogenesis: (i) P450scc (side-chain cleavage) mediates the conversion of cholesterol
to pregnenolone, a reaction involving three separate activities (20ct-hydroxylation, 22-
hydroxylation and cleavage of the cholesterol side-chain between C20 and C22) (see
Figure 1.4). (ii) P450cll mediates 11-hydroxylase, 18-hydroxylase and 18-methyloxidase
activities, (iii) P450cl7 mediates 17a-hydroxylase and 17,20-lyase activities, while (iv)
P450arom (aromatase), more commonly found in the gonads, but also present in the
adrenal, mediates aromatisation of androgens to estrogens. In addition, pregnenolone is
converted to progesterone by one or more enzymes with 3(3-hydroxysteroid
dehydrogenase and A5 >A4 isomerase activity, while a 17-keto reductase mediates the
conversion of androstendione to testosterone. P450scc and P450cll are mitochondrial
enzymes, while P450cl7 and P450arom are located in the endoplasmic reticulum.
The first, and rate-limiting step in the synthesis of the steroid hormones is the conversion
of cholesterol to pregnenolone by P450scc (Figure 1.4). Each step in the reaction
sequence requires reducing equivalents from NADPH, and these are supplied by a
mitochondrial electron transport system. Electrons from NADPH are accepted by
adrenodoxin reductase, a membrane-bound flavoprotein, and transferred to P450scc via
adrenodoxin, a soluble iron/sulphur protein of the mitochondrial matrix (reviewed in
Miller, 1988). The conversion of cholesterol to pregnenolone is the major hormonally-
regulated step of the steroidogenic pathway (see section 1.3).
P450cl7 exhibits both 17a-hydroxylase and 17,20 lyase activities, formerly attributed to
two separate enzymes. Pregnenolone, once formed from cholesterol, can therefore enter
either mineralocorticoid, glucocorticoid or androgen synthetic pathways, depending on
the activity of P450cl7 (see Figure 1.5). If neither hydroxylase nor lyase activity is
present, pregnenolone is converted to progesterone and then ultimately to aldosterone. If
hydroxylase activity alone is present, P450cl7 converts pregnenolone and progesterone to
17a-hydroxypregnenolone and 17a-hydroxyprogesterone respectively, which can be
converted to Cortisol via 11-deoxycortisol. The 17a-hydroxylated steroids can however
be further metabolised by the 17,20-lyase activity of P450cl7 to dehydroepiandrosterone
(DHEA) and androsterone respectively, the precursors of testosterone and estradiol.
The factors determining which activity (hydroxylation or lyase) P450cl7 performs











FIGURE 1.5 : Simplified diagram showing the major steroid interconversions occurring
in the mammalian adrenal cortex. Reactions confined to particular adrenocortical zones
are enclosed in dotted boxes. The principal secretion products are indicated by solid
boxes. Abbreviations: 3(3 HSD, 3(3 hydroxysteroid dehydrogenase; isom., isomerase.
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it receives reducing equivalents from P450 reductase and cytochrome b5 (Kominami et al,
1980; Tamburini & Gibson, 1983). The availability of electrons to P450cl7 appears to
influence its activity. The ratio of lyase/hydroxylase activity can be increased by
increasing the ratio of P450 reductase to P450cl7 in vitro (Onoda & Hall, 1982).
Furthermore, the association of P450cl7 with P450 reductase and cytochrome b5 can be
influenced by phospholipids and other small molecules (Muller-Enoch et al, 1984), and
this may represent a mechanism whereby intracellular messengers could determine the
dominant enzymatic activities of the cell.
The major adrenocortical steroids Cortisol and aldosterone are synthesised from 11-
deoxycortisol and corticosterone respectively by the action of a single enzyme,
cytochrome P450cll. This raises the question as to how aldosterone and Cortisol
secretion can be confined to the zg and zfr respectively, since previous studies had
suggested the presence in the zg of a unique aldosterone-synthesising enzyme (Meuli &
Muller, 1983,1984). In the rat adrenal cortex, P450cll is now known to exist in two
different isoforms, both of which have been cloned and shown to be the products of
different genes (CYP11B1 and CYP11B2) (Nonaka et al, 1989; Matsukawa et al, 1990).
Both isoforms show 11(3- and 18-hydroxylase activties, although only one form
(CYP11B2) exhibits aldosterone synthetase (methyl oxidase) activity. The gene
transcript of this isoform is present exclusively in the zg, while that of the non-
aldosterone synthesising isoform (CYP11B1) is present throughout the adrenal cortex
(Yabu et al, 1991). Furthermore, mRNA levels of the two isoforms are subject to
differential regulation by factors known to selectively influence Cortisol and aldosterone
secretion such as dexamethasone treatment, angiotensin II infusion and sodium restriction
(Malee 8c Mellon, 1991; Shibataera/, 1991; Imai et al, 1992b).
Similar isoforms of P450cll have since been identified in mouse adrenal cortex
(Domalik et al 1991), and mRNA encoding the aldosterone-synthetic isoform was
identified in hyperplastic adrenocortical tissue from human patients with primary
aldosteronism (Kawamoto et al, 1990; Ogishima et al, 1991) and in cultured human zg
cells (Curnow et al, 1991). Thus the presence of two distinct P450cl 1 enzymes provides
a mechanism for the selective synthesis of aldosterone in rat, mouse and human adrenal
cortex. However, the situation in the bovine adrenal gland is less well understood.
Although cDNAs encoding two different cytochromes P450cll have been cloned and
sequenced in this species (Kirita et al, 1988), both isoforms are present throughout the
adrenal cortex, and show identical enzymatic activities (ie. synthesise Cortisol from 11-
deoxycortisol and aldosterone from corticosterone) when expressed in COS-7 cells
(Morohashi et al, 1990). It is possible that in the inner bovine adrenocortical zones, the
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local mitochondrial environment does not support the aldosterone synthase activity of
P450cll, perhaps influenced by the steroid gradient across the cortex, although this
hypothesis has not been tested to date.
1.3 STIMULATION OF STEROIDOGENESIS
1.3.1 The hypothalamic-pituitary-adrenal axis
The major hormonal stimulus to glucocorticoid secretion from the adrenal cortex is
adrenocorticotropin (ACTH), a 39-amino acid peptide derived from proopiomelanocortin
(POMC). The most potent adrenocortical agonist known, ACTH has been reported to
stimulate glucocorticoid secretion from isolated adrenocortical cells at concentrations as
low as 10"16M (Seelig & Sayers, 1973). In addition to its steroidogenic effect on both
Cortisol and aldosterone secretion, ACTH also increases blood flow through the adrenal
by inducing vasodilatation of the adrenocortical blood vessels (reviewed in Vinson et al,
1985). Long term ACTH treatment induces both hypertrophy and hyperplasia of
adrenocortical cells, and is associated with a marked depletion of cellular lipid and
reduction in adrenocortical cholesterol content.
Synthesised within, and released from, the basophilic corticotrophs of the anterior
pituitary, ACTH secretion is regulated almost exclusively by corticotropin- releasing
hormone (CRH), a 41-amino acid peptide whose structure was not identified until 1981
(Spiess et al, 1981). Within the CNS, CRH is found mainly within the parvocellular
region of the hypothalamic paraventricular nucleus (PVN). These neurons form dense
projections to the median eminance, where neurally-released CRH gains access to the
hypothalamohypophysial portal system and thus to the pituitary. In addition,
immunoreactive CRH has been detected in many other brain areas and peripheral tissues
including cerebral cortex, limbic system, brainstem nuclei, lung, adrenal medulla, gut and
testes, where the peptide is thought to act as a neurotransmitter (reviwed in Owens &
Nemeroff, 1991).
CRH stimulates the release of pituitary ACTH (and other POMC-derived peptides such as
p-endorphin) both in vitro (Vale et al, 1983) and in vivo (Donald et al, 1983). In
addition, a trophic action of CRH on pituitary corticotrophs has been reported (Westlund
et al, 1985; McNicol et al, 1988). It is generally agreed that these actions are mediated
by a single class of CRH receptor positively coupled to adenylyl cyclase (Ur &
Grossman, 1992), although stimulation of phosphatidylinositol hydrolysis has been
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reported to occur in response to CRH in rat hypothalamic slices (Owens & Nemeroff,
1991).
(i) Regulation of CRH release
The secretion of CRH is influenced by a complex interaction of nervous and humoral
factors. Immunocytochemical studies (reviewed by Ownes & Nemeroff, 1991) have
provided evidence for synaptic connections between CRH-containing neurones in the
PVN and noradrenergic, adrenergic, cholinergic, serotonergic, dopaminergic and
GABAergic fibres arising from higher brain centres, as well as possible autoregulatory
interactions between CRH neurones themselves. The effects of acetylcholine,
noradrenaline and serotonin appear to be stimulatory (Tsagarakis et al, 1988; Calogero et
al, 1989), whereas those of GABA are inhibitory (Ur & Grossman, 1992). The secretion
of CRH is also inhibited by other components of the HPA axis. Thus, both
glucocorticoids and ACTH, as well as CRH itself, inhibit the release of hypothalamic
CRH, representing long, short and ultrashort feedback loops respectively (Calogero et al,
1988).
(ii) Regulation ofACTH release
Although CRH is the major stimulus to ACTH secretion in most species, other
neuropeptides possess ACTH-releasing activity and may be important in the regulation of
the HPA axis either alone, or in concert with CRH. For example, arginine vasopressin
(AVP) weakly stimulates ACTH release by itself, but exerts a marked synergism with
CRH in this respect (Gillies et al, 1982; Fischman & Moldow, 1984). Similar
potentiation of the effects of CRH have also been observed with oxytocin, angiotensin II,
neuropeptide Y and the intestinal peptide PHI-27 (Gibbs et al, 1984; Schoenenberg et al,
1987; Koenig, 1990; Tilders et al, 1984). It should be noted that in ovine species, AVP
rather than CRH appears to be the major stimulus to ACTH secretion (Familari et al,
1989).
(iii) Regulation of CRH and ACTH release by glucocorticoids
Circulating glucocorticoids exert a negative feedback influence at various sites within the
HPA axis. Glucocorticoid receptors exist on CRH-containing neurons in the
hypothalamic PVN (Uht et al, 1988), and stress-induced increases in hypophysial portal
vessel CRH concentration can be blocked by dexamethasone treatment or increased
19
plasma corticosterone concentration (Plotsky & Vale, 1984; Plotskey et al, 1986). In
addition, evidence exists to suggest that glucocorticoid receptors in higher brain centres
such as the hippocampus may be involved in the negative feedback of glucocorticoids on
CRH release (Sapolsky et al, 1989).
Glucocorticoid feedback inhibition of ACTH secretion also occurs at the level of the
pituitary, and comprises two phases: a rapid onset inhibition (occuring within hours) of
CRH-stimulated, but not basal, ACTH secretion, and a slower component (days) during
which both basal and CRH-stimulated ACTH secretion are impaired (see Ur &
Grossman, 1992). This long-term effect is associated with a decrease in pituitary CRH
receptor number (Hauger et al, 1987). The interactions between the various components
of the HPA axis are shown diagramatically in Figure 1.6.
1.3.2 The intra-adrenal CRH-ACTH axis
Recent observations have suggested the presence of both CRH and ACTH within the
adrenal gland itself, confined mainly to the adrenal medulla, raising the possibility that
the adrenal gland may possess an active CRH-ACTH system which may be involved in
the regulation of steroidogenesis. CRH-like immunoreactivity has been observed in
human phaeochromocytoma tissue and bovine adrenal medulla (Suda et al, 1986;
Minamino et al, 1988), and the presence of ACTH within the rat adrenal gland has been
suggested by the stimulatory effects of exogenous CRH on steroidogenesis (Andreis et al,
1991). Indeed, ACTH immunoreactivity was reported in the human adrenal medulla
(Suda et al, 1986), and POMC gene expression reported in the bovine adrenal medulla
(Throne et al, 1991). That secretion of these trophic hormones may occur under
physiological conditions is suggested by the increase in adrenal vein POMC and ACTH
concentrations reported to occur on stimulation of the splanchnic nerve in the bovine
species (Jones & Edwards, 1990).
1.3.3 The renin-angiotensin system
The renin-angiotensin system (RAS) was 'discovered' almost one hundred years ago
following the observation that a saline extract of the kidney was capable of producing a
rise in blood pressure. This hypertensive renal extract was subsequently shown to contain
the enzyme renin, and later work demonstrated that renin catalysed the conversion of a
plasma protein to yield an active pressor substance. In 1940, the pressor substance was





FIGURE 1.6 : The hypothalamic-pituitary-adrenal axis. Stimulatory and inhibitory
pathways are indicated by solid and dashed lines respectively. Question marks indicate
putative interactions. Abbreviations: CNS, central nervous system; ACh, acetylcholine;
NorAdr, noradrenaline; 5HT, serotonin; GABA, y-amino butyric acid; ANP, atrial
natriuretic peptide; SubP, substance P; All, angiotensin II; AVP, arginine vasopressin;
OXT, oxytocin; NPY, neuropeptide Y; CRH, corticotropin releasing hormone; ACTH,
corticotropin.
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respectively, and in 1958 the internationally agreed nomenclature of angiotensin was
adopted.
Renin is a 42K proteolytic enzyme secreted principally by the juxtaglomerular cells of the
kidney, which store the enzyme in intracellular granules. Renin acts on a 57K plasma a2
globulin, angiotensinogen, cleaving it at the leu]0-leun bond to produce the biologically
inactive decapeptide angiotensin I (AI) (see Figure 1.10, section 1.6). AI is further
metabolised by angiotensin converting enzyme (ACE) to produce the active octapeptide
AIL ACE, located primarily in the pulmonary vascular bed, is a relatively non-specific
peptidase, and also metabolises peptide inflammatory mediators such as bradykinin. All
has a relatively short plasma half life (ca. 60 sec), being rapidly broken down by
angiotensinase peptidases to produce inactive peptide fragments.
The physiological actions of All are many and varied, and in concert act to maintain
blood pressure and volume. Next to endothelin, All is the most potent pressor substance
known (ca. 40 times more potent than noradrenaline (mol/mol)), and produces intense
vasoconstriction in most vascular beds, especially those of the skin, kidney and intestines.
All potently stimulates adrenocortical steroidogenesis, and stimulation of aldosterone
secretion can be observed at sub-constrictor doses (picomolar). All also directly
stimulates sodium reabsorption in the renal proximal tubule, and enhances sympathetic
nerve transmission by stimulating noradrenaline release from peripheral nerve endings,
stimulating tyrosine hydroxylase activity and inhibiting noradrenaline uptake into nerves.
Central effects of All contribute to this pressor activity: All reduces the vagal inhibitory
tone of the heart via stimulation of the area postrema, and promotes thirst and drinking
behaviour via All receptors located in the subfornical organ and paraventricular nuclei.
The RAS is activated in conditions of sodium depletion, hypotension and congestive
heart failure. Thus, sodium depletion stimulates release of renin and subsequent
formation of All, and the resulting increase in aldosterone secretion leads to enhanced
renal sodium resorption. The adrenal sensitivity to All is also increased through
increases in All receptor number and affinity (Aguilera et al, 1978). A fall in blood
pressure, due either to excess vasodilation or fluid loss also results in increased release of
renin. This effect is mediated by sympathetic stimulation of the renal juxtaglomerular
cells following baroreceptor inactivation, and can be mimicked by injection of (3j-
adrenergic agonists. Increased plasma renin activity due to enhanced sympathetic nerve
activity can also be measured following a change in posture from the supine to erect
position. The role of the RAS in the control of blood pressure and electrolyte
homeostasis is reviewed in Hall et al (1990).
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1.3.4 The intra-adrenal renin-angiotensin system
In 1969, a renin-like enzyme was identified in the rabbit adrenal gland (Ryan, 1969).
Since this observation, renin has been found in many tissues including ovary, testes,
uterus, pituitary, heart, vascular smooth muscle, brain and adrenal (Field et al, 1984;
Dzau et al, 1987; Suzuki et al. 1988; Deschepper et al, 1986). Since the adrenal cortex is
a major target tissue for All, much study has been made of the significance of intra-
adrenal renin. Renin has been identified in the adrenal cortex of rat, murine, canine,
bovine and human species (Ganten et al, 1974, 1976; Hayduk et al, 1970; Ryan, 1972;
Naruse et al, 1983), and the demonstration of renin mRNA in rat mouse and human
adrenal cortex suggests that adrenal renin is synthesised locally and not simply taken up
from the circulation (Deschepper et al, 1986; Field et al, 1984; Shionoiri et al, 1992).
Furthermore, in rat adrenal cortex there exists at least the potential for an active intra-
adrenal RAS since in this tissue, all the components of the peripheral RAS have been
identified (renin, prorenin, angiotensinogen, angiotensins I and II, angiotensin converting
enzyme) (Reviewed in Mulrow et al, 1988).
The physiological significance of adrenal renin has been a subject of much debate in
recent years. Localised mainly in the outer zg of the rat adrenal (Brecher et al, 1989),
increasing evidence suggests that adrenal renin release may be regulated by the same
factors which stimulate release of renal renin. Thus, adrenal renin was increased in
sodium depleted or potassium loaded rats (Doi et al, 1984). In cultured bovine zg cells,
cellular renin activity and release of renin were stimulated by catecholamines and
dibutyryl cAMP (Gupta et al, 1992). This is particularly interesting in view of the
demonstration of a sympathetic innervation of the adrenal cortex (Gilchrist et al, 1993;
Charlton et al, 1992), and the known involvement of sympathetic tone in the release of
renal renin (Osborn & Johns, 1989).
A number of observations suggest that locally synthesised renin may regulate aldosterone
secretion. In cultured rat zg cells, ACTH and potassium stimulated both aldosterone
secretion and renin activity (Yamaguchi et al, 1990). This increase in renin activity was
associated with elevated levels of renin mRNA (Wang et al, 1992). Furthermore,
lisinopril, an ACE inhibitor, reduced the aldosterone secretory response to ACTH and
potassium without affecting renin activity (Yamaguchi et al, 1990). Similar inhibitory
effects of ACE inhibitors on ACTH-stimulated aldosterone secretion have been reported
in humans in vivo (Ramirez et al, 1988).
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Less information is available regarding the renin content of zfr cells. Renin is present in
both the zg and inner zfr of the mouse adrenal cortex, and in some species of mouse is
mainly present in the zfr (Naruse et al, 1984). By contrast, rat adrenal renin is confined
to the zg (Brecher et al, 1989). Significantly, TGR (mRen-2)27 rats (rats transfected
with the Ren-2 mouse renin gene which causes severe hypertension (Mullins et al, 1990))
differ from normal rats in that their adrenal renin is elevated and present in both the zg
and zfr (Yamaguchi et al, 1992). While bovine zg cells in culture clearly synthesise renin
(Gupta et al, 1992), the renin content of the bovine inner zone is unknown. However, it
seems likely, given the centripetal nature of the adrenocortical blood supply, that All
synthesised locally within the zg would be accessible to the inner zfr, even if zfr cells do
not themselves possess an active local RAS.
1.3.5 Other factors
Until relatively recently it was widely assumed that aldosterone secretion from the zg was
controlled exclusively by the renin angiotensin system, while ACTH was considered to
be the sole stimulus to Cortisol secretion from the inner adrenocortical zones. However, it
is now becoming clear that the regulation of steroidogenesis is multifactorial, and a
variety of different hormones and neurotransmitters have been reported to stimulate (or
inhibit) adrenocortical steroidogenesis (reviewed in Tait et al, 1980a; Bird et al, 1990b).
Table 1.2 summarises reported agonist effects on steroidogenesis in adrenocortical
preparations. It is emphasised that the data in Table 1.2 represents a compilation of
results from in vitro and in vivo studies in several species, and is intended only to
illustrate the wide variety of agonists which are capable of stimulating steroidogenesis.
Several important species differences exist. For example, serotonin stimulates
aldosterone secretion from rat, but not bovine zg cells, and angiotensin II is a potent
stimulus for bovine, but not rat zfr cells. A more detailed consideration of agonist effects
on steroid secretion and second messenger formation in bovine adrenocortical cells is
given in Table 1.3.
With the exception of potassium, which stimulates aldosterone secretion through a
receptor-independent mechanism, the agonists detailed in Table 1.3 stimulate
steroidogenesis by activating either the adenylate cyclase/cAMP signalling system or the
inositol phosphate/calcium signalling system. Rather than consider each agonist in turn,
the general mechanisms by which activation of adenylate cyclase and stimulation of
phosphatidylinositol turnover lead to increased steroidogenesis will be considered. More
detailed descriptions of the mechanisms by which acetylcholine and angiotensin II
stimulate steroidogenesis in adrenocortical cells will follow in sections 1.5 and 1.6.
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TABLE 1.2
Agonist Steroidogenesis Comments Reference
mineral. Glucocort.
ACTH + + In all species studied 1,2
All + + Not steroidogenic in rat/ovine
zfr cells. Via AT] receptor in
bovine zg
1-3









{ Not steroidogenic in rat zfr cells
{
(Via (31 receptor in bovine zfr cells
7-9,55
Serotonin + + 5HT4 receptor-mediated effect
on Cortisol in human tissue and
corticosterone in frog tissue
10-12,
19,20
Dopamine - 7 Inhibits agonist-stimulated
aldosterone secretion in rat and
bovine zg cells
13-15
AVP + + Stimulates aldosterone in rat and
bovine zg, Cortisol in bovine zfr. AVT
stimulates corticosterone in frog
16-18
Adenosine ? - Inhibits basal and ACTH-stimulated
corticosteroid in rat via A\ receptor
49
ATP + + Stimulates cAMP and Ca2+ in bovine
zfr cells
48,50,51
ANF - - Potently inhibits All-stimulated
aldosterone in rat and bovine zg.
Inhibits Cortisol in bovine zfr
21-24
BNP - - In cultured bovine and human
adrenocotncal cells
24,25
Substance P - (rat) + Ca2+/calmodulin dependent in BAC.



















Tonic inhibitory effect on
aldosterone in rat zg both 29-32
in vitro and in vivo
Stimulates both rat zg and zfr
cells. Linked to cAMP in bovine 33-36
zg cells
Possibly via release of medullary 37-39
catecholamines in intact rat gland
In rat, bovine and human zg and zfr 40-45
cell suspensions
In cultured BAC 27
Inhibits basal and ACTH-stimulated
aldosterone/18-OH corticosterone in 28,46
isolated rat zg cells.
Potentiated ACTH- and a-MSH-
stimulated corticosterone in rat zfr 35,47
cells
In rat and bovine zg cells 36
Prostaglandin-dependent stimulation
of corticosterone in rat adrenocortical 52,53
cells. Not steroidogenic in bovine zfr
Stimulates aldosterone in bovine zg 54
cells. Also synergistic with All
TABLE 1.2 : Reported agonist-stimulated steroidogenic responses of adrenocortical
preparations. Original references are given overleaf. Abbreviations: ACTH,
adrenocorticotropin; All, angiotensin II; AVP, arginine vasipressin; AVT, arginine
vasotocin; ATP, adenosine trisphosphate; ANF, atrial natriuretic factor; BNP, brain
natriuretic peptide; a-MSH, a-melanocyte-stimulating hormone; VIP, vasoactive
intestinal peptide; NKA/B, neurokinin A/B; NPY, neuropeptide Y; PTH, parathyroid




1. Aguilera ,1993 46.
2. Bird et al, 1990b 47.
3. Balla et al, 1991 48.
4. Rosenfield, 1955 49.
5. Kojima et al, 1986a 50.
6. Walker etal, 1990 51.
7. De Lean et al, 1984 52.
8. Walker et al, 1988 53.
9. Shima et al, 1984 54.
10. Albano et al, 1974 55.
11. Tait etal, 1980a
12. Lefebvre et al, 1992
13. Aguilera & Catt, 1984
14. Braley et al, 1983
15. Stern et al, 1986
16. Balla et al, 1985b
17. Bird et al, 1990a
18. Hinson et al, 1987
19. Idres et al, 1991
20. Davies et al, 1991
21. Elliot & Goodfriend, 1986
22. Barrett era/, 1991
23. Isales et al, 1992
24. Nawata et al, 1991
25. Hashiguchi etal, 1989
26. Yoshida et al, 1992a
27. Yoshida et al, 1992b
28. Neri et al, 1990
29. Jones et al, 1984
30. Mazocchi et al, 1992
31. Kasprzak et al, 1991
32. Hausdorff et al, 1989
33. Kapas et al ,1992
34. Mazzocchi etal, 1987
35. Szalay& Folly, 1992
36. Ganguly et al, 1989
37. Cunningham & Holzwarth, 1989
38. Ehrhart-Bornstein et al, 1991
39. Hinson et al, 1992
40. Zeng et al, 1992
41. Imai etal, 1992a
42. Hinson et al, 1991a
43. Hinson et al, 1991b
44. Mazzocchi et al, 1990




Feuilloley et al, 1992
Kawamura et al, 1991
Matsui, 1991
Tominaga et al, 1991
Hanley et al, 1992
Isales et al, 1991
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+, stimulatory effect; inhibitory effect; 0, no effect; ?, no data available
TABLE 1.3 : Acute steroid and second messenger responses in purified bovine
adrenocortical cell preparations. Original references are given overleaf. Abbreviations;
ACTH, adrenocorrictropin; ANP, atrial natriuretic peptide; All, angiotensin II; adr,
adrenaline; ACh, acetylcholine; AVP, arginine vasopressin; ATP, adenosine




1. Taker a/, 1980a
2. Aguilera, 1993
3. Marie & Jard, 1983
4. Bird etal, 1989
5. Hadjian et al, 1984b
6. Vallotton et al, 1981
7. Bird et al, 1988
8. DeLean etal, 1984
9. Walker etal, 1988
10. Williams etal, 1989
11. E. Davies & B.C. Williams, unpublished observations
12. McKennaera/, 1979
13. Ganguly et al, 1989
14. Kojima etal, 1986a
15. Hadjian et al, 1982
16. Walker etal, 1990
17. Hadjian etal, 1984a
18. Bird etal, 1990a
19. McFarland et al, 1991
20. G. Dell, personal communication
21. Nitsu et al, 1992
22. Hoey et al, 1994
23. Kojima etal, 1985e
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1.3.6 Adenylate cyclase
Numerous hormones and neurotransmitters exert their cellular effects by increasing the
levels of the intracellular second messenger cAMP in their target cells. The concentration
of cAMP is regulated by two separate enzymes: adenylate cyclase, which catalyses the
formation of cAMP from ATP, and cAMP-specific phosphodiesterase, which breaks
down cAMP to form 5'AMP. Increased levels of cAMP lead to the activation of cAMP-
dependent protein kinases, which in turn increase protein phosphorylation, resulting in the
measured cellular response.
Hormonally-regulated adenylate cyclase, first described by Sutherland and co-workers
(Robison et al, 1967), is a ubiquitous multicomponent system comprised of five
functional units (Figure 1.7). The transmembrane catalytic unit which hydrolyses ATP is
linked to agonist receptors which either stimulate the enzyme via a stimulatory G protein
(Gs) or inhibit it via an inhibitory G protein (G;). Gs and G1 are each composed of three
subunits a, (3 and y. The (3 and y subunits of both Gs and Gt are highly homologous
(Hildebrandt et al, 1984) and exist as tightly associated complexes. The a subunits,
though also highly homologous, are structurally different, and the identity of the various
a subunits are used to define a given G protein heterotrimer. At present, 12 different a
subunits of Gs or G, have been characterised, of which two are known to stimulate
adenylate cyclase (as(s) and aolf), and two to inhibit the enzyme (ai3 and az) (Hepler &
Gilman, 1992). The a subunits of the Gs family are targets for ADP-ribosylation by
cholera toxin, while those of the G1 family can be ADP-ribosylated by pertussis toxin
(although au and aa, which stimulate cGMP-specific phosphodiesterase, appear to be
susceptible to both toxins (Hepler & Gilman, 1992)). The mode of coupling of adenylate
cyclase to stimulatory hormone receptors is reviewed in detail in Levitzki (1986).
Agents known to stimulate adrenocortical steroidogenesis via adenylate cyclase include
ACTH and (3-adrenergic agonists (Table 1.3). However, the majority of information
regarding the mechanism of cAMP-induced steroidogenesis in adrenocortical cells, has
come from the study of ACTH.
1.3.7 Mechanism ofaction ofACTH in adrenocortical cells
Numerous studies have established that ACTH increases the concentration of cAMP in
adrenocortical cells, through activation of adenylate cyclase (Tait et al, 1980a). The
principal locus of the steroidogenic action of ACTH is the conversion of cholesterol to



















FIGURE 1.7 : Structure of hormonally regulated adenylate cyclase. Steroidogenic
agonists such as ACTH interact with stimulatory receptors (Rs) which activate the
enzyme catalytic unit (C) via a pertussis toxin-insensitive G protein (Gs). The enzyme
can also be inhibited by agents which interact with receptors linked to inhibitory G
proteins (Gi). cAMP thus formed on activation of stimulatory receptors stimulates
cAMP-dependent protein kinases, eventually leading to activation of steroidogenesis.
Steroidogenic enzymes known to be phosphorylated in response to adenylate cyclase
agonists include cholesterol esterase (C.£.), cholesterol ester synthetase (C.E. synthetase)
and P450 side-chain cleavage (P450scc).
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pathway (Stone & Hechter, 1955). The effects of increased intracellular cAMP levels in
response to ACTH are reviewed in Tait et al (1980a) and Hornsby (1988), and include
phosphorylation of cholesterol esterase and cholesterol ester synthetase, leading to the
respective activation and inactivation of these enzymes and a consequent increase in the
availability of free cholesterol from cholesterol ester, enhancement of cholesterol
transport into mitochondria, and facilitation of cholesterol binding to P450scc. In
addition, ACTH has been reported to enhance the release of newly-formed pregnenolone
from P450scc. These effects of ACTH are believed to be mediated by a cAMP-
dependent protein kinase, since protein phosphorylation is an early event in the
steroidogenic action of ACTH (Koroscil & Gallant, 1980; Bristow et al, 1981; Mikami &
Strott, 1986). Indeed, inhibitors of protein kinase A dose-dependently inhibit the
aldosterone-secretory response of rat zg cells (Kurscheid-Reich et al, 1992). However,
the exact substrates for protein kinase-mediated phosphorylation have not been identified,
although several phosphoproteins have been proposed as candidates. For example, a 28K
phosphoprotein was identified in rat adrenal cortex mitochondria which was produced
with a time course and concentration-dependence similar to that of ACTH-stimulated
aldosterone secretion (Epstein et al, 1989). ACTH-stimulated phosphorylation of a
cytoplasmic protein (APS 150) has also been reported (Podesta et al, 1979).
These acute actions of ACTH are confined to the P450scc-mediated synthesis of
pregnenolone. ACTH does however exert long-term chronic effects directly at the level
of the steroidogenic enzymes. The production of P450scc mRNA in bovine
adrenocortical cells is abolished in the absence of ACTH (DuBios et al, 1981). Thus, the
presence of ACTH appears to be necessary for P450scc synthesis. Indeed, both ACTH
and cAMP stimulate the accumulation of P450scc mRNA in bovine adrenocortical cells
(Simonian et al, 1979b). ACTH has also been reported to stimulate the synthesis of other
steroidogenic enzymes including P450c21, P450cll, P450cl7 and adrenodoxin in bovine
adrenocortical cells, and increase mRNA levels for P450scc and P450cl7 in human foetal
adrenal cells (reviewed in Miller, 1988).
1.3.8 Adrenocortical ACTH receptors
The identification and characterisation of adrenocortical ACTH receptors has been
hampered in the past by the relatively low biological activity of radiolabeled ACTH.
More recently, the availability of 125I-labelled ACTH analogues has allowed the
identification of ACTH binding sites in adrenocortical preparations from several species
including rat, sheep, cattle and human (Penhoat et al, 1991 and references therein). The
binding affinity of ACTH was found to be similar in these preparations (KD=0.2 nM). A
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second low affinity/high capacity binding site (KD=2-10nM) has been reported in rat
(Gallo-Payet & Escher, 1985) and bovine (Penhoat et al, 1989) adrenal cortex, although
this remains controversial (Penhoat et al, 1991).
A second approach to the characterisation of ACTH receptors has been covalent cross-
linking of 125I-ACTH with disuccinimidyl suberate to adrenocortical preparations. Such
studies have shown the ACTH receptor of bovine zff cells and human adrenal cortex
membranes to be a membrane-associated protein of Mr=43kD (Penhoat et al, 1993). In
bovine adrenal cortex membrane fractions, affinity labelling experiments identified an
ACTH-binding protein of Mr=40kD (Mizuno et al, 1989). Although these studies
provide a first step for the purification and cloning of the ACTH receptor, this has proved
to be extremely difficult, since solubilisation of the receptor destroys its ligand binding
capability.
The ACTH receptor was cloned by Mountjoy et al (1992) who performed polymerase
chain reaction using cDNA from a human melanoma rich in MSH receptors. Two clones
were identified which encoded functional MSH and ACTH receptors respectively. The
ACTH receptor, although containing the seven predicted transmembrane domains
characteristic of the G protein-coupled receptor superfamily, represents the smallest such
receptor thus far cloned, at 297 amino acids. This predicted amino acid sequence
corresponds to a protein of around 35kD, suggesting that the biochemical studies
discussed above identified the glycocylated form of the receptor. Functional coupling to
adenylate cyclase was demonstrated in Cloudman S91 cells transfected with human
ACTH receptor DNA, which showed a ten-fold elevation of cAMP in response to
physiological concentrations of ACTH (InM) (Mountjoy et al, 1992). Expression of
ACTH receptor mRNA in rhesus monkey adrenal gland was concentrated in the zf, but
also present in the zr and inner regions of the zg. No receptor mRNA was detected in the
capsule or medulla.
1.3.9 Phosphatidylinositol metabolism
The understanding of the cellular mechanisms involved in the steroidogenic action of
ACTH and other agonists which stimulate adenylate cyclase advanced markedly during
the 1970s and 1980s, and the relationships between hormone stimulated cAMP
generation and activation of steroidogenesis became clear. However, it was observed that
some agonists stimulated steroidogenesis without increasing cAMP levels, but with an
accompanying increase in the concentration of intracellular calcium (fCa2+]i). At this
time, the involvement of phosphoinositide turnover in the cellular action of agonists in
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other systems was established, and it was accepted that at least two independent
mechanisms, adenylate cyclase and phosphatidylinositol turnover, were involved in the
regulation of adrenocortical steroidogenesis.
Hormone-stimulated metabolism of membrane phosphoinositides was first described by
Hokin and Hokin (1953), who demonstrated increased incorporation of 32P into
phospholipids in response to ACh in the pancreas. The link between this metabolism of
phospholipids and agonists which stimulate increases in [Ca2+]i was made by Michell
(1975), and the importance of inositol 1,4,5-trisphosphate (Ins(l,4,5)P3) in regulating
intracellular Ca2+ was established (Irvine & Berridge, 1984).
The major pathways of phosphoinositide metabolism are shown in Figure 1.8.
Phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2), a minor membrane phospholipid
accounting for less than 1% of total cellular inositol (Michell et al, 1970), is produced by
a two-stage phosphorylation of phosphatidylinositol (Ptdlns), and dephosphorylated by
specific phosphomonoesterases, creating a dynamic equilibrium between Ptdlns,
phosphatidylinositol 4 phosphate (PtdIns4P) and PtdIns(4,5)P2. PtsIns(4,5)P2 is rapidly
degraded by the action of hormone-sensitive phospholipase C during agonist activation of
receptors to form the second messengers Ins(l,4,5)P3 and diacylglycerol (DAG).
Ins(l,4,5)P3 is rapidly inactivated by sequential dephosphorylation by intracellular
phosphatases to form free inositol via Ins(l,4)P2 and Ins(4)P. Alternatively, Ins(l,4,5)P3
can be further phosphorylated to inositol tetrakisphosphate (Ins(l,3,4,5)P4) before
dephosphorylation via Ins(l,3,4)P3, Ins(l,4)P2 and Ins(3)P to form free inositol. The final
dephosphorylation of the inositol monophophosphates to free inositol can be inhibited by
lithium, the inclusion of which in experimental media allows the accumulation of inositol
phosphates for assay. DAG is converted via phosphatidic acid (PA) to cytidine
diphosphodiacylglycerol (CDP-DAG) which combines with free inositol to reform
Ptdlns. Thus, although stimulation of phospholipase C results in increased breakdown of
PtdIns(4,5)P-,, the net effect is to increase phosphoinositide turnover, rather than to
decrease phosphoinositide mass.
The cleavage of PtdIns(4,5)P2 by PLC results in the formation of two independent
intracellular second messengers, Ins(l,4,5)P3 and DAG, which act to mobilise [Ca2+]l and









FIGURE 1.8 : Phosphoinositide metabolism in adrenocortical cells. Phospholipase C
(PLC), activated in response to receptor (R) occupancy via a stimulatory G protein (G),
hydrolyses phosphatidylinositol(4,5) bisphosphate (PtdIns(4,5)P2) to produce the second
messengers inositol (1,4,5) trisphosphate (Ins(l,4,5)P3) and diacylglycerol (DAG).
Ins(l,4,5)P3 is recycled back to free inositol (Ins) by sequential
phosphorylation/dephosphorylation, the final steps of which are inhibited by lithium
(dotted lines). DAG is recycled through conversion to phosphatidic acid (PtdOH) and
cytidine diphosphodiacylglycerol (CDP-DAG), which combines with free inositol to
reform phosphatidylinositol (Ptdlns). The aqueous phosphoinositols and free inositol are
cytosolic; all other species shown here are associated with the plasma membrane.
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1.3.10 Ins(l ,4y5)P-s and. Ca2+ mobilisation
Calcium mobilising agonists frequently stimulate a biphasic Ca2+ response in target cells.
The initial response, a transient mobilisation of Ca2+ from intracellular stores, is followed
by a more sustained influx of extracellular Ca2+. Inositol phosphates are thought to play a
role in both phases of Ca2+ mobilisation.
The link between Ins(l,4,5)P3 and Ca2+ mobilisation was established in 1983. Addition
of Ins(l,4,5)P3 to permeablised pancreatic cells resulted in the release of Ca2+ from
endoplasmic reticulum (Sterb et al, 1983). Many subsequent cell fractionation studies
have confirmed that Ins(l,4,5)P3 releases Ca2+ from a membrane fraction derived
exclusively from the endoplasmic reticulum (Rana & Hokin, 1990) The size of the
Ins(l,4,5)P3-sensitive Ca2+ pool appears to vary markedly between cell types from around
20% of endoplasmic reticular Ca2+ in adipocyte membrane fractions (Delfert et al, 1986)
to around 90% in permeablised insulinoma (RINm5F) cells (Prentki et al, 1985).
Ins(l,4,5)P3 mobilises Ca2+ by binding to specific receptors which promote the opening
of endoplasmic reticulum Ca2+ channels. The Ins(l,4,5)P3 receptor undergoes a
conformational change on binding of Ins(l,4,5)P3 which is thought to be involved in the
coupling of the receptor to Ca2+ channel opening (Berridge, 1993). It has been estimated
that the binding of one Ins(l,4,5)P3 molecule promotes the release of around 20 Ca2+ ions
(Joseph et al, 1984).
The sustained rise in [Ca2+]1 observed on agonist stimulation occurs via influx of
extracellular Ca2+. Although Ins(l,4,5)P3 does not itself promote Ca2+ release from
plasma membrane vesicles (Delfert et al, 1986), there is evidence that its metabolite
Ins(l,3,4,5)P4 may directly stimulate Ca2+ influx. Injection of Ins(l,3,4,5)P4 into sea
urchin (Lytechninus variegatus) eggs resulted in the immediate elevation of the
fertilisation envelope, a process known to require the presence of extracellular Ca2+
(Irvine & Moor, 1986). Since Ins(l,4,5)P3 is converted to Ins(l,3,4,5)P4 by the action of
a Ca2+-sensitive calmodulin-dependent 3-kinase, the direct stimulation of Ca2+ influx by
Ins(l,3,4,5)P4 represents a Ca2+-induced Ca2+ entry.
It has also been argued that Ins(l,4,5)P3 may stimulate Ca2+ influx indirectly through its
effect on intracellular Ca2+ stores. The endoplasmic reticulum is functionally connected
to the plasma membrane in many cell types, and extracellular Ca2+ has been demonstrated
to flow into the endoplasmic reticulum when its store becomes depleted (Putney, 1986).
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Thus, Ins(l,4,5)P3, by depleting intracellular Ca2+ stores, may itself promote an influx of
extracellular Ca2+.
1.3.11 Diacylglycerol and protein kinase C activity
The other product of PLC-mediated hydrolysis of PtdIns(4,5)P2 is DAG, which acts as an
intracellular messenger by stimulating PKC. PKC is a family of enzymes (PKC a, (3,, (3n
and y) which play a key role in the initiation and modulation of receptor-mediated cellular
responses through the phosphorylation of specific intracellular proteins. PKC requires
Ca2r and phospholipid for activity, and DAG acts to stimulate the enzyme by modulating
its affinity for Ca2+ and phosphatidylserine (Nishizuka. 1984). Activation of PKC is
associated with the Ca2+-dependent translocation of the enzyme from the cytosol to the
membrane, a process thought to prime the enzyme to the stimulatory effects of DAG.
It has proved extremely difficult to identify the exact substrates for PKC, although at least
18 endogenous proteins and 8 receptors have been proposed as targets for
phosphorylation by PKC (Niedel & Blackshear, 1986).
Tumour-promoting agents such as phorbol-12-myristate-13-acetate (PMA) mimic the
action of DAG, binding with high affinity to the regulatory region of the enzyme,
strongly activating it (Nishizuka, 1984). Phorbol esters have been used extensively in the
study of PKC, and, when administered concurrently with a Ca2+ ionophore such as
A23187, can mimic the cellular effects of PLC agonists.
1.3.12 Mechanism of action in adrenocortical cells
Compared to the adrenocortical adenylate cyclase/cAMP signalling system, relatively
little is known regarding the transduction of the Ins(l,4,5)P3/DAG signal to the activation
of steroidogenesis. The metabolic pathways outlined in Figure 1.8 have been shown to
occur in adrenocortical cells (reviewed in Bird et al, 1990b). In particular, the enzymatic
activities necessary for the rapid removal of Ins(l,4,5)P3, namely 3-kinase and 5-
phosphatase, have been demonstrated in both rat and bovine zg cells (Balla et al, 1988;
Rossier et al, 1986), and the DAG kinase and Ptdlns synthetase enzymes required for
metabolism of DAG are present in adrenocortical cells (Bird et al, 1990b). Specific high-
affinity binding sites for both Ins(l,4,5)P3 and Ins(l,3,4,5)P4 exist in bovine adrenal
cortex (Baukal et al, 1985; Rossier et al, 1986), and PKC activity has been identified in
both bovine adrenal cortex membranes and rat zfr cells (Coyne et al, 1987; Widmaier &
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Hall. 1985). Thus, the enzymatic machinery necessary for Ins(l,4,5)P3 and DAG to act as
second messengers is present in adrenocortical cells.
The mechanism by which Ins(l,4,5)P3 and DAG stimulate steroidogenesis has been most
studied in zg cells, which secrete aldosterone in response to angiotensin II via increased
Ptdlns turnover (see section 1.6.4). In superfused bovine zg cells, neither administration
of the Ca2+ ionophore A23187 nor of the phorbol ester 12-0-tetradecanoylphorbol-13-
acetate (TPA) alone could reproduce the steroidogenic effect of All in full; the effect of
A23187 was transient, whereas that of TPA was slower and of much lower magnitude
than that of All (Kojima et al, 1984). The prolonged stimulatory action of All could,
however, be reproduced by co-administration of A23187 and TPA, indicating that both
sustained activation of PKC and Ca2+ influx are necessary for stimulation of
steroidogenesis by PLC agonists (Kojima et al, 1984). In the same preparation,
administration of nitrendipine, which blocks Ca2+ influx through plasma membrane Ca2+
channels in adrenocortical cells (Kojima et al, 1985a), abolished the sustained
steroidogenic effect of All but had no effect on the initial transient rise in aldosterone
secretion in response to All (Kojima et al, 1985b,d). Thus, the sustained stimulation of
steroidogenesis by PLC agonists requires the sustained influx of extracellular Ca2+.
This sustained Ca2+ influx may depend on phosphorylation of plasma membrane Ca2+
channels by PKC. At least nine different proteins were phosphorylated in response to All
in bovine zg cells (Barret et al, 1986b). The pattern of phosphorylation was mimicked by
the combined administration of A23187 and TPA. Furthermore, the early (1 min)
phosphorylation events were reproduced by A23187 but not by TPA, whereas the
converse was true for the late (30 min) phosphorylation events (Barret et al, 1986b).
Villgrain et al (1984) have shown that PKC can selectively phosphorylate purified
P450scc at specific serine and threonine residues. Furthermore, both P450scc and PKC
were found to be present in bovine adrenocortical mitochondria. Thus, the rate limiting
step in the steroidogenic pathway may be subject to regulation by PLC agonists via a
mechanism analogous to that of adenylate cyclase agonists.
1.4 DISEASES OF THE ADRENAL CORTEX
Acute deficiency of adrenocortical hormones is fatal if untreated. Such deficiency may
arise from bilateral adrenalectomy, or from Addisonian crisis (see below). Symptoms of
glucocorticoid deficiency include muscle weakness, gastrointestinal disturbances and
impaired resistance to infection. Plasma ACTH levels are elevated due to the absence of
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cortisol-mediated negative feedback effects at the pituitary. Chronic deficiency of
mineralocorticoids results in fluid loss, reduced plasma sodium concentration and parallel
increased plasma potassium leading to hypotension. Glucocorticoid excess is
characterised by fat deposition around the abdomen and neck, loss of fat around the
limbs, impaired immune function, susceptibility to bruising and osteoporosis. There is
frequently hypertension due to the weak mineralocorticoid effects of Cortisol.
Mineralcorticoid excess results in sodium retention and potassium loss with consequent
hypertension and alkalosis.
The clinical manifestation of adrenocortical insuficiency is Addison's disease. Formerly
a common complication in tuberculosis, Addison's disease is now more usually associated
with autoimmune disorders. While plasma Cortisol levels are usually low, ACTH and
pituitary peptide levels are extremely high (primary adrenocortical insuficiency), leading
to skin pigmentation. Treatment is by hormone replacement, both glucocorticoid (eg.
dexamethasone) and mineralcorticoid (eg. fludrocortisone). Secondary adrenocortical
insufficiency is caused by pituitary disease resulting in impaired ACTH secretion.
Inappropriately elevated levels of Cortisol results in Cushing's syndrome. Plasma Cortisol
is high at all times (ie. no diurnal rhythm), and usually unaffected by dexamethasone.
Causes of Cushing's syndrome include adrenocortical tumours, in which ACTH is
suppressed (common in children), pituitary tumours, in which ACTH is elevated and
drives the cortex (common in adults), ectopic production of ACTH (eg. from lung
tumours), and possibly alcohol-related factors. Treatment includes surgical removal of
tumours, if possible, or bilateral adrenalectomy with replacement therapy.
Mineralcorticoid excess associated with low plasma renin activity is termed primary
aldosteronism, or Conn's syndrome. This is usually caused by an adrenocortical
ademoma, and results in hypertension with hypokalemia. The exact incidence of Conn's
syndrome is unknown, but it has been estimated to account for up to 1% of all cases of
hypertension. Treatment is either unilateral adrenalectomy, if only one adrenal is
involved, or administration aldosterone antagonists such as spironolactone.
Several genetic diseases of the adrenal cortex have been described, of which the most
common is 21-hydroxylase deficiency. This results in an inability to synthesise Cortisol
or aldosterone, and is associated with elevated plasma ACTH and consequent adrenal
hyperplasia. Since androgen synthesis is unaffected, this excessive drive to the cortex
causes increased androgen secretion resulting in virilisation in females and early sexual
development in males. Treatment is by replacement therapy.
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1.5 ACETYLCHOLINE
1.5.1 Synthesis and metabolism
Acetylcholine (ACh), first described in 1900, was originally identified as an adrenal
gland extract capable of producing a fall in blood pressure in the rabbit following removal
of the hypertensive adrenaline from the extracts. ACh is now known to act as a
neurotransmitter released from postganglionic parasympathetic nerve endings,
parasympathetic and sympathetic ganglionic synapses, voluntary smooth muscle motor
endplate and sympathetic nerve endings in the adrenal medulla. Stimulation of these
systems produces a huge variety of effects, primarily affecting cardiac, visceral, ocular
and endocrine tissues.
Within nerve endings, ACh is svnthesised from free choline and acetyl Co-A by the
action of the axoplasmic enzyme choline acetyl transferase. Choline is synthesised
mainly in the liver, and taken up from the plasma into the neuron by an active
mechanism. Acetyl CoA, formed in the mitochondria through the tricarboxylic acid
(TCA) cycle, is impermeable to the mitochondrial membrane, and is transported from the
mitochondria to the cytosol as citrate (Figure 1.9). ACh is stored in synaptic vesicles, and
released on arrival of a nerve impulse by exocytosis. Free ACh within the synaptic cleft
is hydrolysed by acetylcholinesterase (AChE), located within the cholinergic synaptic
cleft. Although several rather non-specific cholinesterase enzymes, such as
butyrylcholinesterase (BuChEe) exist, only AChE is particularly associated with nerve
endings, and is much more specific for ACh. AChE is therefore a useful marker for the
identification of cholinergic innervation.
In 1914, Dale classified the actions of ACh as muscarinic and nicotinic, based on the
ability of the natural compounds muscarine and nicotine to reproduce the actions of ACh.
This distinction subsequently led to the recognition of muscarinic and nicotinic receptor
subtypes.
1.5.2 Muscarinic acetylcholine receptor subtypes
Muscarinic receptors were originally shown to be heterogeneous based on the ability of
pirenzepine to discriminate between binding sites in different tissues (Hammer et al,
1980). Those sites exhibiting high affinity for pirenzepine (in the brain) were termed M,,
while the lower affinity receptors in peripheral tissues were termed M2 receptors



















FIGURE 1.8 : Synthesis of acetylcholine in nerve terminals. Abbreviations: AChE,
acetylcholinesterase; CoA, coenzyme A; cat, choline acetyltrasferase; cl, citrate lyase;
cs, citrate synthase
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M2(glandular)), which resulted in some confusion until the internationally accepted
nomenclature of M,, M2 and M3 was adopted, where M2 refers to the old M2a/M-,(cardiac)
classification, and M3 refers to M2(3/M2 (glandular) (see Table 1.4). None of the currently
available specific muscarinic antagonists is completely selective for a given receptor
subtype, and antagonist affinity ratios between subtypes rarely exceed ten. The
pharmacological classification of muscarinic receptor subtypes therefore requires
estimation of the affinity of a range of selective antagonists. Such antagonists include
pirenzepine (M, > M2 = M3) (Hammer et al. 1980), methoctramine (M2 > > M3)
(Melchiorre et al, 1987), hexahydro-sila-difenidol (HHSD) (M, = M3 > M2) (Fuder et al,
1985) and p-fluoro-hexahydro-sila-difenidol (p-FHHSD) (M3 > M, = M2) (Lambrecht et
al, 1988).
Other putative receptor subtypes have been proposed. Differences in antagonist effects
have been observed between hippocampal and ganglionic M, receptors, termed Mlot and
M,p respectively (Mei et al, 1989). McN-A-343, an Mj-selective agonist, was much
more potent in stimulating activity at M](J than at M)a receptors. A further receptor
subtype has been proposed (M4) exhibiting high affinity for pirenzepine and AF-DX-116
(Lazareno et al, 1990; Garcia-Villalon et al, 1991). This putative M4 receptor is
distinguished from the M, receptor by its high affinity for himbacine (Caulfield & Brown,
1991).
Five genes encoding distinct muscarinic receptors have been cloned (ml-m5, see Table
1.4) (Bonner et al, 1987,1988; Peralta et al, 1987; Liao et al, 1989). The deduced amino
acid sequences show high homology between the subtypes, and each exhibits seven
hydrophobic regions of 20 - 30 amino acids which are assumed to be the transmembrane
regions common to other G protein-linked receptors (Bonner, 1989). The antagonist
binding profiles of the cloned receptors expressed in mammalian cells or Xenopus
oocytes have shown that the ml-m4 gene products correlate with the pharmacologically-
defined M,-M4 receptors (Buckley et al, 1989; Tietje et al, 1991). The ml, m3 and m5
receptors transfected into mammalian cells link to increased Ptdlns turnover, while the
m2 and m4 gene products inhibit adenylate cyclase (reviewed in Bonner (1989)). The
ml, m3 and m5 receptors also appear to stimulate cAMP formation, although it is not




















































TABLE 1.4 : Pharmacological and molecular classification of muscarinic receptors.
Abbreviations: meth. methoctramine: (p-F)HHSD. (para-fluoro)hexahydro-sila-
difeniaol; 4-DAMP, 4-diphenylacetoxyl-N-methyl piperidine methiodide.
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1.5.3 Acetylcholine effects on adrenocortical steroidogenesis
Although is has been known for some time that ACh stimulates catecholamine release
from preganglionic sympathetic nerve terminals in the adrenal medulla, the possible
effects of ACh in the adrenal cortex received little attention until the 1950s. Electrical
stimulation of the splanchnic nerve in hvpophysectomised dogs resulted in increased
corticosteroid output from the adrenal cortex, although this was attributed to an indirect
effect of adrenaline released into the general circulation from chromaffin cells, acting
either at the level of the pituitary thereby stimulating ACTH release, or directly at the
cortical cells themselves (Vogt, 1944). This possibility was eliminated by Okinaka et al
(1952), who showed that following splanchnic nerve stimulation, venous adrenal
corticosteroid concentration was elevated on the stimulated, but not the contralateral side,
suggesting that the effect was independent of stimulatory agents in the general
circulation.
Evidence for a direct stimulatory effect of ACh on adrenocortical cells was first provided
by Rosenfield (1955), who demonstrated an increased production of 17 hydroxylated
steroids in response to ACh in the isolated perfused calf adrenal gland. ACh has since
been reported to stimulate corticosterone secretion from the perfused rat adrenal (Porter et
al, 1988), as well as Cortisol secretion from unpurified bovine adrenocortical cells in
culture (Kawamura et al, 1985), and from purified bovine zfr cells both acutely isolated
(Hadjian et al, 1982; Walker et al, 1990) and following primary culture (Walker et al,
1990). A direct effect of ACh on zg cells has also been demonstrated: ACh stimulated
aldosterone secretion ffom the perfused rat (Porter et al, 1988) and frog (Benyamina etal,
1985) adrenal gland, and from isolated purified bovine zg cells (Kojima et al, 1986a).
While observations such as these clearly indicate that ACh can stimulate steroidogenesis
in vitro, somewhat less is known regarding the possible in vivo role of cholinergic
systems. The concentrations of ACh and acetylcholinesterase (AChE) in the adrenal
cortex are about one third that of the medulla, suggesting the presence of an active
cholinergic system in the cortex (Feldberg & Schild, 1934; Antopol & Glick, 1940).
Indeed, AChE-positive innervation of the adrenal cortex has been described in several
species, including man (see section 1.1.5). In concious hypophysectomised calves
(supported by ACTH infusion), ACh infusion resulted in an increase in both adrenal
Cortisol secretion and plasma Cortisol levels (Jones & Edwards, 1991). This effect was
attributed both to a direct muscarinic effect of ACh on adrenocortical cells, and to an
increase in adrenocortical blood flow, as indicated by a reduction in adrenal vascular
resistance, thus enhancing the delivery of ACTH to the gland (Jones et al, 1991). It is
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significant, given the evidence for an intra-adrenal CRH-ACTH axis (section 1.3.2), that
ACh infusion also stimulated the secretion of CRH from the adrenal medulla (Jones et al,
1991).
Few studies have addressed the possible adrenocortical effects of ACh in man. While
administration of muscarinic agonists to normal human volunteers had no effect on
plasma aldosterone levels, the plasma aldosterone response to infusion of angiotensin II
was inhibited by the muscarinic antagonist atropine (Stern et al, 1989), suggesting that
cholinergic mechanisms may exert a modulatory effect on the actions of other
adrenocortical agonists. Such interactions are considered further in section 1.7.
1.5.4 Mechanism of action of acetylcholine in adrenocortical cells
The mechanism by which ACh stimulates steroidogenesis in adrenocortical cells has
received much attention in recent years, and seems to be similar in both zg and zfr cells.
Although the effects of ACh on adenylate cyclase activity in rat adrenocortical cells have
not been studied, no effect of ACh on cAMP levels has been demonstrated in bovine zfr
cells (Hadjian et al, 1982; Walker et al, 1990) or bovine zg cells (Kojima et al, 1986a).
The steroidogenic effect of ACh in bovine zfr cells was abolished in the absence of
extracellular Ca2+ (Kawamura et al, 1985; Hadjian et al, 1982), and the cholinergic
agonist carbachol stimulated an increase in both 45Ca2+ fractional efflux ratio and 45Ca2+
influx into bovine zg cells (Kojima et al, 1986a), indicating the involvement of the
calcium messenger system in the response to ACh.
Subsequent studies have confirmed that ACh stimulates steroidogenesis via increased
Ptdlns turnover. ACh stimulated dose-dependent increases in 32Pi labelling of Ptdlns in
bovine zfr cells (Hadjian et al, 1984a). The dose-dependency of the steroidogenic and
32Pi-labelling effects of ACh were similar, and 32Pi-labelling was found to precede any
measurable increase in Cortisol secretion. In primary cultures of bovine zfr cells labelled
with [3H]inositol, ACh stimulated the rapid formation of [3H]phosphoinositols (Walker et
al, 1990). HPLC analysis of the labelled products showed that their time course of
appearance was consistent with the phospholipase C-mediated breakdown of
PtdIns(4,5)P^, ie. an early (within 5 seconds) increase in Ins(l,4,5)P3 followed by a later
increase in InsP,, InsP: and Ins(l,3,4)P3. Similar findings have been reported in bovine
zg cells; although the individual phosphoinositol isomers were not separated, addition of
carbachol promoted a rapid and sustained rise in [3H]InsP3 followed by slower increases
in inositol bis- and monophosphates (Kojima et al, 1986a).
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Stimulation of hormone-dependent phospholipase C by ACh would be expected to lead to
an increase in [Ca2+]1 through the action of Ins(l,4,5)P3 (Berridge & Irvine, 1989).
Specific intracellular receptors for Ins(l,4,5)P3 have been identified in bovine adrenal
cortex (Baukal et al, 1985), and rapid increases in [Ca2"1"], in response to ACh have been
reported in aquorin loaded bovine zg cells (Kojima et al, 1986a) and fura-2 loaded bovine
zfr cells (Walker et al, 1991). The Ca2+ signal in bovine zfr cells was maintained in the
presence of low (120nM) extracellular Ca2+, although it decayed more rapidly than in
control cells. These findings are consistent with a rapid transient release of intracellular
Ca2+ in response to Ins(l,4,5,)P3, followed by a sustained influx of extracellular Ca2+
maintaining the intracellular signal.
The above studies were carried out using cell populations, and were therefore unable to
detect the possible occurrence of oscillations in [Ca2+]j which have been shown to occur
in response to phospholipase C agonists in single cells from a variety of different tissues
(Fewtrell, 1993). Complex oscillations in [Ca2+]1 in response to angiotensin II have been
reported in single fura 2 loaded rat (Quinn et al, 1988) and bovine (Johnson et al, 1989)
zg cells. It is not known at present whether similar oscillatory behaviour occurs in
response to ACh in zfr cells.
1.5.5 Adrenocortical acetylcholine receptors
Although a nicotinic response to ACh has been reported in the feline adrenal cortex
(Rubin & Warner, 1975), this study was limited in many ways. The preparation used was
an enzymatic digest of the whole cat adrenal cortex. Since nicotine is known to stimulate
catecholamine secretion from the feline adrenal medulla (Douglas & Rubin, 1961), the
possibility of an indirect effect of nicotine on catecholamine release from contaminating
chromaffin cells (with catecholamines subsequently stimulating steroid secretion) cannot
be ruled out. In addition, while nicotine was shown to stimulate corticosteroid production
in this system, the effects of other cholinergic agonists/antagonists were not studied. The
remaining studies which have investigated the nature of the adrenocortical cholinoceptor
agree on the occurrence of a muscarinic response. ACh-stimulated steroid secretion from
the calf adrenal gland was inhibited by atropine, and could not be reproduced by
administration of nicotine (Rosenfield, 1955). In purified bovine zf cell suspensions,
nicotine was without effect on Cortisol secretion while muscarine and the muscarinic
agonists carbachol, methacholine, oxotremorine. pilocarpine and arecholine significantly
increased Cortisol secretion (Hadjian et al, 1982). This steroidogenic response was
inhibited by atropine, but not by the nicotinic antagonists hexamethonium and (+)-
tubocurarine. The 32Pi labelling of Ptdlns in response to ACh in the same preparation
& a
was also inhibited by atropine, and unaffected by nicotinic antagonists (Hadjian et al.
1984a). Furthermore, the increase in [Ca2+]1 stimulated by ACh in bovine zfr cells was
inhibited by atropine (Walker et al, 1990). In isolated bovine zg cells, ACh-stimulated
aldosterone secretion was inhibited by atropine but not by hexamethonium (Kojima et al,
1986a), and muscarinic stimulation of aldosterone secretion was also demonstrated in the
isolated perfused frog adrenal gland (Benyamina et al, 1985,1987).
Specific high affinity binding sites for the muscarinic ligand [3H]L-quinuclinidyl
benzylate C[3H)-QNB) have been demonstrated in crude membrane preparations from
bovine adrenocortical tissue (Hadjian et al, 1981). [3H]-QNB binding was potently
inhibited by a variety of muscarinic antagonists, although no subtype-specific antagonists
were available at that time.
The muscarinic cholinoceptor subtype mediating ACh-stimulated Cortisol secretion has
not been definitively classified, although preliminary evidence for the presence of the M3
subtype in cultured bovine zfr cells has been obtained (Walker et al, 1990). The Mj-
selective agonist McN-A-343 was without effect on Cortisol secretion at concentrations
up to 10"4M, and although the M,/M3-selective antagonist HHSD dose-dependently
inhibited ACh-stimulated Cortisol secretion, the affinity of the antagonist was not
estimated.
1.6 ANGIOTENSIN II
Angiotensin II (All), the effector peptide of the renin angiotensin system (RAS), is
produced by the actions of renin, a 42K proteolytic enzyme secreted by the juxta¬
glomerular cells of the kidney, and angiotension converting enzyme (Figure 1.10). The
physiology of the renin-angiotensin system has been considered (section 1.3.3), and the
following discussion is concerned with recent developments in the classification of All
receptors, and the adrenocortical effects of AIL
1.6.1 Angiotensin II receptor subtypes
All receptors were originally identified by 125I-All binding studies in adrenal cortex,
uterus and kidney (Lin & Goodfriend, 1970). Subsequent studies using 14C- or 3H-
labelled All identified All binding sites in each of the tissues known to be stimulated by
the peptide, and the binding parameters of All in these target tissues were found to be
similar (reviewed in Catt & Aguilera, 1980).
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FIGURE 1.10 : Synthesis of angiotensin II from angiotensinogen. Renin, secreted by the
renal juxtaglomerular ceil, cleaves plasma angiotensinogen at the leu]0-leun bond
(indicated by heavy arrows) producing the inactive decapeptide angiotensin I.
Angiotensin I is further metabolised by angiotensin converting enzyme to the active
hormone angiotensin II, which interacts with cell surface receptors. Angiotensinase
enzymes break down angiotensin II to produce inactive/low activity peptide fragments.
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Early investigations of the precise cellular location of All receptors were confused by the
demonstration that All could enter the cell nucleus (Robertson & Khairallay, 1971).
However, a variety of cell fractionation experiments confirmed the presence of All
binding sites exclusively in the plasma membrane (Devynck & Meyer, 1987). These
discrepant results have subsequently been explained by the demonstration that
radiolabeled All is internalised by receptor-mediated endocytosis in adrenocortical cells
(Crozat etal, 1986).
Initial investigations of All receptor pharmacology studied the ability of structural
analogues of All to inhibit specific binding of 125I-AII in whole cell or crude microsomal
membrane preparations. The binding affinities of these peptide fragments correlated well
with their ability to stimulate/inhibit All-mediated responses in intact cells, and binding
inhibition curves were invariably best fitted to single site functions (Catt & Aguilera,
1980). However, a number of observations indicated that All receptors may be
heterogeneous: (i) All was found to use multiple mechanisms of signal transduction - in
bovine adrenocortical zg cells, All both stimulated Ptdlns metabolism (Catt et al, 1988)
and inhibited adenylate cyclase (Marie & Jard, 1983). It was not clear whether a single
receptor coupled to multiple effectors, or whether distinct receptor subtypes coupled to a
single effector, (ii) Differential tissue sensitivity to All and the heptapeptide AIII ((des-
asp)-AII) was reported - AIII was more potent than All in stimulating aldosterone
secretion from the adrenal cortex, whereas this order of potency was reversed when the
pressor effect of the peptides was measured (Goodfriend & Peach, 1975; Campbell &
Pettinger, 197,9). (iii) Differential effects of structural analogues of All between tissues
were observed - (Sar)5-AII and (Pro)3-AII were weak agonists/partial antagonists of All-
stimulated adrenocortical steroidogenesis, but acted as full agonists in aortic smooth
muscle (Capponi et al, 1991). (iv) Heterogeneity of All binding sites was reported - two
distinct All binding sites were described in rat liver membranes, with affinity constants
differing by some ten-fold. Binding of 125I-AII to these sites was differentially affected
by treatment with the sulphydryl-reducing agent dithiothreitol (DTT) (Gunther, 1984).
While studies such as these provided preliminary evidence of All receptor heterogeneity,
the lack of subtype-specific antagonists precluded a definitive classification.
Unsuccessful efforts to synthesise selective All antagonists centred around the structural
modification of the peptide molecule, and it was not until 1989 that the existence of All
receptor subtypes were conclusively demonstrated using non-peptide antagonists (Chiu et
al, 1989b).
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The first non-peptide compounds reported to exhibit All-antagonistic actions, S8307 and
S8308, were described by Furukawa et al (1982a,b). Further study of S8308 revealed it
to be a weak (ca. ten thousand times less potent than saralasin) but specific competitive
antagonist of All lacking the partial agonistic properties common to peptide analogues of
All (Chiu et al, 1988). An effort to synthesise more potent derivatives of this compound
for possible clinical use led to the development of losartan potassium (DuP753) and
analogues (Timmermans et al, 1991).
Losartan and related compounds were shown to potently inhibit All-mediated responses
including constriction of rabbit aorta, Ca2+ mobilisation in rat vascular smooth muscle
cells, and to exert an antihypertensive effect in renal artery ligated rats (Chiu et al,
1989a). The binding affinities of these compounds correlated well with their functional
antagonistic potency. However, in rat adrenocortical microsomes, losartan displaced only
80% of specific 125I-All binding, while the residual 20% was displaceable by the related
compound EXP655 (now termed PD123177) (Chiu et al, 1989b). Autoradiographic
localisation of these binding sites revealed a predominance of PD123177-sensitive sites in
the rat adrenal medulla, with the majority of losartan-sensitive sites located in the outer
zones of the cortex (Chiu et al, 1989b).
The existence of two distinct subtypes of All binding site in the rat adrenal gland was
confirmed by Chang and Lotti (1989) using the non-peptide antagonists DuP89 and WL-
19, and also by Whitbread et al, using CGP42112A and Ex89 (Whitbread et al, 1989).
The two binding sites were shown to be differentially affected by treatment with DTT,
which potentiated binding to the losartan-sensitive site and inhibited binding to the
PD123177-sensitive site (Whitbread et al, 1989). These binding sites were termed AT,
and AT2 respectively (Bumpus et al, 1991).
A variety of ligand binding and autoradiographic experiments revealed the presence of
AT, and AT2 binding sites throughout the body; both subtypes of binding site were
present in rat and human adrenal (Chiu et al, 1989b; Whitbread et al, 1989; Chang &
Lotti, 1989), rat uterus (Whitbread et al, 1989) and rat brain (Tsutsumi & Saavedra,
1991a). AT., sites were exclusively present in human uterus (Whitbread et al, 1989) and
rat anterior cerebral arteries (Tsutsumi & Saavedra, 1991b), whereas cultured rat vascular
smooth muscle cells contained only AT, sites (Whitbread et al, 1989). In the rabbit
kidney, AT, sites were confined to renal medulla and glomeruli, while the outer fibrous
sheath contained only AT2 sites (Herblin et al, 1991). Marked species differences in the
distribution of All binding sites have been reported; rat brain containes more AT2 than
AT, sites, whereas rabbit brain contains predominantly AT, sites (Chang & Lotti, 1991).
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The ratio of AT, : AT-, binding sites in rabbit aorta is greater than 10:1, compared with
2:1 in rat and monkey aortae (Chang & Lotti, 1991).
An intensive effort has been made to characterise the functional significance of these
distinct All binding sites. In rat liver clone 9 cells, which express AT, binding sites only,
All-stimulated inositol phosphate accumulation was inhibited by losartan but not by
PD123177, suggesting that in this cell line, AT, receptors are coupled to PLC activation
(Dudley et al, 1990). In undifferentiated neuroblastoma NG108-15 cells, which also
contain only AT, sites, All stimulated a dose-dependent accumulation of Ins(l,4,5)P3 and
elevation of [Ca2"1"], (Tallant et al, 1991). Both responses were inhibited by losartan but
not by CGP42112A (AT,-selective antagonist). AT, receptors have also been shown to
mediate the inhibition of ACTH-stimulated cAMP formation by All in rat adrenal
glomerulosa cells (Balla et al, 1991), suggesting that AT, receptors are coupled to both
adenylate cyclase and PLC. This has been confirmed by Crawford et al (1992), who used
7315c tumour cells, known to contain AT, receptors only, to show that losartan, but not
PD 123177, could inhibit both All-stimulated PLC activation via a pertussis toxin (PTX)-
insensitive G protein, and All-induced inhibition of adenylate cyclase via a PTX-sensitive
G protein.
All the known effects of All have since been shown to be mediated by the AT, receptor.
Thus, AT, receptors mediate both aldosterone secretion and inhibition of ACTH-
stimulated cAMP formation in rat zg cells (Balla et al, 1991), constriction of rabbit and
rat aortae (Dudley et al, 1990; Chiu et al, 1991), growth of rat vascular smooth muscle
cells (Chiu et al, 1991), growth of the bovine adrenocortical AC1 cell line (Natarajan et
al, 1992), and effects of All on noradrenergic neurotransmission in rats (Tofovic et al,
1991). In vivo, the pressor effect of All can be abolished by losartan, which also lowers
blood pressure in renal artery ligated rats (Dudley et al, 1990). In spontaneously
hypertensive rats, the effects of All on blood pressure are mediated by the AT, receptor
(Tofovic et al, 1991), and in normal rats losartan inhibits the dipsogenic response to All
(Fregly & Rowland, 1991).
The function of the AT-, binding site is unknown at present. AT2 binding sites do not
appear to couple to G proteins (Dudley et al, 1990,1991) (although see section 1.6.2). In
R3T3 cells, a cell line expressing AT2 sites only, All had no effect on Ptdlns turnover,
cAMP levels, tyrosine kinase activity, arachadonic acid release, cell growth, mitogenesis
or hypertrophy (Dudley et al, 1991). Mitogenic responses elicited by growth factors such
as epidermal growth factor (EGF), bombesin of fibroblast growth factor (FGF) were
unaffected by PD 123177.
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It had been anticipated that the discovery of AT, and AT, receptor subtypes would help to
explain the large diversity of effects of All and its use of multiple signal transduction
pathways. However, the AT., binding site cannot yet be classed as a receptor since its
function remains unknown. It is possible however that further subtypes of All receptor
exist, and indeed novel All binding sites have been described. Binding of All to Xenopus
laevis cardiac membranes was unaffected by either losartan or PD123177, and
CGP42112A was around three orders of magnitude less potent in displacing 125I-AII in
this preparation than in other tissues (Sandberg et al, 1991). A similar losartan and
PD123177-insensitive All binding site has been reported in differentiated murine
neuroblastoma neuro-2A cells (Chaki & Inagami, 1992a). In these cells, All promoted
dose-dependent increases in cGMP formation, a response which could be blocked by
nonselective peptide antagonists of All but not by either losartan or PD123177 (Chaki &
Inagami, 1992b), indicating that this novel All receptor subtype may be coupled to
guanylate cyclase activation. It is not known at present whether this receptor subtype
exists in other tissues/species. However, definitive evidence for the existence of further
subtypes of All receptor has been provided by molecular biological studies.
1.6.2 Cloning of the angiotensin II receptor.
The All receptor was first cloned by Murphy et al (1991) and Sasaki et al (1991) who
used expression cloning strategies to derive complementary DNAs (cDNAs) encoding the
AT, receptor from rat vascular smooth muscle and bovine adrenal cortex respectively.
The receptor protein contained 359 amino acid residues and possessed 7 hydrophobic
transmembrane regions typical of G protein linked receptors. Transfection of mammalian
COS-7 cells with the receptor cDNA allowed the ligand binding characteristics of the
receptor to be investigated, which were shown to be typical of native AT, receptors. The
vascular AT, receptor was shown to couple to PLC activation in COS-7 cells, as
demonstrated by increased inositol phosphate formation in response to All (Murphy et al,
1991), and cells transfected with either the adrenal or vascular receptor cDNAs responded
to All with an increase in [Ca2+], (Murphy et al, 1991; Sasaki et al, 1991).
The human AT, receptor cDNA was isolated from a human liver cDNA library and
shown to encode a protein 95% identical to the rat and bovine AT, receptor, also
containing 359 amino acids and seven transmembrane regions (Bergsma et al, 1992).
The receptor was coupled to Ca2+ mobilisation in Xenopus oocytes, and exhibited a ligand
binding profile characteristic of native AT, receptors when expressed in COS-7 cells
(Bergsma et al, 1992). Isolation of a genomic AT, receptor clone showed the entire
coding region to be contained in a single exon devoid of introns (Furuta et al. 1992).
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The availability of All receptor cDNA probes has resulted in the identification of
subtypes of AT, receptor which would not otherwise have been identified in the absence
of specific antagonists. Two subtypes of AT, receptor (AT1a and AT,B) were isolated
from a rat adrenal cDNA library. The clones were 96% identical and exhibited similar
ligand binding profiles (Iwai & Inagami, 1992). Distinct AT,a and AT,B receptor genes
were subsequently isolated from a rat genomic library and shown to both contain a 1077
base pair open reading frame encoding proteins of 359 amino acids (Elton et al, 1992).
The AT,b receptor iacked two serine residues (potential PKC phosphorylation sites)
which were present in the AT1a receptor. Similar AT, receptor subtypes have been
cloned from a murine genomic library (Sasamura et al, 1992). No functional differences
have yet been detected between AT,a and AT,B receptor subtypes expressed in intact
cells. Although both receptor subtypes couple to Ca2+ mobilisation (Kakar et al, 1992), it
is not clear at present whether this reflects an acrivation of PLC or a direct effect on
plasma membrane Ca2+ channels. Furthermore, effects of the cloned receptor subtypes on
adenylate cyclase activity have not been studied. In rat tissues, AT,a and AT1B receptor
mRNA expression appears to tissue specific. AT1B receptor mRNA was detected
primarily in vascular smooth muscle and lung, whereas AT,a receptor mRNA was
preferentially expressed in adrenal gland and pituitary (Kakar et al, 1992). Sandberg et al
recently reported the cloning and expression of a novel rat All receptor subtype which
was designated AT3 (Sandberg et al, 1992). AT3 receptor mRNA was most abundant in
adrenal cortex and pituitary, and structural analysis revealed two additional
phosphorylation sites for PKC. Compared with previously characterised All receptors,
this subtype exhibited slightly higher affinity for All, A III and losartan, although further
data will be required to distinguish this receptor from the AT,a subtype.
Recently, two independent groups succeeded in the cloning and expression of an AT2
receptor from rat foetus (Mukoyama et al, 1993) and rat pheochromocytoma
(Kambayashi et al, 1993). In both cases, a 363-amino acid protein was encoded sharing
32-33% sequence homology with the AT, receptor and containing seven putative
transmembrane sequences. Following expression of the receptor in COS-7 cells, no
effect of All on Ptdlns metabolism, fCa2+]|, cAMP or cGMP levels was observed
(Mukoyama et al, 1993), confirming the results of experiments on native AT-, receptors
(section 1.6.1). However, Kambayashi et al observed a dose-dependent inhibition of
phosphotyrosine phosphatase activity in response to All or to the AT.,-selective agonist
CGP42112A, an effect which could be blocked by AT,-selective antagonists but not by
losartan. This represents the first clear demonstration of an AT2 receptor-mediated
response. While agonist binding to the AT, receptor was unaffected by non-hydrolysable
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GTP analogues, the inhibition of phosphotyrosine pohosphatase activity by All was
sensitive to pertussis toxin, suggesting that this receptor may belong to a unique class of
G protein coupled receptors.
In summary, pharmacological analyses have defined at least two subclasses of native All
receptor, only one of which, the AT, receptor, has been shown to couple functionally to
intracellullar messengers. Cloning strategies have identified subtypes of AT, receptor,
although functional differences between them have not as yet been demonstrated. The
current state of All receptor classification, based on both pharmacological and molecular
studies, is outlined in Table 1.5.
1.6.3 Steroidogenic effects of angiotensin II in zfr cells
The steroidogenic effects of All on aldosterone secretion from zg cells are well
documented (see (Tait et al, 1980a) for review). All binds to specific plasma membrane
receptors and stimulates PLC via a pertussis toxin-insensitive G protein (Kojima et al,
1986b), leading to the formation of Ins(l,4,5)P3, with an associated increase in [Ca2"1"],
(reviewed in Bird et al, 1990b). Although All does not stimulate cAMP formation in zg
cells, it has been reported to inhibit adenylate cyclase in bovine zg cells (Marie & Jard,
1983).
Over the past fifteen years it has become clear that All also stimulates glucocorticoid
secretion from inner zone cells. All stimulated Cortisol secretion from bovine and canine
adrenals (Kaplan & Bartter, 1962; Mulrow & Ganong, 1961), from bovine (Peytremann
et al, 1973; Hepp et al, 1977) and human (McKenna et al, 1978) zf cell suspensions, and
from bovine zfr cells both acutely isolated and following primary culture (Bird et al,
1989). Early studies using rat zfr cells produced conflicting results. High doses of All
amide stimulated corticosterone secretion in rat zfr cell suspensions, but this was
subsequently shown to be due to an ACTH-like impurity in the preparation of All
employed (Hypertensin) (Tait et al, 1980a). Later studies failed to demonstrate any
steroidogenic effect of purified All on rat zfr cells at concentrations up to 10"4M (Tait et
al, 1980b); where stimulation of Cortisol secretion by All was demonstrated in zfr cells
from other species, it occurred at low physiological concentrations similar to those found
to stimulate zg cells Curiously, rat zfr cells were subsequently shown to contain All
binding sites, and exhibit a clear second messenger response to the peptide, even though



























TABLE 1.4 : Pharmacological classification of angiotensin II receptors. Although at
least three separate binding sites have been identified for angiotensin II, only the AT. site
can presently be classed as a receptor, since the AT2 and AT3 sites have not as yet been
definitively linked to specific cellular responses and/or second mesenger systems.
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1.6.4 Mechanism of action of angiotensin II in zfr cells
Early studies on the second messenger system associated with the steroidogenic effect of
All were also confused by the use of "Hypertensin". Increases in cAMP formation in
response to high concentrations of Hypertensin were attributed to the ACTH-like
impurity (Tait et al, 1980a), and subsequent studies using purified All failed to show any
effect of All on cAMP levels in bovine zfr cells (Tait et al, 1980a; Vallotton et al, 1981;
Bird et al. 1988). Increasing evidence pointed to the stimulation of PLC by All: In
bovine adrenocortical zf cell suspensions labelled with 3:P, All stimulated the dose-
dependent incorporation of 32P into phosphatidic acid and membrane phosphoinositides
(Hadjian et al, 1984b). The dose-responsiveness of 32P labelling and steroidogenesis in
response to All correlated closely. Furthermore, addition of All to 32P labelled bovine zfr
cell suspensions resulted in a rapid loss of radioactivity from PtdIns(4,5)P2 (Hadjian et al,
1984b). This response was abolished in the presence of the peptide All antagonist (Sar,-
Alag)-AII (saralasin). Later work confirmed that All stimulates a phosphoinositide-
specific phospholipase C in bovine zfr cells. In primary cultures of bovine zfr cells
labelled with f3H]inositol. All stimulated the rapid dose-dependent formation of
[3H]phosphoinositols (Bird et al, 1989). The formation of InsP3 and InsP2 (isomers not
characterised) was shown to precede that of InsP. The predominant InsP3 isomer
produced on sustained (15 min) stimulation with All was Ins(l,3,4)P3, the only known
precursor of which is Ins(l,4,5)P3, consistent with the involvement of a PLC in the
response to AIL
In rat zfr cells, All stimulates Ptdlns turnover and inositol phosphate production, but is
not steroidogenic (Whitley et al, 1982). A similar situation appears to exist in ovine zfr
cells; All stimulated inositol phosphate accumulation in [3H]inositol-labelled cells, but
did not stimulate Cortisol secretion (Viard et al, 1990). A rapid formation of InsP3 was
demonstrated in response to All, which appeared to be functionally coupled to effector
mechanisms, since All also stimulated a rise in [Ca2+]1 (Viard et al, 1990). Furthermore,
the cells were steroidogenically viable since ACTH was an effective stimulus to Cortisol
secretion. The reasons for these discrepant results in rat and ovine zfr cells are unclear.
The second messenger system involved in the stimulation of human zfr cells by All has
not been characterised in detail. However, in collagenase-dispersed suspensions of
human adrenocortical cells, both A23187 and TPA were able to stimulate Cortisol
secretion (Laird et al. 1991), suggesting that inositol phosphate production and PKC
activation may regulate human inner zone cells. Furthermore, in primary cultures of
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human zfr cells, All stimulated the breakdown of membrane PtdIns(4,5)P-, without
affecting cAMP levels (Ian M. Bird. Personal Communication).
1.6.5 Angiotensin II and adrenocortical Ca2+ mobilisation
The majority of studies on All-induced Ca2+ mobilisation have been performed using zg
cells. As discussed in section 1.3.9, All stimulates a biphasic Ca2+ response in zg cells,
the initial rise occurring as a result of Ins(l,4,5)P3-induced release of Ca2+ from
intracellular stores, and the sustained increase occurring due to influx of extracellular
Ca2+. Both phases of Ca2+ mobilisation are necessary for the sustained steroidogenic
action of All. Using fluorescent Ca2+-binding indicators, increases in [Ca2+]1 have been
demonstrated in cell suspensions isolated from the rat (Braley et al, 1986) and bovine
(Capponi et al. 1984) zg. In single fura-2 loaded bovine zg cells, oscillations in [Ca2+]; in
response to All have been reported (Johnson et al, 1989). An initial transient increase in
[Ca2+]l, independent of extracellular Ca2+, was followed by regular oscillations in [Ca2+]t,
which could be abolished by removal of extracellular Ca2+. Similar oscillatory behaviour
has been observed in single fura-2 loaded rat zg cell (Quinn et al, 1988). Interestingly, rat
zg cells exhibited a latency period following application of All, the duration of which
was dependent on the concentration of All employed. Furthermore, the frequency of
oscillations was related to the dose of All used, suggesting that All may stimulate
aldosterone secretion through modulation of the frequency of [Ca2+1, oscillations.
The changes in [Ca2+]; occurring in zfr cells following stimulation with All are less well
documented. Rat zfr cells did not exhibit an increase in fCa2+]i in response to All (Braley
et al, 1986), or a release of Ca2+ from intracellular stores (Williams et al, 1981). In
contrast, All did stimulate dose-dependent increases in fCa2+], in primary cultures of
bovine zfr cells (Walker et al, 1991). In low Ca2+ medium the response declined to
baseline more rapidly than in normal Ca2+ medium, consistent with the requirement for
extracellular Ca2+ to sustain the Ca2+ signal. Evidence was also obtained that All and
ACh stimulate the release of Ca2+ from a common intracellular pool in bovine zfr cells
(Walker et al, 1991). To date, the nature of the intracellular Ca2+ response to All in
single zfr cells is unstudied.
1.6.6 Adrenocortical angiotensin II receptors
All receptors have been characterised in the adrenal cortex of various species by 125I-AII
binding inhibition studies using non-peptide antagonists. In the rat, monkey and rabbit
adrenal cortex, both AT, and AT-, sites are present, although the relative proportions of
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binding sites are variable between species. Monkey and rabbit adrenal cortex contains
mostly AT, sites (ratio AT, : AT2 >9:1) (Chang & Lotti, 1991), while around 20 % of
All binding sites in the rat adrenal cortex are AT, (Chiu et al, 1989b: Chang & Lotti,
1991). Conflicting data have been presented for the bovine adrenal cortex. In
membranes prepared from unpurified bovine adrenocortical cells only AT, sites were
detected (Balla et al, 1991). In contrast both AT, and AT-, sites were detected in cultured
bovine zf cells (Ouali et al, 1992), although the proportion of AT-, sites was rather small.
Further study will be required to resolve this discrepancy.
Adrenocortical All binding sites have been visualised by autoradiography. In the rat
adrenal cortex, 125I-All binding sites extended through the outer and inner adrenocortical
zones. Around 80% of these sites were AT,, and the remaining AT2 sites were distributed
uniformly in the zg (Chiu et al, 1989b). Similarly, in the rabbit adrenal cortex both the
zfr and the zg were labelled with 125I-AII. However, in the presence of losartan, AT2 sites
were revealed to be organised in discrete ball-like clusters throughout the cortex (Herblin
et al, 1991). These organised patches of AT, sites have no known anatomical correlate,
and their presence remains a mystery.
1.7 INTERA CTIONS BETWEEN AII, A Ch, AND OTHER ADRENOCORTICAL
AGONISTS
While All and ACh are clearly capable of stimulating steroidogenesis in both zg and zfr
cells from a variety of species, an important consideration is whether such agonists can
modulate the effects of other adrenocortical stimuli. It is well established that All can
inhibit adenylate cyclase in bovine and rat zg cells (Marie & Jard, 1983). This results in a
dose-dependent inhibition of both basal and ACTH-stimulated cAMP production in
bovine zg cell membrane fractions (Marie & Jard, 1983) and isolated rat zg cells (Balla et
al, 1991). The physiological significance of this effect is unknown, but is may reflect a
diversion of steroidogenesis from a glucocorticoid pathway to a mineralocorticoid
pathway in response to AIL This is suggested also by the effects of ACTH and All on the
expression of steroidogenic genes. The activity of P450cl7 determines whether
pregnololone enters glucocorticoid or mineralocorticoid synthetic pathways (see section
1.2.3). P450cl7 levels in the zg are very low in vivo, allowing the preferential synthesis
of mineralocorticoids (Hornsby, 1988). ACTH is known to stimulate expression of
P450cl7, and this effect can be inhibited by All in bovine, ovine and human
adrenocortical cells (Rainey et al, 1991; Bird et al. 1992b; McAllister & Hornsby, 1988).
This effect of All on P450cl7 expression results in an inhibiton of chronic ACTH-
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stimulated Cortisol secretion by All in ovine zfr cells (Bird et al, 1992b), even though All
has no apparent effect on basal Cortisol secretion in this system (Viard et al. 1990).
Interactions between All and ACTH have been reported to occur in vivo. Although All
infusion in humans has no effect on plasma Cortisol levels (Mason et al, 1976,1977), All
did produce dose-dependent increases in plasma Cortisol when infused simultaneously
over a low constant background infusion of ACTH (Mason et al, 1979). In canine
species, a potentiation of All-stimulated Cortisol secretion by low concentrations of
ACTH was also reported (Bravo et al, 1975; Slater et al, 1963).
1.8 SUMMARY AND AIMS OF THE THESIS
Following an introduction to the adrenal cortex and its steroid hormones, the effects of
ACh and All on adrenocortical steroidogensis have been reviewed, with particular
reference to the inner zfr cell. Human zfr cells in vitro respond to both agonists with
increased Cortisol secretion via the activation of PLC, and it appears likely that ACh and
All may regulate Cortisol secretion in man, in vivo. Although important species
differences exist with respect to the adrenocortical effects of ACh and All, the physiology
of human zfr cells appears to be most closely reflected by that of bovine zfr cells in
culture, and this preparation would therefore seem a good model with which to study the
cellular physiology and pharmacology of these agonists in the adrenal cortex.
While it is clear that ACh stimulates Cortisol secretion via muscarinic but not nicotinic
receptors, the cholinoceptor subtype involved in this response has not been identified.
Neither has the receptor subtype mediating All-induced Cortisol secretion been
investigated. Following an initial characterisation of the bovine zfr cell culture system in
Chapter 3, Chapters 4 and 5 aim to classify the ACh and All receptor subtypes mediating
the steroidogenic effects of these agonists using subtype-selective antagonists.
The remaining chapters of this thesis compare the effects of ACh and All on
phosphoinositide hydrolysis and intracellular Ca2+ signalling. There appear to be many
similarities in the actions of ACh and All in adrenocortical cells. For example, both
agonists stimulate PLC and phosphoinositide turnover. However, it is not clear whether a
common pool of phosphoinositides is metabolised in response to ACh and All, or
whether each agonist stimulates the breakdown of discrete pools of lipids. This question
is addressed in Chapter 6. Finally, although ACh and All have previously been shown to
mobilise Ca2+ from a common intracellular pool, and to generate similar profiles of Ca2+
mobilisation in cell populations, the effects of these agents at the single cell level in zfr
59
cells is unknown. Investigations at the single cell level may reveal differences in the
actions of ACh and All not detectable in cell populations, and the abilities of ACh and
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2.2.1 Cell isolation and culture
Bovine adrenocortical zfr cells were isolated and purified from the zfr of the adrenal
gland from 1- to 2- year old steers according to the method of Williams et al (1989).
Glands were obtained from freshly slaughtered cattle (Gorgie Abattoir, Edinburgh) and
transported on ice to the laboratory within 60 minutes. All work was carried out in a
sterile class II laminar flow cabinet (MDH Ltd.).
After removal of the surrounding fat. the cortex was sectioned into approx. 100 (lm slices
using a Stadie-Riggs microtome. The first slice (capsule and zg) was discarded, while the
second slice (zfr) was collected into 5 - 10 ml Earl's balanced salt solution (EBS)
containing 0.2% (w/v) bovine serum albumin (BSA). 4 - 5 g of zfr tissue were routinely
collected. The tissue was minced into 1 mm2 sections, washed thoroughly with 50 - 60
ml EBS, and digested for 2 h in 50 ml EBS containing 2% (w/v) BSA and 2 mg/ml
collagenase. The tissue was gently agitated at 30 min intervals during digestion, after
which the resulting suspension was filtered through coarse and medium nylon gauze (250
(im and 100 pim respectively), and the cells harvested by centrifigation at 450 x g for 30
min. The cell pellet was resuspended in EBS / 0.2% BSA and filtered through fine (30
pim) nylon gauze.
Further purification was achieved by the column filtration method of McDougall et al
(1979). The cell suspension was applied to a scintered glass Allihn funnel (100 mm x 20
mm disc / 16 - 40 pim pore size) containing 15 ml Sephadex G-10 covered by 5 ml
Sephadex G-50, and encouraged through the column by gentle suction applied with a
syringe. This procedure trapped intact cells within the Sephadex beads, while allowing
contaminating red blood cells, cell debris and the smaller zona reticularis and
glomerulosa cells to pass through. The column was washed with 20 ml EBS / 0.2% BSA,
and the cells harvested by passing the resuspended gel through 30 (im nylon gauze, thus
trapping the Sephadex beads while allowing the cells through. The cell suspension was
centrifuged at 450 x g for 30 min and finally resuspended in 50 ml culture medium
(Ham's F10 medium containing 10% (v/v) Controlled Serum Replacement No. 5
(CPSR5), penicillin (50 IU / ml), amphotericin B (2.5 pig / ml) and streptomycin (50 pig /
ml). Cells were counted using an improved Neubauer haemocvtometer. The isolation
and purification procedure routinely yielded 50 - 100 x 106 cells essentially free from cell
debris and contaminating glomerulosa cells (Williams et al, 1989).
Freshly isolated cells were either used immediately or seeded to confluence in 12- or 24-
well plates at densities of 330000 or 165000 cells / ml / well respectively. For
fluoresence microscopic studies, sterile glass coverslips (thickness No. 1, 22 mm
diameter) were placed into 12-well plates, and cells seeded onto the coverslips at half
normal density (165000 cells / ml / well). In some experiments, cells were seeded in 25
cm2 or 75 cm2 tissue culture flasks at densities of 3 x 106 cells / flask (5 ml) and 10 x 106
cells / flask (15 ml) respectively. In all cases, cells were maintained at 37°C in an
atmosphere of 5% C02 in a humidified incubator (Scotlab VSL) until required. The
medium overlying the cells was renewed 24 h after initial plating.
2.2.2 Preparation of zfr microsomal membranes
Crude zfr cell membrane fractions were prepared by a modification of the method of Catt
et al (1980). 48 h after initial plating, cells cultured in 75 cm2 flasks were washed with
10 ml pre-warmed EBS and left under 5 ml Ca2+- and Mg2+-free EBS. Cells were
incubated at 37°C with occasional agitation for 5 min or until they had completely lifted
from the bottom of the flask. Following centrifugation at 450 x g for 30 min at 4°C, cells
were resuspended in 20 mM ice-cold NaHC03 (1ml / 10 x 106 cells), kept on ice and
sonicated (20 |im amplitude, 6 x 2s). The resulting cell homogenates were centrifuged at
3000 x g for 10 min at 4°C, and the combined supernatants centrifuged at 20000 x g for
30 min at 4°C. The resulting pellet was washed with membrane buffer (20 mM TRIS /
HC1, 120 mM NaCl, 0.2% BSA, pH 7.4), and finally resuspended in 1-2 ml of the same.
A small aliquot was removed for protein determination.
2.2.3 Stimulation of Cortisol secretion
(i) Freshly isolated cells
Freshly isolated cells (in culture medium) were centrifuged at 450 x g for 30 min and
resuspended in EBS with added BSA (0.2% w/v) and glucose (0.1% w/v) (EBSBG) at a
density of 330000 cell / ml. Cells were dispensed into 1.5 ml Eppendorf tubes (1ml /
tube), pelleted by centrifigation at 500 x g for 3 mins in a Heraeus Christ Biofuge B, and
resuspended in 1 ml EBSBG. The centrifugation step was repeated, and the cells
resuspended in 0.45 ml EBSBG. Following preincubation at 37°C for 5 min, agonists
were added to a final volume of 0.5 ml, and stimulation allowed to proceed for 60 min
before the cells were pelleted by centrifugation and the cell - free medium recovered and
stored at -20°C prior to Cortisol radioimmunoassay.
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(ii) Cultured, cells
The basic protocol for stimulation of cultured and freshly isolated cells was similar,
except that for medium changes on cultured cells, the medium was removed by aspiration
and replaced with fresh medium. Cells in 12 well plates were washed twice with 1 ml
EBSBG and left under 0.45 ml medium. Following preincubation for 5 min at 37°C,
agonists and / or antagonists were added to a final volume of 0.5 ml. Cells were
incubated at 37°C for the times indicated before the overlying medium was removed and
stored at -20°C prior to Cortisol radioimmunoassay.
2.2.4 Stimulation of c\MP secretion
cAMP secretion into the medium was measured in freshly isolated or cultured cells
following a protocol exactly the same as described above (sections 2.2.3i/ii) except that
the final incubation volume was 1 ml. At the end of the incubation, the recovered
medium was split into 2 x 0.5 ml aliquots. One aliquot was stored at -20°C for Cortisol
radioimmunoassay, while the other was transferred to a glass tube, acidified to pH 5.0 by
the addition of 5 pi acetic acid (20% v/v), and immediately acetylated by the addition of
15 pi of a 2:1 mix (v/v) of triethylamine and acetic anhydride. Acetylated samples were
stored at -20°C prior to cAMP radioimmunoassay.
2.2.5 Stimulation ofphospholipase C
Phospholipase C activation was determined by measuring the agonist-stimulated
production of [3H]phosphoinositols (in the presence of LiCl) in [3H]inositol prelabelled
cells. This technique allows the radioactivity associated with cellular phosphoinositide,
phosphoinositol and free inositol fractions to be monitored.
(i) Cell labelling with pH]inositol
Where steady state labelling was required, cells were plated out in 12 well multiwell
plates as described. 24 h after plating, the overlying culture medium was replaced with
fresh medium containing wryof3Hlinositol (10 pCi / ml). Cells were incubated at 37°C for
a further 48 h before use.
In some experiments, the responsiveness of cells to phosphoinositidase C agonists was
studied on each of the first five days in primary culture. In this case, cells (either freshly
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isolated or following specific periods of primary culture) were incubated with [3H]inositol
(10 |iCi / ml) included in the culture medium for 5 h only before use.
Where the effect of acetylcholine or manganese stimulation on phosphoinositide labelling
was investigated, cells were cultured under normal conditions for 66 h. [3H]Inositol (10
|iCi / ml) was added for a further 6 h. in combination with either MnCl2 (1 mM) for the
entire 6 h labelling peroid, or ACh (0.1 mM) for the last 1 h of labelling only. ACh
stimulation was terminated by the addition of 5 (il of atropine (1 (iM final concentration)
to each well for 5 min.
(ii) Agonist stimulation ofphospholipase C
Once labelling had been achieved, the [3H]inositol containing culture medium was
removed and replaced with 0.5 ml EBSBG. Cells were incubated for 15 min at 37°C after
which the overlying medium was replaced with 0.45 ml fresh medium containing LiCl
and inositol (both 10 mM). Following a further 15 min incubation, agonists and / or
antagonists were added to a final volume of 0.5 ml, and stimulation allowed to proceed
for 15 min. Stimulation was terminated by the addition of ice-cold perchloric acid (15%
v/v, 250 \l\ / well). Wells were scraped using a 1 ml syringe stopper and the well contents
transferred (with a 0.5 ml water wash) to a 1.5 ml Eppendorf tube. Following
centrifugation at 3300 x g for 3 min, the [3H]phosphoinositol - containing supernatant
was removed to glass tubes for neutralisation. Neutralisation was achieved by the
extraction of perchloric acid using a 1:1 mixture (v/v) of 1,1,2-trichlorotrifluoroethane
and tri-n-octylamine (1.5 ml / tube). Tubes were thoroughly mixed and the resulting
three phases separated by brief centrifugation. The neutral top phase was recovered and
stored at -20°C prior to [3H]phosphoinositol assay. The insoluble pelleted material
recovered from the perchloric acid extracts was frozen at -20°C under 200 pil of water for
assay of [3H]phosphoinositides.
(Hi) Freshly isolated cells
Freshly isolated cells in suspension (330000 cells / 0.5 ml) were labelled with [3H]inositol
for 5 h as described above (section 2.2.5i). Cells were dispensed to 1.5 ml Eppendorf
tubes (0.5 ml / tube) and centrifuged at 500 x g for 3 min. Cells were resuspended in
EBSBG (0.5 mi / tube) and incubated for 15 min at 37°C. Following recentrifugation,
cells were resuspended in 0.45 ml EBSBG with added LiCl and inositol (both 10 mM)
and incubated for 15 min after which agonists were added to a final volume of 0.5 ml.
Stimulation was continued for 15 min after which 250 |il of 15% (v/v) perchloric acid
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followed by 0.5 ml water were added to each tube. The perchloric acid extracts and
pelleted material were then processed as above (section 2.2.5ii).
2.2.6 Measurement of intracellular Ca2+
Intracellular Ca2+ concentration was measured in single fura-2 loaded zfr cells by
fluorescence microscopy. Fura 2 acetoxymethyl ester (fura-2 AM) is taken up by cells
and cleaved by intracellular esterases to produce the membrane-impermeable Ca2+
sensitive (free acid) form of the dye. Since fura-2 undergoes an absorption shift to
shorter wavelengths on Ca2+ binding (see Figure 2.1), measurement of fluorescence
intensities emitted at excitation wavelengths specific for the Ca2+-bound and Ca2+-free
forms of the dye produce a fluorescence ratio directly proportional to [Ca2+]i; independent
of the dye concentration.
(i) Loading offura-2
In order to optimise conditions for the loading of fura-2 into the cytosolic compartment of
cultured cells, the time course and concentration dependence of dye uptake was
investigated. Freshly isolated cells were seeded in 25 cm2 tissue culture flasks (3 x 106
cells / flask) and used 48 h later. Fura 2 AM (20 (ll) or vehicle (dimethyl sulphoxide,
DMSO) was added to the overlying culture medium at various concentrations for the
times indicated at 37°C. Following loading, cells were washed four times with 5 ml
modified Kreb's buffer (MKB) containing (mM): NaCl, 140; KC1, 4.5; MgC^, 1.0;
NaH-,PC>4, 1.0; CaCl2, 2.5; glucose, 5.0; HEPES, 10.0, pH 7.4, and left under 2 ml MKB.
Cells were harvested using a cell scraper with a 2 ml wash, and sonicated (20 p.m
amplitude, 6 x 2 s) to release intracellular fura 2. 2 ml aliquots of the cell suspensions
were transferred to a quartz cuvette (1cm path length) and fluorescence measurements
carried out at 37°C at an excitation wavelength of 362 nm, recording at 510 nm
emmission on a Perkin-Elmer model LS-5 luminescence spectrophotometer. The
suspensions were stirred throughout using a magnetic microstirrer. The fluorescence
values were corrected for autofluorescence obtained from cells loaded with DMSO only.
(ii) Single cell fluorescence measurements
Freshly isolated cells were seeded onto glass coverslips and used after 48-72 h. Cells
were loaded with 5 ql fura 2 AM in 0.5 ml culture medium (final fura-2 concentation 10
|iM) for 1 - 2 h at 37°C. Following the loading period, cells were washed with 3 x 1 ml
MKB to remove extracellular fura 2. The glass coverslip was placed in a thermostated
69
FIGURE 2.1
FIGURE 2.1 : Theoretical excitation-emission relationships for fura-2 free acid in
solutions containing increasing concentrations of free Ca2+ ranging from zero to a
saturating concentration (around 1 pM). This diagram shows the shift to shorter
wavelengths of the dye emission maxima occurring on Ca2+ binding, and also illustrates
the isosbestic point of fura-2 (362 nm).
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superfusion chamber attached to a Nikon diaphot inverted microscope, and the ceils
perfused with prewarmed (37°C) MKB at a flow rate of 2 ml / min. Test substances were
dissolved in MKB to achieve the stated final concentrations and delivered to the cells as
continuous perfusions.
An adjustable apperture allowed the field of view to be reduced so as to encompass a
single cell only. Cells were excited alternately at 340 and 380 nm, and the fluorescence
intensity emitted at 505 nm at each excitation wavelength was detected by a pair of
photomultipliers and the data stored on an Amstrad 2086 microcomputer. The ratio of
fluorescence intensities recorded at excitation wavelengths of 340 and 380 nm was
corrected for background fluorescence and analysed using software (IBM "COUNT",
V3.3) developed by Dr. J. Greenwell, Dept. Physiology, University of Newcastle.
In some experiments, the fluorescence ratios were calibrated for free Ca2+ concentration.
0.5 ml of MKB with known concentrations of free Ca2+ from 50 to 800 nM (prepared as
described in section 2.2.6iii) and containing fura 2 free acid (1 juM) was placed in the
perfusion chamber, and the fluorescence ratio (F340/F3g0) recorded.
(Hi) Preparation of Ca2+ / EGTA - buffered solutions
Two stock Kreb's solutions were prepared: 1) Ca2+-free MKB, and 2) MKB containing 10
mM CaCl2 instead of EGTA. 3ml Ca2+-free MKB were placed in a quartz cuvette and
fura 2 free acid added to a final concentration of 1 p.M. The fluorescence value at 340 nm
excitation, 505 nm emmision was recorded at 37°C using a luminescence
spectrophotometer with constant stirring. This value represented the fura-2 fluorescence
at zero Ca2+ concentration (F • ). The 10 mM CaCL MKB solution was titrated into thev miny Z
cuvette in 5 (il volumes, and fluorescence readings (F) taken after each addition. The dye
was then saturated with calcium by the addition of 100 mM CaCl2 until no further
increase in fluorescence was observed (Fmax). The free Ca2+ concentration after each
addition of CaCl2 was calculated according to Grynkiewiez et al (1985):
[Ca2+] (nM) = [ (F - Fmin) / (Fmax - F) ] x Kd
The equilibrium dissociation constant (Kd) for fura 2 was taken to be 224 nM, as
previously determined (Grynkiewicz et al, 1985). Figure 2.2 shows an example of the
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FIGURE 2.2 : Preparation of buffered Ca2+ solutions. Aliquots of stock Ca2+ solution
were titrated into medium containing fura-2 free acid, and the Ca2+ concentration after
each addition calculated from the fluorescence signal. The amount of stock CaCl2
solution to be added to a given volume of medium was extrapolated from the calibration
curve.
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2.2.7 Measurement of1251-angiotensin II binding
(i) Preparation of1251-angiotensin
Monoiodinated 125I-angiotensin II was prepared by the chloramine T method and purified
by anion exchange chromatography.
10 (il each of angiotensin II (lmg / ml), Nat25I (lmCi, 13-17 mCi / jig I) and 0.5 M
phosphate buffer (pH 7.4) were mixed together in a 1.5 ml Eppendorf tube. The reaction
was initiated by the addition of 10 p.1 chloramine T (5 mg / ml, in phosphate buffer).
After 60 s the reaction was terminated by addition of 10 |il sodium metabisulphite (5 mg /
ml phosphate buffer) followed by 0.5 ml 0.1 M phosphate buffer containing 0.1% (w/v)
sodium azide. The iodination mixture was applied to a 0.9 x 60 cm ion exchange column
(Pharmacia K-9) containing pre-swollen DEAE Sephadex A25 in 0.1 M phosphate buffer,
0.1% sodium azide (pH 7.4), and allowed to drain into the column. 1 ml of 0.1 M
phosphate buffer was then added, and allowed to drain into the column. 0.1 M phosphate
buffer (0.1% azide, pH 7.4) was pumped through the column (18 ml / h) and fractions
collected every 4 min. 10 p.1 aliquots of the fractions were counted in a gamma counter,
and the peak fraction plus the 2 adjacent fractions on either side of the peak fraction
pooled. The purified 125I-angiotensin II was diluted 1:10 with 0.1 M phosphate buffer
containing 0.1% sodium azide, 100 KI Trasylol and 0.5% (w/v) BSA, and stored frozen
until required. The specific activity of the monoiodinated angiotensin II ranged from 500
- 1000 mCi / mg as determined by self-displacement radioimmunoassay (see section
2.2.9iii).
(ii) Binding of ,25I-angiotenin II to cultured zfr cells
Cells were plated out in 24-well multiwell plates and used for binding experiments
following various times of primary culture. Cells were washed with 0.5 ml EBS / 0.1%
BSA, and preincubated at 22°C for 20 min under 0.8 ml EBS / 0.1% BSA. Test
substances or buffer were added in a volume of 100 (il followed by 100 (il 125I
angiotensin II (diluted to 105 cpm / 100 (il in EBS, equivalent to a final assay
concentration of 0.15 nM). Non-specific binding of label was assessed as binding
observed in the presence of 10 5M AIL Cells were incubated for the times indicated at
22°C after which the unbound tracer was removed by rapidly washing the wells three
times with 1 ml ice-cold phosphate buffered saline (0.1M, pH 7.4) (PBS). The plates
were briefly blotted on absorbent paper, and 0.5 ml 1% (v/v) Triton X-100 added to each
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well to solubilise the cells. The cell-bound radioactivity was recovered to plastic tubes
with a 1 ml wash, and counted on a Nuclear Enterprise NE 1600 gamma counter.
(iii) Binding of1251-angiotensin II to freshly isolated cells
Freshly isolated cells were centrifuged at 450 x g for 30 min and resuspended in EBS /
0.1% BSA at a density of 165000 cells / 0.4 ml. Incubations were set up containing 400
p.1 EBS / 0.1% BSA, 100 (il I25I-angiotensin II (105 cpm) and 100 jil test substances or
buffer. The reaction was initiated by the addition of 400 pi of the cell suspension, and
binding allowed to proceed at 22°C for the times indicated. The reaction was terminated
by the addition of 3 ml ice-cold PBS and the cell-bound radioactivity trapped by
immediate filtration through millipore filters (GF/C). The filters were washed with 2x3
ml ice-cold PBS, dried under air, and the filter-bound radioactivity assessed by gamma
counting.
(iv) Binding of1251-angiotensin II to zfr cell membranes
Aliquots of membrane suspension (150 (il, approx. 100 (ig protein) were incubated with
125I-angiotensin II (105 cpm) and test substances (dissolved in membrane buffer: 20 mM
TRIS / HC1; 120 mM NaCl; 0.2% BSA, pH 7.4) to a final volume of 250 (il. Incubation
was for 70 min at 22°C after which the reaction was terminated by the addition of 0.5 ml
ice cold washing buffer (20 mM TRIS/HC1; 120 mM NaCl, pH 7.4). Bound and free
tracer were separated by immediate centrifugation at 10000 x g for 5 min. The membrane
pellet was washed with 0.5 ml ice-cold washing buffer, resuspended in a further 0.5 ml
buffer and recentrifuged. The resultant pellet was resuspended in 200 (il 50 mM TRIS /
HC1 (pH 7.4) containing 0.5% (v/v) Triton X-100 and incubated for 20 min at 4°C. The
membrane suspension was centrifuged for 10 min at 10000 x g and the solubilised
fractions collected for isoelectric focusing.
2.2.8 Analytical isoelectric focusing
Isoelectric focusing was performed using a Pharmacia 2117 multiphor II electrophoresis
system. 115 x 240 x 2 mm slab gels of 4.85% (w/v) acrylamide containing 0.15% (w/v)
N,N'-methylenebisacrylamide and 5% (v/v) pharmalyte (5.0 - 8.0) were prepared and cast
onto GelBond PGA polyacrylamide gel support films. Ammonium persulphate (0.5 mg /
ml of gel solution) was added and polymerisation achieved in 60 min at room
temperature. Gels were applied to the cooling plate with a uniform layer of Nonidet P50
to ensure efficient heat transfer from the gel during isoelectrofocusing. The multiphor
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chambers were filled with 1 M NaOH in order to improve the basic regions of the gel.
Electrolyte solutions of 0.5 M acetic acid (anode) and 0.5 M NaOH (cathode) were used.
Gels were prefocused for 45 min at 2000 V, 20 mA and 20 W, after which samples (30
(il) were applied to 4 x 6 mm pieces of filter paper positioned approximately 30 mm from
the cathode. Calibration of the pH gradient was achieved by including standard pi
markers (Pharmacia isoelectric focusing calibration kit 5.0 - 10.5). Isoelectrofocusing
was for 4 h at 2000 V, 20 mA and 20 W.
Following the focusing period the gel was cut in half. The portion containing the
membrane samples was dried (90 min at 60°C) and autoradiography performed for 24 -
48 h at -70°C using Kodak X-OMAT XAR-5 X-ray film. The portion of the gel
containing the pi calibration markers was immersed in fixing solution (3.46% (w/v)
sulphosalicylic acid, 11.5% (w/v) trichloroacetic acid) for 30 min, followed by destaining
solution (67:25:8 water / ethanol / 17.5M acetic acid) for 15 min. Gels were stained in
hot (60°C) staining solution (0.115% (w/v) Coomassie Blue in destaining solution) for 10
min, and left overnight in destaining solution.
2.2.9 Assay procedures
(i) Cortisol radioimmunoassay
Cortisol was measured by a modification of the method of Gray et al (1983), using a
double antibody preprecipitate for separation of bound and free tracer.
Cortisol standards (1 to 2000 nM) were prepared by dilution of stock hydrocortisone (10
mM) in EBSBG and stored at -20°C until required. Cortisol tracer (cortisol-3-(<9-
carboxymethyl)oximino-(2-[125Iliodohistamine)) was diluted in 0.1 M citrate buffer
(0.2% (w/v) gelatine, pH 4.0) to 105 cpm / 700 (il. Antibody preprecipitate solution
contained (per 500 ml citrate buffer): normal sheep serum (530 |il), reconstituted sheep
anti-cortisol (650 (il), donkey anti-sheep (goat) (15 ml). The preprecicitate was stored at
4°C, and was diluted 1:2 (v/v) with 0.1 M citrate buffer before use.
Assay tubes containing 700 (il tracer solution, 100 (il standard / sample / QC and 250 (il
antibody preprecipitate were incubated at 37°C for 2 h. Following centrifugation at 1800
x g for 30 min at 4°C, the supernatant was decanted and the pellets counted for 120 s in a
gamma counter. Standard curves were fitted to a 4 parameter logistic model using the
software package R1ACALC (LKB/Pharmacia) on an IBM PC. The intra assay CV was
< 10% over the range 12-2000 nM, and < 20% over the range 3-12 nM. The inter-assay
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CV was < 10% over the range 12-2000 nM.
curve obtained by this assay.
(ii) cAMP radioimmunoassay
Figure 2.3 shows an example of the standard
cAMP was measured by a modification of the method of Harper and Brooker (1975)
involving an overnight incubation with cAMP antibody followed by incubation with a
second antibody to separate bound and free tracer.
Standard solutions of cAMP (0.0625 - 8.0 nM) were prepared in 50 mM acetate buffer
(pH 5.0) and stored at -20°C until required. Pre-acetylated standards (acetylated as
described in section 2.2.4), QCs and samples (50 |il) were added to 200 pi antibody /
label mix and incubated overnight at 4°C. (Antibody / label mix consisted of 50 mM
acetate buffer, 0.1% BSA, pH 5.0 containing anti-cAMP antibody (1/10000) and tracer
(adenosine 3',5'-cyclic phosphoric acid 2'-0-succinyl-3-[125I]iodo-tyrosine, 105 cpm /
tube)). Assay tubes were incubated at room temperature for 1 h with 100 pi second
antibody preprecipitate (20 ml donkey anti- rabbit antibody and 1.5 ml normal rabbit
serum / 50 ml 50 mM phosphate buffer, pH 7.4). 1.5 ml wash solution (0.15% (v/v) Brij
containing 500 mg / 1 microcrystalline cellulose) was added and the assay tubes
centrifuged at 1800 x g for 30 min at 4°C. The supernatant was decanted and the pellets
counted for 200 s in an LKB/Pharmacia 1261 multigamma counter. The standard curve
was constructed using a smoothed spline fit (LKB / Pharmacia RIACALC package).
Intra-assay CV was < 10% over the range 0.3 - 3 nM and < 20% over the range 0.1 - 20
nM. The inter-assay CV was less than 13% over the range 0.3 - 3 nM. Figure 2.4 shows
an example of the cAMP standard curve generated using this assay.
(Hi) Angiotensin II radioimmunoassay
Specific activity of 125I-angiotensin II prepared by the chloramine T method was
established by the self-displacement method. Separation of bound and free radiolabel
was achieved by adsorption of unbound tracer onto activated charcoal.
Incubations consisted of 100 pi anti-angiotensin II antibody (1 / 300000 final dilution),
100 pi 125I-angiotensin II and 50 pi standard angiotensin II (0.02 - 10.24 ng / ml). All
reagents were prepared in 0.1 M phosphate buffer, 0.1% (w/v) BSA, pH 7.4. Tubes were
incubated overnight at 4°C after which 0.5 ml charcoal solution (0.1 M phosphate buffer
containing 0.5% activated charcoal, 0.05% dextran 0.03% gelatine, pH 7.4) was added.
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FIGURE 2.3 : Representative standard curve for the 125I radioimmunoassay of Cortisol.
Standard solutions of Cortisol (in EBS/BSA/glucose, 1 - 2000 nM) were assayed in
duplicate, and the inhibition curve fitted to a four parameter logistic equation. Label












FIGURE 2.4 : Representative standard curve for the 125I radioimmunoassay of cAMP.
Standard solutions of cAMP (pre-acetylated in EBS/BSA/glucose, 0.0625 - 8 nM) were
assayed in duplicate, and the inhibition curve fitted using a smoothed spline fit. Label
binding in the absence of Cortisol was typically 55-65% of total.
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FIGURE 2.5 : Representative standard curve for the self-displacement of 125-I
angiotensin II by unlabelled (cold) angiotensin II. Standard solutions of angiotensin II
(0.02 - 10.24 ng/ml, in phosphate buffer) were assayed in triplicate. The specific activity
of the label calculated from the standard curve ranged from 500 - 1000 mCi/mg AIL
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charcoal pellets containing free (unbound) tracer counted for 120 s in a gamma counter.
A typical standard curve is shown in Figure 2.5
(iv) Total [3H]phosphoinositol assay
Aqueous neutralised samples recovered from perchloric acid extracts were thawed and
EDTA added to a final concentration of 1 mM. Samples were loaded onto individual
columns of AG1-X8 anion exchange resin (0.25 ml) and the columns washed twice with
4 ml water. The combined eluates from loading and washing (containing free
[3H]inositol) were collected into a 20 ml scintillation vial. Bound [3H]phosphoinositols
were then eluted directly into fresh scintillation vials with 1 M ammonium formate / 0.1
M formic acid. (2x2 ml). Following addition of scintillation fluid (10 ml), radioactivity
was determined by counting on a Canberra Packard 1900CA liquid scintillation counter.
Samples were counted for 10 min each, or to an error of < 1%.
(v) [3H]phosphoinositide assay
The insoluble pellets recovered from the perchloric acid extracts were broken up by
vortexing and dissolved by the addition of 750 ql CHC13 / MeOH / conc. (11.7M) HC1
(100:200:1 v/v) followed by 250 ql each of CHC13 and HC1 (both 0.1 M). The resulting
aqueous and organic phases were separated by centrifugation at 20 x g for 5 min, and 400
ql of the lower [3H]phosphoinositide - containing phase recovered to a scintillation vial.
The solvent was removed under air using a Techne sample concentrator and 3 ml
scintillation fluid added. Radioactivity was determined by scintillation counting.
(vi) Protein assay
Protein content of wells, isolated cells and membrane fractions was determined by the
method of Bradford (1976), adapted for use on the Cobas Fara (Roche) centrifugal
analyser. Samples were washed with 2 x 1 ml 0.9% (w/v) saline, solubilised in 1% (v/v)
Triton X-100 and frozen at -20°C until required. Samples were diluted 1 : 10 with water
and assayed against a standard of BSA made up in 0.1% Triton X-100.
(vii) Cellular lactate dehydrogenase (LDH) assay
Cells were washed twice with 1 ml EBSBG and resuspended in 0.45 ml intracellular
buffer (mM: KC1, 120; NaCl, 20; MgS04, 4.18, EGTA, 1; HEPES, 20, pH 7.4). Cells
were permeabilised by the addition of digitonin (final concentration 50 qM) for 15 min at
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37°C after which cells were centrifuged at 3000 x g for 3 min and the cell-free
supernatant decanted and stored at 4°C prior to assay. Samples were stable for several
days at 4°C but LDH activity was reduced on freezing.
LDH activity was assayed by a modification of the method of Brydon and Smith (1973)
adapted for use on the Cobas Fara centrifugal analyser. Stock NADH (0.2 mM) solution
and stock sodium pyruvate (7.7 mM) solutions were prepared in 0.1 mM KH2P04, pH
7.4. 200 pi NADH solution and 10 pi sample were incubated in each rotor cuvette at
37°C. Blank absorbances were read at 340 nm, and stock pyruvate solution (25 pi) added
to initiate the reaction. Absorbance changes were read at 10 s intervals for 100 s. LDH
activity was determined from the initial rate of decrease of absorbance and expressed as
LDH activity units.
2.2.10 Analysis of data
Unless otherwise stated in the figure legends, data points represent the mean of triplicate
determinations. Where data have been combined from several experiments, the mean ±
standard error of the mean (s.e.m.) is presented. Otherwise, where single representative
experiments are shown, errors are expressed as the standard deviation of the mean (SD).
Statistical differences between mean values were assessed using unpaired Student's t test.
Where data were transformed, statistics were preformed on the raw (untransformed) data.
Transformed data were also analysed using the Mann-Whitney rank sum test. In all
cases, a value of p<0.05 was considered significant.
(i) Analysis of radioligand binding data
For analysis of 125I-angiotensin II binding to cultured cells, All receptor number and
affinity were estimated from the inhibition of equilibrium bound 125I-AII by unlabelled
AIL IC50 values for All obtained from inhibition curves were converted to dissociation
constants (K,) by application of the Cheng-Prusoff transformation (Cheng & Prusoff,
1973):
K; = IC50 / (1 + (L / Kd)
where K, = the equilibrium dissociation constant for the inhibitor, IC50 = the
concentration of inhibitor reducing the binding of label to 50%, L = the concentration of
label, and KD = the label dissociation constant. Assuming that the dissociation constants
for 125I-AII and cold All are similar, the above equation reduces to:
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Kd - IC50 - L
The value of KD thus derived was used to calculate the total number of receptors present
by use of the Langmuir equation:
b = Bmax.L / (L + Kd)
where b = the amount of label bound at equilibrium, Bmax = the total receptor
concentration and L and KD are the label concentration and equilibrium dissociation
constant respectively. The validity of the above approach was confirmed by analysing
inhibition curves as for saturation analysis. At each concentration of inhibitor (unlabelled
All), the specific activity of the label was corrected to take into account dilution of 125I-
AII by cold All:
SA' = SA.L / (L + I)
where SA and SA' are the original and corrected specific activity respectively, and L and
I are the total concentrations of labelled and unlabelled AIL SA' was then used to
calculate the total binding of All (labelled and unlabelled) at each concentration of total
All, and the binding parameters obtained from the resulting saturation curve following
linearisation by Scatchard analysis (b/L vs b). The estimates of KD and Bmax obtained by
this alternative method agreed well with those obtained from values.
(ii) Analysis offunctional data
For analysis of antagonist inhibition curves, data were fitted to a three parameter logistic
function to provide estimates of ID50 values, and ID50 values quoted in the text are the
mean of three such determinations from separate cell preparations.
In order to obtain estimates of dose response parameters, data were fitted using the
function:
y = Rm«/(i + (EC5„/x)f)
where Rmax = maximum response, EC50 = agonist concentration producing 50% of the
maximum response and P = slope factor. Dose response curves in the presence and
absence of antagonist were tested for parallelism according to Kenakin (1987), and
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antagonist pA2 values (-log10 antagonist dissociation constant) estimated according to
Arunlakshana and Schild (1959):
logjo (r-1) = nlog10 [B] + pA2
where r is the dose ratio observed at antagonist concentration [B], and n is the slope of
the Schild regression. pA2 was obtained by extrapolation of the line log10(r-l) vs
log10(B). (Further details regarding the use of Schild analysis for the estimation of
competitive antagonist affinity are given in Chapter 4). The confidence limits of pA2
were calculated as:
pA2 ± ts(l/n + (X)2 / S(B - X)2)1/2
where t = Student's t value, s is the square root of the mean sum of squares about
regression, n is the number of data points and X represents the mean value of log[B].
Where the slope of the Schild regression (n) was not significantly different from unity,
pA2 was calculated using a Shild regression with slope constrained to unity (Mackay,
1978). The confidence limits associated with this estimate were calculated as:
pA2 ± ts / (N),/2
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CHAPTER 3
CHARACTERISATION OF THE DAY-BY-DAY RESPONSIVENESS OF
CULTURED BOVINE ZONA FASCICULATA/RETICULARIS CELLS TO
ACETYLCHOLINE AND ANGIOTENSIN II
3.1 INTRODUCTION
Cultured adrenocortical cell preparations have been widely used for the study of agonist-
stimulated steroidogenesis. The advantages of cell culture systems over other in vitro
adrenocortical preparations have been discussed in section 1.1.6. While zona
glomerulosa cells from a variety of species have routinely been purified and cultured in
the past, few investigators have established purified cultures of inner zone cells.
Although purified rat inner zone cell preparations have previously been widely studied, as
discussed in section 1.6.4, rat zfr cells do not respond steroidogenically to angiotensin II,
and are therefore of limited use as a model for the human adrenal cortex. Bovine
adrenocortical zfr cells, which model more closely the human adrenal cortex, have only
recently been purified and cultured; the majority of investigators have used either acutely
isolated unpurified cells from bovine adrenal cortex slices (Hepp et al, 1977), or
unpurified cultured cells from bovine inner adrenocortical zones.
Williams et al (1989) used the column filtration method originally devised by McDougall
et al (1979) for the purification of rat adrenocortical cells, to establish a primary culture
system of bovine zfr cells. Compared with freshly isolated cells, cells which had been
maintained in primary culture for three days showed better preservation of ultrastructure,
elevated cellular lipid content and enhanced responsiveness to ACTH (Williams et al,
1989). Other workers using bovine zfr cells have observed a similar increase in
steroidogenic responsiveness following primary culture. Kawamura et al (1984) found
that cells were maximally responsive to ACTH following 48-72 h of culture, after which
their sensitivity decreased. A similar culture time-dependent increase in cellular
responsiveness to catecholamines has been reported: freshly isolated cells were
unresponsive to adrenaline, but exhibited a progressively increased response to this agent
following primary culture (Walker et al, 1988). If cultured cells are to be used as an
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experimental model, knowledge of such changes in responsiveness are essential. The aim
of this chapter was to characterise the day-by-day responsiveness of the cell culture
system to All and ACh with respect to steroidogenesis and second messenger generation,




3.2.1 Steroidogenic and second messenger responses to angiotensin II and
acetylcholine
Bovine zfr cells were prepared by collagenase digestion as described in section 2.2.2ii.
Immediately following isolation (day 1), and following 24, 48, 71 and 96 h in primary
culture (days 2 - 5), Cortisol secretion (over 1 h) and [3H]phosphoinositol production
(over 15 min) were measured in response to All (0.1 |lM) (Figure 3.1, upper panel). This
concentration of All is known to maximally stimulate Cortisol secretion from bovine zfr
cells (Bird et al, 1989) Results are expressed as n-fold stimulation ratios to allow data to
be combined from several different experiments. Freshly isolated cells secreted Cortisol
in response to All. Following 24 h in primary culture (day 2), the Cortisol secretory
response to All was significantly reduced, compared to the response of freshly isolated
cells (p<0.05). Steroidogenic responsiveness to All increased to reach a maximum on
day 3 (p<0.01), before declining on days 4 and 5.
The day-by-day changes in [3H]phosphoinositol production in response to All did not
parallel the changes in Cortisol secretion. All-stimulated f3H]phosphoinositol production
was significantly increased on day 2 compared to the response of freshly isolated cells
(p<0.01), and reached a maximum on day 3 (p<0.01) before declining thereafter.
The steroidogenic responsiveness of zfr cells to a maximally effective concentration of
ACh (0.1 mM, Walker et al, 1990) over culture days 1 - 5 is shown in figure 3.1 (lower
panel). As observed for the response to All, cells were consistently less responsive to
ACh on day 2 than on day 1 (p<0.05). In two out of three experiments, the Cortisol
response to ACh was completely absent on day 2. Maximum steroidogenic
responsiveness to ACh occurred on day 3, after which cells became progressively less
responsive to ACh, declining to a minimum on day 5.
[3H]Phosphoinositol production in response to ACh increased over the first three days in
culture (p<0.05), reaching a maximum on day 3 before declining on days 4 and 5.
3.2.2 Day-by-day changes in protein levels/LDH activity
In order to ascertain whether changes in cell number could account for the observed
changes in steroidogenic responsiveness, the protein content of wells was measured on




FIGURE 3.1 : Cortisol secretory response and phospholipase C response (generation of
[3H]phosphoinositols) of bovine zfr cells stimulated with (Top panel) angiotensin II (0.1
fiM) or (Bottom panel) acetylcholine (0.1 mM) on day of isolation (day 1) and on
successive days in primary culture (days 2-5). Results are expressed as n-fold stimulation
ratios, and show the mean + s.e.m. of triplicate determinations from 3 separate cell
preparations. Mean basal values for Cortisol secretion were 6.40, 1.25, 3.25, 5.60 and
2.75 pmol/h/100 fig protein for days 1-5 respectively, and mean basal
[3H]phosphoinositol production was 345, 657, 723, 346 and 321 dpm/15min/100 jig
protein respectively. Results significantly different from that of the previous day are

























































FIGURE 3.2 : Cellular protein content (solid line) and LDH activity (broken line) of
bovine zfr cells on day of isolation (day 1) and on successive days in primary' culture
(days 2-5). Cells were cultured plated down in 12 well culture plates (Top panel), or in
suspension culture in bacterial petri dishes (untreated for cell culture) (Bottom panel).
Results are normalised to a percentage of the control (day 1) levels, and show the mean +
s.e.m. of triplicate determinations from 3 separate cell preparations.
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wells did not vary by more than 20% over the period of study. In addition, LDH activity
released from digitonin-permeablised cells was assayed as an independent measure of cell
number. The levels of LDH activity on each experimental day were in close agreement
with protein levels.
3.2.3 Day-by-day responses of cells cultured in suspension
The possibility that the process of cell adhesion to culture dishes may affect cellular
responsiveness and give rise to the reduced steroidogenic responses to All and ACh
observed on day 2 was investigated using cells maintained in suspension culture. Freshly
isolated cells were maintained in bacterial petri dishes (untreated for cell culture). Under
these conditions cells did not plate down, and could be loosened from the plate by gentle
scraping with a cell harvester. The day-by-day changes in protein levels and LDH
activity under conditions of suspension culture are shown in Figure 3.2 (lower panel).
Protein levels declined slightly over the first 5 days of culture, reaching 75% of the day 1
value after 96 h. As was observed for plated cells, protein content was closely parallelled
by LDH activity on each experimental day.
Cells cultured in suspension were generally less responsive to All and ACh than were
plated cells, although qualitatively similar results were obtained in each case (Figure 3.3).
For both All and ACh, steroidogenic responsiveness was markedly reduced on day 2
compared to the response of freshly isolated cells, and peak responsiveness occurred on
day 3. The [3H]phosphoinositol responses to All and ACh increased steadily from day 1
to day 4, before declining on day 5.
3.2.4 Steroidogenic and second messenger responses to ACTH and adrenaline
The reduced Cortisol secretory responses to All and ACh observed on day 2 of primary
culture appeared to contradict previous studies in this system with other agonists which
indicated that cellular responsiveness to ACTH and adrenaline was increased following
24 h of culture. For comparison, the day-by-day changes in Cortisol secretion and cAMP
formation in response to these agents are shown in Figure 3.4.
Cortisol secretion in response to ACTH increased on each successive day in culture
reaching a maximum on day 4, and declined thereafter (Figure 3.4, upper panel). The
increased responsiveness to ACTH was associated with increased formation of cAMP
over days 1 to 4.
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FIGURE 3.3
FIGURE 3.3 : Cortisol secretory response and phospholipase C response of bovine zfr
cells stimulated with (■) angiotensin II (0.1 |iM) or (□) acetylcholine (0.1 mM) on day of
isolation (day 1), and on successive days after maintenance in primary culture (days 2-5).
Cells were maintained in suspension culture in bacterial petri dishes. Data points are the
mean + SD of triplicate determinations from a single representative experiment.




FIGURE 3.4 : Cortisol and cAMP secretory responses of bovine zfr cells stimulated for
1 h with the (Top panel) ACTH (1-24) (0.1 nM) or (Bottom panel) adrenaline (1 pM) on
day of isolation (day 1) and on successive days after maintenance in primary culture
(days 2-5). Results are expressed as n-fold stimulation ratios and show the mean + s.e.m.
of triplicate determinations from 3 separate cell preparations. Mean basal values for
Cortisol secretion were 6.80, 7.84, 13.10, 11.76 and 15.12 pmol/h/100 pg protein for days
1 to 5 respectively, and mean basal cAMP secretion was 0.129, 0.234, 0.288, 0.176 and
0.190 pmol/h/100 pg protein respectively. Results which differ significantly from the
value of the previous day are indicated (*p<0.05, **p<0.01).
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As previously reported (Walker e: al, 1988), freshly isolated cells did not secrete Cortisol
in response to adrenaline (Figure 3.4, lower panel). However, a small but significant
(p<0.05) response was observed following 24 h in primary culture. This response was
progressively increased on days 3 and 4 before declining on day 5. The increased
steroidogenic responsiveness to adrenaline was paralleled by increased cAMP formation
over days 1 to 4 respectively.
3.2.5 Steroidogenic responsiveness to 8-Bromo cAMP, phorbol ester and Ca2+
ionophore
While steroidogenic responsiveness to ACTH and adrenaline was increased on day 2, that
of All and ACh was clearly reduced. Moreover, the loss of response to All and ACh
occurred at a time when second messenger ([3H]phosphoinositol) formation in response
to these agents was increased. Since different second messenger responses are associated
with the actions of ACTH and adrenaline (adenylate cyclase) compared with All and
ACh (phospholipase C), it was decided to investigate the day-by day responses to 8-
BrcAMP, a cell permeable analogue of cAMP, and a combination of A23187 and PMA,
which mimic the effects of phospholipase C agonists by increasing [Ca2+]; and
stimulating protein kinase C (section 1.3.11).
Cortisol secretion in response to 8-BrcAMP increased progressively over days 1 to 4,
before declining on day 5 (Figure 3.5, upper panel). In contrast, Cortisol secretion in
response to a combination of A23187 and PMA was reduced on day 2 (p<0.01) before
recovering to reach a maximum on day 3, and declining thereafter (Figure 3.5, lower
panel). The effects of A23187 and PMA in isolation were also studied. Although
A23187 alone was relatively ineffective in stimulating Cortisol secretion, no significant
reduction in the Cortisol response to this agent occurred on day 2. However, Cortisol
secretion in response to PMA alone was markedly reduced on day 2 compared with the
response observed in freshly isolated cells.
3.2.6 Day-by-day changes in All receptor number and affinity '
All receptor number and affinity were estimated on each experimental day by measuring
the inhibition of 125I-All binding to cells by unlabelled All. The binding of 125I-AII
reached equilibrium after 60 min at 22°C, and non-specific binding (defined as 125I-AII
binding in the presence of 10 |iM All) represented 1.8% of the total binding (Figure 3.6).
Binding inhibition curves obtained on culture days 1-4 are shown in Figure 3.7, and the
changes in All receptor number and affinity summarised in Table 3.1. While no
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FIGURE 3.5
FIGURE 3.5 : (Upper panel) Cortisol response of bovine zfr cells to 8-bromoadenosine
3':5'-cyclic monophosphate (1 mM) on each of the first 5 days of primary culture. Data
points are the mean + s.e.m. of triplicate determinations from 3 separate experiments.
Mean basal secretion of Cortisol on days 1 to 5 was 6.80, 7.84, 13.10, 11.76 and 15.12
pmol/h/100 jig protein respectively. Values significantly different from those of the
preceeding day are indicated at *p<0.05 and **p<0.01.
(Lower panel) Cortisol secretory response at A23187 alone (A), phorbol 12-myristate
13-acetate (PMA) alone (▼) or A23187 and PMA combined (♦) (both 1 jiM) on days 1
to 5 of culture. Values are the mean + SD of triplicate determinations from a single
representative experiment. Qualitatively similar results was obtained in a total of five





FIGURE 3.6 : Time course of 125I-AII binding to day 3 primary cultures of bovine
adrenal zfr cells. Cells were incubated with 125I-All (105 cpm, approx 0.15 nM) for the
times indicated in a total volume of 1 ml EBS, at 22°C. Non-specific binding was
measured in the presence of 10 (iM unlabelled All, and was 1.8% of the total bound
radioactivity at 60 min.
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FIGURE 3.7
FIGURE 3.7 : Representative experiment showing inhibition of 125I-AfI binding to
primary cultures of bovine zfr cells by unlabelled All on each of the first 4 days of
culture. Cells were incubated with 125I-All (105 cpm, approx. 0.15nM) for 60 min at




Day of culture (nM) Bmax (fmol/mg)
1 1.07 ± 0.21 1203 ± 408
2 2.77 ± 0.82 2661 ± 292*
3 2.62 ± 0.74 3491 ± 670
4 2.05 ± 0.53 2942 ± 687
TABLE 3.1 : Binding parameters for displacement of 125I-angiotensin II by angiotensin
II on each of the first four days in primary culture. Data are the mean ± s.e.m. of
determinations from three separate cell preparations. Values significantly different from
those of the previous day are indicated at *p<0.05.
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difference in All receptor affinity was detected over culture days 1-4, receptor number
was significantly increased over days 1 to 3, consistant with the enhanced
[3H]phosphoinositol response to All observed over this period.
3.2.7 Intracellular Ca1+ response to All
Stimulation of bovine zfr cells by All and ACh is associated with a rise in intracellular
calcium concentration in response to Ins(l,4,5)P3 produced by the action of PLC (Bird et
al, 1990b). Figure 3.8 shows the increase in intracellular calcium in response to All (0.1
(iM) in a single representative day 2 cell following loading with the fluorescent calcium
indicator fura-2. Forty cells from 5 different cell preparadons were analysed in this way.
An increase in intracellular calcium was observed in 68% of cells in response to AIL
These findings are comparable with the intracellular calcium response to All observed on




FIGURE 3.8 : Intracellular calcium response to All (0.1 p.M) from a single fura-2
loaded bovine zfr cell on day 2 or primary culture. The cell was perfused continuously
with modified Kreb's buffer, and All was infused at the time indicated (arrow). The




Consistent with previous observations (Williams et al, 1989; Bird et al, 1988; Walker et
al, 1988), bovine zfr cells showed enhanced responsiveness to ACTH and adrenaline
when maintained in primary culture, compared with the responses of freshly isolated
cells. The increase in Cortisol secretion in response to these agents over experimental
days 1-4 was parallelled by increased formation of cAMP, possibly due to increases in
receptor number or adenylate cyclase units, or indicative of a more efficient coupling of
the receptor/G protein/cyclase complex. However, steroidogenic responsiveness to a
constant dose of 8-BrcAMP also increased over this period, indicating that in addition to
increased cAMP formation, the enhanced responses to ACTH and adrenaline may also be
a result of post-second messenger factors resulting in a tighter coupling between
activation of adenylate cyclase and steroidogenesis. Such factors may include an increase
in the availability of cAMP-dependent protein kinases, or increased steroid synthetic
capacity. Indeed, compared to freshly isolated cells, bovine zfr cells were reported to
show a marked increase in cellular lipid content following primary culture (Williams et
al, 1989). This may reflect an enhanced store of steroid precursors, and could account for
the increased steroidogenic responsiveness to adenylate cyclase agonists observed in this
study.
In contrast, the Cortisol secretory responses to All and ACh were reduced by 24 h in
culture, and then rose to reach peak responsiveness at 48 n, before again declining. This
reduced responsiveness on day 2 was not due to a reduction in cell number, as determined
both by well protein content and digitonin-releasable LDH activity (Figure 3.2). Neither
was the loss of the Cortisol response to All and ACh a consequence of cells plating down
onto culture plastics, since qualitatively similar results were obtained when cells were
maintained in suspension culture. Surprisingly, the fall in Cortisol secretion on day 2 was
accompanied by an increase in PLC activity in response to All and ACh, as determined
by the agonist-stimulated production of [3H]phosphoinositols. Thus, the loss of
responsiveness to All and ACh was not due to reduced second messenger formation,
thereby excluding reduced receptor number or affinity, G-protein availability or PLC
activity as an explanation. Indeed, All receptor number increased in parallel with
[3H]phosphoinositol formation in response to All over days 1-3, and no change in All
receptor affinity was observed.
The loss of response to All and ACh on day 2 of culture was clearly not due to a defect in
the steroid synthetic or secretory mechanisms, as no reduction in sensitivity to ACTH or
adrenaline was observed at this time. Indeed, steroid (Cortisol) secretion increased on day
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2 in response to ACTH and adrenaline. Neither was it due to a failure of the second
messengers formed in response to PIC activation to elevate intracellular Ca2+
concentration, since a clear rise in [Ca2"1"^ was observed in response to All in fura-2
loaded day 2 cells. Moreover, administration of a combination of A23187 and PMA,
which elevate [Ca2+]i and stimulate protein kinase C independently of the receptor/ G
protein complex, failed to restore the reduced Cortisol response on day 2.
It is more likely that day 2 cells are unable to couple the increased Ca2+/DAG signals
formed on receptor activation to the activation of cytochrome P450 side-chain cleavage
enzyme (P450scc), the rate limiting step of the steroid pathway (Stone & Hechter, 1955).
Since the steroidogenic effect of ACTH in bovine adrenocortical cells is Ca2+ dependent
(Yanagibashi, 1979; Kojima et al, 1985c), and the Cortisol response to ACTH was clearly
elevated on day 2, it is unlikely that the coupling of the intracellular Ca2+ signal to the
activation of P450scc is impaired at this time. It is more likely that the loss of
steroidogenic responsiveness to All and ACh on day 2 is due to a failure of DAG formed
on receptor activation to stimulate the protein kinase C signalling system, either due to a
loss of protein kinase C itself, or a loss of one or more of its substrates. In support of this
hypothesis, the steroidogenic effect of PMA, which mimics the effect of endogenous
DAG, was markedly reduced on day 2, while that of A23187, which increases
intracellular Ca2+ concentration, was unchanged (Figure 3.5).
These findings are of interest when compared to the ability of phospholipase C agonists
to stimulate steroidogenesis in other cultured cell systems. While vasopressin has been
reported to stimulate corticosterone secretion from both the pefused rat adrenal gland and
from isolated superfused rat adrenocortical zfr cells (Hinson et al, 1987), it is not
steroidogenic in 3 day primary cultures of rat zfr cells, even though stimulation of PIC
activity by vasopressin can be demonstrated in this system (Gallo-Payet et al, 1986). A
similar stimulation of PIC activity without an accompanying steroidogenic response has
also been reported in Y-l adrenal tumour cells stimulated by vasopressin or All (Langlois
et al, 1988,1990). Furthermore, ovine adrenocortical zf cells do not respond
steroidogenically to All, but exhibit a clear PIC response and increase in intracellular
Ca2+ when stimulated with All (Viard et al, 1990). The data presented in this chapter
indicate that bovine zfr cells enter a non-responsive state similar to that of the rat and
ovine cell systems described above, but recover after 24 h. This raises the possibility that
rat and ovine zfr cells may respond steroidogenically to vasopressin and All following
different periods of culture.
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To summarise, the day-by-dav steroidogenic and second messenger responsiveness of
cultured bovine zfr cells has been investigated. Although freshly isolated cells responded
to ACh and All, cells were maximally responsive to each agonist on days 3 and 4 with
respect to both Cortisol secretion and PIC activation. Subsequent experiments were
therefore performed following 48-72 h of primary culture.
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CHAPTER 4
THE MUSCARINIC RECEPTOR SUBTYPE MEDIATING ACETYUCHOUINE
INDUCED CORTISOU SECRETION FROM BOVINE ZONA
FASCICUUATA/RETICUUARIS CEUUS
4.1 INTRODUCTION
Since stimulation of adrenocortical steroidogenesis in response to ACh was first
demonstrated (Rosenfield, 1955), a number of studies have attempted to classify the
adrenocortical ACh receptor. With the exception of the work of Rubin and Warner
(1975), in which a nicotinic response to ACh was demonstrated in the feline adrenal
cortex, the remaining reports over the last ten years have described a muscarinic response
to ACh in both zg and zfr cells from various species (see section 1.5.5). However, the
muscarinic receptor subtype(s) present in the adrenal cortex have not been identified,
either by radioligand binding or functional analysis, in any species.
Muscarinic receptors are classified according to the differential affinities of selective
antagonists for the various receptor subtypes (section 1.5.2). Antagonist affinity is
expressed as the antagonist equilibrium dissociation constant (KD), the ratio of
association and dissociation rate constants for the combination of antagonist and receptor.
Being a chemical term, KD is largely independent of species or receptor function. The
antagonist KD can be estimated either by direct measurement of the binding of
radiolabeled ligands to receptor preparations (Hulme & Birdsall, 1992), or by analysis of
the antagonism of the functional response to a receptor agonist. Of the various methods
of calculating KD from functional data, two have attracted widespread use. The first
method involves the inhibition of a response to a constant fixed dose of agonist by
increasing concentrations of antagonist. KD is then calculated form the inhibition curve
according to the Cheng-Prusoff relationship (Cheng & Prusoff, 1973). (At present, some
doubt exists regarding the correct transformation of the Cheng-Prusoff equation from
enzyme kinetics to pharmacology - see Craig, 1993; Leff & Dougall, 1993). A more
reliable estimate of KD can be obtained by examining the rightward shifts of a full agonist
dose-response curve in the presence of increasing concentrations of antagonist. The
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degree of shift of the dose-response curve (dose ratio, r) is dependent only on the
antagonist concentration IB) and its dissociation constant (KD), which can be calculated
from the Gaddum-Schild equation (Gaddum, 1937; Arunlakshana & Schild, 1959):
(r-1) = [B] / Kd
The latter method offers a number of advantages over 'Cheng-Prusoff analysis . Firstly,
although both methods are valid only for competitive antagonists, Schild analysis
contains a number of criteria which must be met if the antagonism is truly competitive: a
competitive antagonist should produce parallel shifts of the dose-response curve without
depressing the upper asymptote. Furthermore, a plot of log10 (r-1) versus log10 [B]
should be linear, with gradient not significantly different from unity, for competitive
antagonism. With 'Cheng-Prusoff analysis, the antagonism is assumed to be
competitive, without any experimental justification. Secondly, the calculation of KD from
inhibition curves provides only a single estimate of KD, while the logarithmic Schild plot
described above provides one estimate for each antagonist concentration used to construct
the plot: the Schild regression crosses the x axis at logI0 KD. Finally, the experimental
slope and 'linearity' of the Schild regression provides valuable information regarding the
equilibrium state of the system, and any receptor sub-populations which may be present
(Kenakin, 1985).
In this chapter, following initial investigation of the time course and desensitisation of the
ACh response, the antagonism of ACh-stimulated Cortisol secretion by a number of
selective muscarinic antagonists is investigated by Schild analysis, allowing the
muscarinic receptor subtype mediating ACh-induced Cortisol secretion to be classified for
the first time in adrenocortical cells.
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4.2 RESULTS
4.2.1 Time course ofACh-stimulated Cortisol secretion
Incubation of zfr cells with ACh (0.1 mM) resulted in a time -dependent increase in
Cortisol secretion. As shown in figure 4.1, this response was linear for up to 30 minutes,
after which no further increase in Cortisol secretion was observed. The absolute levels of
Cortisol secretion stimulated in the presence of ACh were very variable between different
cell preparations, even after correction for cell number (as assessed by the well protein
content), making the combination of data from different cell preparations unfeasible.
However, in three out of three experiments, no significant difference between the 30 min
and 60 min time points was observed.
4.2.2 Desensitisation ofACh-stimulated steroidogenesis
In order to ascertain whether the observed deviation from linearity of ACh-stimulated
Cortisol secretion after 30 min was due to breakdown of ACh, or represented a
desensitisation phenomenon, the effect of ACh preincubation on the subsequent
steroidogenic response to ACh was examined. Following exposure to ACh (0.1 mM) for
various lengths of time, cells were washed thoroughly and challenged with fresh ACh
(0.1 mM - 0.1 mM) for 30 min. (figure 4.2). In control cells (preincubation with vehicle
alone) ACh stimulated a dose-dependent increase in Cortisol secretion over the
concentration range 0.1 p.M - 0.1 mM. In two out of three experiments the dose response
curve to ACh was significantly depressed following 30 min preincubation with ACh, with
the maximum response to ACh (0.1 mM) reduced by 64% and 92% respectively. In all
experiments, following 60 or 90 min preincubation, cells were completely unresponsive
to further challenge with ACh. As shown in figure 4.3, this loss of responsiveness was
associated with a reduction in the [3H]phosphoinositiol response to ACh in [3H]inositol
prelabelled cells.
4.3.3 Schild analysis of the antagonism of ACh-stimulated steroidogenesis by selective
muscarinic antagonists
Having established the maximum incubation time possible without inducing
desensitisation, a series of Cortisol dose-response curves to ACh were set up in the
presence of increasing concentrations of the muscarinic antagonists pirenzepine
(M,>M2=M3), methoctramine (M2>Mj=M3), HHSD (M,=M3>M2) and p-FHHSD
(M3>M!=M2) (figures 4.4 - 4.7, upper panels). In each experiment two different
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FIGURE 4.1
FIGURE 4.1 : Time course of ACh-stimulated Cortisol secretion from bovine zfr cells.
Cells were incubated with (A) ACh (0.1 mM) or (■) vehicle for the times indicated.
Data points are the mean + SD of triplicate determinations from one representative
experiment. Significant stimulation relative to time zero is shown at *p<0.05, **p<0.01.
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FIGURE 4.2
FIGURE 4.2 : Desensitisation of ACh-stimulated Cortisol secretion. Cells were
challenged with ACh (0.1 mM) following preincubation with ACh (0.1 mM) for the
following peroids of time: (■) zero; (A) 30 min; (▼) 60 min; (♦) 90 min. Data show
the mean ± SD of triplicate determinations from a single representative experiment.
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FIGURE 4.3 : Desensitisation of ACh-stimulated phosphoinositol production. Cells
were challenged with ACh (0.1 mM) following preincubation with ACh (0.1 mM) for the
following peroids of time: (■) zero; (A) 30 min; (T) 60 min; (♦) 90 min. Data show
the mean ± SD of triplicate determinations from a single representative experiment
Significant inhibition relative to control (no preincubation) values is indicated at *p<0.05,
**p<0.01.
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concentrations of antagonist were assessed, and six such experiments from different cell
preparations performed for each antagonist to generate data for Schild analysis.
Basal Cortisol secretion was 10.4 + 1.4 pmol/well/30 min (mean ± s.e.m., n = 24
experiments). The dose response curve for ACh-stimulated Cortisol secretion fell in the
concentration range 0.1 |aM - 10 mM, and the ED50 for ACh was 1.1 p.M (range 0.4 pM -
7.2 pM). Maximal stimulation of Cortisol secretion occurred at 10 pM ACh, at which
concentration Cortisol secretion was 143.4 + 12.9 pmol/well/30 min (mean ± s.e.m., n =
24).
The effect of each of the antagonists studied was to shift the log dose response curve to
ACh to the right. None of the antagonists had any effect on the maximal response
attainable by ACh, or on the slope of the dose response curve (figures 4.3 - 4.7, upper
panels). The rank order of antagonist potency was HHSD > p-FHHSD > pirenzepine >
methoctramine. For estimation of antagonist affinities, the dose-ratio (r) for each
concentration of antagonist was obtained and Schild plots (log10 (r-1) versus log10
[antagonist]) constructed (figures 4.4 - 4.7, lower panels). The estimated pA2 values and
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FIGURE 4.4 : (Upper panel) Concentration response curves for the secretion of Cortisol
produced on stimulation with ACh alone (■) and in the presence of pirenzepine (T)
3.3(iM, (♦) 10|iM. Data points are the mean + SD of triplicate values from a
representative experiment.
(Lower panel) Schild regression of the antagonism of ACh-stimulated Cortisol secretion
by pirenzepine. Cumulative data from 6 experiments from separate cell preparations (2
concentrations of antagonist per experiment).
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FIGURE 4.5
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FIGURE 4.5 : (Upper panel) Concentration response curves for the secretion of Cortisol
produced on stimulation with ACh alone (■) and in the presence of methoctramine (▼)
10 p.M, (♦) 100 p.M. Data points are the mean + SD of triplicate values from a
representative experiment.
(Lower panel) Schild regression of the antagonism of ACh-stimulated Cortisol secretion
by methoctramine. Cumulative data from 6 experiments from separate cell preparations
(2 concentrations of antagonist per experiment).
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FIGURE 4.6 : (Upper panel) Concentration response curves for the secretion of Cortisol
produced on stimulation with ACh alone (■) and in the presence of HHSD (T) 33 nM,
(♦) 100 nM. Data points are the mean + SD of triplicate values, from a representative
experiment.
(Lower panel) Schild regression of the antagonism of ACh-stimulated Cortisol secretion
by HHSD. Cumulative data from 6 experiments from separate cell preparations (2























FIGURE 4.7 : (Upper panel) Concentration response curves for the secretion of Cortisol
produced on stimulation with ACh alone (■) and in the presence of p-FHHSD (T) 33
nM, (♦) 333 nM. Data points are the mean + SD of triplicate values from a
representative experiment.
(Lower panel) Schild regression of the antagonism of ACh-stimulated Cortisol secretion
by p-FHHSD. Cumulative data from 6 experiments from separate cell preparations (2
concentrations of antagonist per experiment).
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TABLE 4.1
Antagonist pA2 ± s.e.m. slope ± s.e m. Published pA2**
Mi M2 M3
pizenzepine 6.95 ±0.28 1.06 ±0.06+ 8.24 6.82 6.88
methoctramine 6.06±0.27 1.01 ±0.04+ 6.85 7.69 6.17
HHSD 8.68 ±0.28 1.02 ±0.10+ 7.92 6.53 7.96
p-FHHSD 7.96 ±0.29 0.95 ± 0.05+ 6.68 6.01 7.84
fSlope not significantly different from unity
**Data from Lambrecht et al (1989)
TABLE 4.1 : Comparison of experimental pA2 values for pirenzepine, methoctramine,
HHSD and p-FHHSD in zfr cells with previously published values.
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4.3 DISCUSSION
Bovine adrenocortical ACh receptors have previously been characterised as muscarinic
both in the outer zg and the inner zfr (Kojima et al, 1986a; Hadjian et al, 1982). Walker
et al (1990) reported the effects of a number of cholinergic agonists and antagonists on
Cortisol secretion from bovine zfr cells, obtaining preliminary evidence for the presence
of the M3 receptor subtype. However, definitive classification of the muscarinic receptor
subtypes present in the adrenal cortex has not been carried out in any species, either by
ligand binding or functional analysis. The data presented in this chapter establish that
ACh-stimulated Cortisol secretion in bovine zfr cells occurs through activation of the M3
receptor, as discussed below.
Preliminary experiments designed to estimate antagonist affinity in zfr cells were
conducted with an incubation time of 60 min, and produced inconsistent and
irreproducible results (data not shown). Investigation of the time-course of ACh-
stimulated Cortisol secretion revealed a deviation from linearity after 30 min stimulation
(figure 4.1), indicating that quantitative measurements made after this time were not
made at equilibrium. It seemed unlikely that the observed plateau at 30 min was due to
breakdown of ACh: although the concentration of cholinesterase present in the culture
system was not assayed, experiments were performed in a simple balanced salts solution
after extensive washing of the cells. This would be expected to completely remove any
residual cholinesterase activity which may have been present in the complete culture
medium. As shown in figure 4.2, the observed deviation from linearity was due to a
rapid desensitisation of zfr cells to the agonist. Desensitisation in response to ACh is well
documented in other tissues (Higuchi et al, 1985), although there is little information on
the phenomenon in adrenocortical cells. Superfused frog interrenal cells stimulated with
ACh exhibited a marked desensitisation with respect to both corticosterone and
aldosterone secretion following 20 min exposure to ACh (Benyamina et al, 1987). The
time course of desensitisation in these two adrenocortical preparations therefore appears
similar. As reported for muscarinic receptor desensitisation in other systems (Kopp et al,
1990), the loss of functional response to ACh was accompanied by a progressive
reduction in second messenger (phosphoinositol) production following agonist
preincubation. This could result from either internalisation and inactivation of agonist
bound receptors, or by the protein kinase C-mediated inhibition of phospholipase C
(Orenella et al, 1985; Nishizuka, 1956; Liles et al, 1986; L'Alleman et al, 1986).
Having established conditions for stimulation which did not cause desensitisation, the
effect of selective muscarinic antagonist on ACh-stimulated Cortisol secretion was
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assessed. Each of the antagonists employed produced parallel shifts of the log dose
response curve to ACh without depressing the maximum response to ACh, and produced
linear Schild regressions with slopes not significantly different from unity, consistent
with competitive antagonism (Kenakin, 1987). The rank potency order (HHSD > p-
FHHSD > pirenzepine > methoctramine) is characteristic of that of the M3 receptor
(Lambrecht et al, 1989). Furthermore, the experimental pA2 values obtained agree
closely with previously published values at M3 receptors: the relatively low potencies of
pirenzepine (pA2 = 6.95) and methoctramine (pA2 = 6.06) suggest that the steroidogenic
response to ACh is not mediated by M, or M2 receptors respectively (see Mei et al (1989)
for review), while the high pA2 values for HHSD (pA2 = 8.68) and p-FHHSD (pA2 =
7.96) are characteristic of M3 receptor function (Fuder et al, 1985; Lambrecht et al,
1988).
Recently a fourth muscarinic cholinoceptor has been pharmacologically characterised
(M4) (Lazareno et al, 1990; Garcia-Villalon et al, 1991) which appears to correspond to
the m4 gene product (Tietje et al, 1991). While the bovine adrenal medulla has been
shown to express mRNA transcripts exclusively for the m4 receptor, a weak signal for m4
receptor mRNA was also detected in the cortex (Fernando et al, 1991). Although the M4
subtype exhibits high affinity for the M3 -selective compounds HHSiD and p-FHHSiD
(Lazareno et al, 1990), it also has a moderate to high affinity for methoctramine similar to
that of pirenzepine in both ligand binding and functional assays (Lazareno et al, 1990;
Caulfield & Brown, 1991). The low pA2 for methoctramine observed in bovine zfr cells
argues against any significant involvement of the M4 receptor in ACh-stimulated Cortisol
secretion, although the existence of this receptor subtype in zfr cells cannot be excluded
on the basis of the present data.
While the observed pA2 values for pirenzepine, methoctramine and p-FFIHSD correlated
well with the known values at M3 receptors in other systems (Mei et al (1989), and Table
1) that for HHSD was slightly higher than would be expected to occur at any muscarinic
receptor subtype. While this result is not inconsistent with an M3 receptor classification,
since HHSD exhibits highest affinity at M,/M3 receptors, it does require comment. It is
possible that this reflects a species-specific heterogeneity between M3 receptors arising
from differences in receptor structure or G protein coupling. A similarly high affinity for
HHSD (pA2 = 8.5) has been reported previously at M3 receptors in ovine detrussor
smooth muscle (Rivera et al, 1991). Although their study used carbachol as the agonist,
this would not be expected to affect the apparent antagonist affinity, since measurements
of antagonist pA2 values by Schild analysis are independent of the agonist used to elicit
the functional response. The possibility that the unusually high pA., value for HHSD
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obtained in the present study reflects an error in the assay method was also considered.
HHSD is known to be a "sticky" compound, and it is feasible that drug adsorption onto
experimental plastics caused errors in the dilution of the antagonist. This seems unlikely
however, since an incomplete solution of the antagonist would be expected to result in a
lower, rather that a higher apparent pA2 value. Also unlikely is the possibility that
inadequate antagonist equilibration time was allowed before measurement of dose ratios.
The existence of a non-equilibrium steady state would be expected to produce a Schild
regression of slope less than unity (Kenakin, 1985,1987): the experimental Schild slopes
for each antagonist were not significantly different from unity.
The presence of the M3 muscarinic receptor is consistent with the previously reported
effects of ACh in bovine zfr cells : (i) stimulation of phospholipase C activity (Hadjian et
al, 1984a; Walker et al, 1990), the second messenger system associated with the cloned
ml, m3 and m5 gene products, and with native Mt and M3 cholinoceptors (Bonner,
1989); (ii) the lack of effect of ACh on cAMP levels in adrenocortical cells (Hadjian et
al, 1982; Walker et al, 1990); (iii) the inability of the M, selective agonist McN-A-343 to
stimulate Cortisol secretion from bovine zfr cells (Walker et al, 1990).
Although the significance of ACh in regulating adrenocortical steroidogenesis remains to
be established, a number of observations support an in vivo function. ACh stimulates
Cortisol secretion from both the isolated perfused adrenal gland and from freshly isolated
bovine zfr cells (Rosenfield, 1955; Walker et al, 1990). In addition, acetylcholinesterase-
positive innervation of the adrenal cortex has been detected in several species, including
sheep and man (Robinson et al, 1977; Charlton et al, 1991), and a possible role for ACh
in regulating steroidogenesis in man has been proposed (Stem et al, 1989).
In conclusion, the antagonist affinity profile presented in this chapter most closely
resemble that of the M3 receptor, and it is proposed that this receptor subtype mediates
ACh-stimulated Cortisol secretion from bovine zfr cells.
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CHAPTER 5
THE RECEPTOR SUBTYPE MEDIATING ANGIOTENSIN II INDUCED
CORTISOL SECRETION FROM BOVINE ZONA
FASCICULATA/RETICULARIS CELLS
5.7 INTRODUCTION
The development of non-peptide antagonists of All has allowed the unambiguous
demonstration of two subtypes of All receptor, termed ATj and AT2 (reviewed in
Timmermans et al, 1993). The pharmacology, function and tissue distribution of these
receptor subtypes, together with the evidence suggesting the existence of further subtypes
of All receptor, have been discussed in section 1.6. With regard to adrenocortical All
receptors, binding studies have identified both AT, and AT2 sites in the adrenal cortex of
rat, rabbit, monkey and human species (Chiu et al, 1989a; Whitbread et al, 1989; Chang
& Lotti, 1991). By contrast, in the bovine adrenal cortex, the majority of All receptors
appear to belong to the AT, class, and AT2 sites have been found to be either completely
absent (Balla et al, 1991), or present at very low density (Ouali et al, 1992).
In bovine adrenal zg cells, the effects of All on aldosterone secretion and inhibition of
ACTH-stimulated cAMP formation are mediated by AT, receptors (Balla et al, 1991). In
addition, growth of the bovine adrenocortical AC1 cell line in response to All occurs via
AT, receptors (Natarajan et al, 1992). However, the receptor subtype mediating the
effects of All in bovine zfr cells has not been characterised, and it is the aim of this
chapter to characterise the receptor subtype mediating All induced Cortisol secretion from
bovine zfr cells.
In view of the increasing evidence suggesting the existence of subtypes of AT, receptors
(see section 1.6.2) it is perhaps insufficient to simply demonstrate sensitivity of a given
response to a selective All antagonist in order to make statements about the receptor
mediating the response. If the current system of muscarinic receptor classification is
considered, in which selective antagonists are active at all muscarinic receptor subtypes,
but differ only in their degree of potency between subtypes, then the need for accurate
117
determination of antagonist potency at All receptors becomes clear. Few investigators
have reported pA2 values for non-peptide All antagonists, and no such measurements
have been made in adrenocortical preparations. For these reasons, it was decided to use
Schild analysis to obtain antagonist pA2 values in bovine zfr cells.
Following a recent report that multiple All receptors could be identified in rat tissues by
isoelectric focusing (Jimenez et al, 1991), it was also decided to apply this methodolgy to
membrane fractions prepared from bovine zfr cells. Isoelectric focusing has been used
for many years as a preparative or analytical method for separating molecules, especially
proteins, according to differences in their isoelectric point (p/), the pH at which the
molecule exhibits a net charge of zero (reviewed in Rilbe, 1976). The technique depends
on the properties of ampholines, polyamino/polycarboxylic acids which line up to form a
natural pH gradient in the presence of an electric field due to their high conductance and
buffering capacity. When incorporated into polyacrylamide gels, ampholines form a pH
gradient across the gel through which proteins migrate to the region of the gel
corresponding to their pi. The position of the proteins in the gradient can be detected by
staining, enzymatic, or, in the case of radiolabeled proteins, by autoradiographic means.
Importantly, the pi of a protein is independent of molecular size, and, since very small
differences between molecules may have a large effect on their pi, closely related
molecules can be separated by this method.
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5.2 RESULTS
5.2.1 Effect of selective and non-selective antagonists on All-stimulated Cortisol
secretion and PLC activity
Previous studies have established that All-stimulated Cortisol secretion from bovine zfr
cells is mediated through the activation of PLC (see section 1.6.4). Cells prelabelled with
[3H]inositol for 48 h secrete Cortisol and produce aqueous [3H]phosphoinositols in
response to All with similar dose-dependency (Bird et al, 1989). The effects of the non¬
selective antagonist saralasin and the AT,-selective antagonist losartan on All-stimulated
Cortisol secretion and [3H]phosphoinositol production are shown in Figures 5.1 and 5.2
respectively.
Mean basal Cortisol secretion was 5.37 + 0.83 pmol/well/h, and secretion stimulated by a
maximally effective concentration of All (10 nM) was 491.4 + 53.1 pmol/well/h. Both
saralasin and losartan dose-dependently inhibited Cortisol secretion in response to All (10
nM) with ID50 values of 120 nM (range 62 - 150 nM) and 3.1 |iM (range 0.2 - 7.9 (iM)
respectively (Figure 5.1). Complete inhibition of All-stimulated Cortisol secretion
occurred at 10 |iM saralasin and 100 p.M losartan.
Mean basal [3H]phosphoinositol production was 4774 ± 286 dpm/well/15 min. In the
presence of All (10 nM) [3H]phosphoinositol production was 59581 ± 8960 dpm/well/15
min. As shown in Figure 5.2, the production of [3H]phosphoinositols in response to All
was also dose-dependently inhibited both by saralasin and losartan with ID50 values of 51
nM (range 19 - 69 nM) and 0.49 (J.M (range 0.3 - 1.1 p.M) respectively.
Figure 5.3 shows the effect of the AT2-selective antagonist PD123177 on All-stimulated
Cortisol secretion and PLC activity. PD1231777 did not significantly affect the
magnitude of the steroidogenic or second messenger responses to All at concentrations
up to 0.1 mM antagonist. However, a small but non-significant depression of All-
stimulated [3H]phosphonositol secretion was observed at low (1-10 nM) concentrations
of PD123177.
5.2.2 Effect of saralasin and losartan on the Cortisol dose-response curve to All
To further characterise the antagonism of All-stimulated Cortisol secretion by saralasin
and losartan, Schild analysis was performed to obtain antagonist pA2 values.
Representative experiments are shown in Figures 5.4 and 5.5. Both saralasin (10 nM -
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FIGURE 5.1
FIGURE 5.1 : Effect of saralasin and losartan on All-stimulated Cortisol secretion by
bovine zfr cells. Cells were incubated with either All (10 nM) alone, or All (10 nM) in
the presence of increasing concentrations of (■) saralasin or (A) losartan. Values are
expressed as a percentage of the control (All, 10 nM) response, and are the mean + s.e.m.
of triplicate determinations from three independent cell preparations. Significant




FIGURE 5.2 : Effect of saralasin and losartan on All-stimulated phosphoinositol
production by bovine zfr cells. Cells were incubated with either All (10 nM) alone, or
All (10 nM) in the presence of increasing concentrations of (■) saralasin or (▲) losartan.
Values are expressed as a percentage of the control (All, 10 nM) response, and are the
mean + s.e.m. of triplicate determinations from three independent cell preparations.




FIGURE 5.3 : Effect of PD123177 on All-stimulated Cortisol secretion (□) and
phosphoinositol production (O) by bovine zfr cells. Cells were incubated with either All
(10 nM) alone, or All (10 nM) in the presence of increasing concentrations of PD123177.
Data points are expressed as a percentage of the control (All, 10 nM) response, and show
the mean + s.e.m. of triplicate determinations from three independent cell preparations.
Significant inhibition relative to the control All response is indicated at (*) p < 0.05 and
(**) p<0.01.
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0.33 |iM) and losartan (0.33 p.M - 10 |iM) produced parallel rightwards shifts of the dose-
response curve to All without depressing the maximum response attainable by All,
consistent with competitive antagonism. The resulting Schild regressions are shown in
Figure 5.6, and the extrapolated pA2 values and Schild slopes for saralasin and losartan,
together with previously published values for these antagonists, summarised in Table 5.1.
.5.2.3 Separation ofAll receptor binding proteins by isoelectric focusing
Membrane fractions from bovine zfr cells were labelled with 125I-All and fractionated by
isoelectric focusing on polyacrylamide gels containing pharmalyte pH 5.0 - 8.0 (Section
2.8). This procedure establishes a pH gradient across the gels (Figure 5.7), through which
proteins migrate to the region of the gel corresponding to their isoelectric point (pi).
Following autoradiography, at least two distinct 125I-AII binding proteins were visible
(Figure 5.8), of pi 7.6 and 7.3 respectively. In two out of five experiments, a third very
faint band was visible at pH 7.1 (Figure 5.8). In order to identify these binding proteins,
incubations were carried out in the presence of selective antagonists. PD123177 (10 p.M)
had no effect on the binding to either the major (pi 7.3) or the minor (pi 7.6) protein,
while in the presence of losartan (10 jiM) 125I-AII binding to both proteins was reduced to




FIGURE 5.4 : Representative experiment showing the effect of saralasin on the dose
response curve for All-stimulated Cortisol secretion from bovine zfr cells. Cells were
incubated with All at the concentrations indicated either in the absence of antagonist (■),
or in the presence of saralasin at the following concentrations: (A), 10 nM; (▼), 33 nM;
(♦), 100 nM. Values are the mean + SD of triplicate determinations.
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FIGURE 5.5
FIGURE 5.5 : Representative experiment showing the effect of losartan on the dose
response curve for All-stimulated Cortisol secretion from bovine zfr cells. Cells were
incubated with All at the concentrations indicated either in the absence of antagonist (■),
or in the presence of losartan at the following concentrations: (A), 0.33 (iM; (▼), 1.0
(iM; (♦), 3.3 (iM. Values are the mean + SD of triplicate determinations.
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FIGURE 5.6
FIGURE 5.6 : Schild regression (least squares fit of log,0 (r-1) vs. log10 [antagonist],
where r = dose ratio) of the antagonism of All-stimulated Cortisol secretion by (•)
saralasin and (■) losartan. Combined data from eight separate cell preparations.
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TABLE 5.1
Antagonist p\2 (95% CL) slope (95% CL) Published pA2
saralasin 8.79 (8.41-9.17) 0.81 (0.66-0.96)+ 9.01~
losartan 7.02 (6.89-7.15) 0.93 (0.85-1.02) 8.48-*
+Slope significantly different from unity, p<0.05
Data from : °°Liu et al (1992), *Chiu etal (1990)
TABLE 5.1 : Comparison of experimental pA2 values for saralasin and losartan in zfr
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FIGURE 5.7 : Calibration of pH gradient across isoelectric focusing gels. Gels were
loaded with protein markers of known isoelectric point and electrofocusing performed as
described in Materials and Methods. The distance of each protein from the cathode is
expressed as a percentage of the inter-electrode distance. Protein markers were (in order
of decreasing Pi): lentil lectin - acidic, myoglobin - basic band, myoglobin - acidic band,
carbonic anhydrase B (human), carbonic anhydrase B (bovine), (3-lactoglobulin A.
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FIGURE 5.8
FIGURE 5.8 : Autoradiography of solubilised 125I-AII binding proteins fractionated by
isoelectric focusing. Crude membrane fractions from cultured bovine zfr cells were
labelled with 125I-All in the presence or absence (-) of the following displacing agents:
(los), losartan 10 (lM; (PD), PD12317, 10 pM; (nsb), unlabelled All, (lOpM). The pH
gradient is indicated on the right.
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5.3 DISCUSSION
Bovine adrenocortical All receptors were originally characterised according to the ability
of peptide analogues of All to inhibit the binding of 125I-AII to adrenocortical
microsomal membrane fractions (Glossman et al, 1974a,b; Catt & Aguilera, 1980).
Although preliminary evidence for All receptor heterogeneity was obtained (see section
1.6.1), definitive evidence for the existence of at least two subtypes of All receptor
awaited the development of the non-peptide antagonists losartan and PD123177, which
bind selectively to ATj and AT2 sites repectively. While both ATj and AT2 sites are
clearly present in rat, rabbit and human adrenal cortex (Chiu et al, 1989b; Whitbread et
al, 1989; Chang & Lotti, 1991), bovine adrenocortical cells (unpurified) were reported to
contain only the ATj site (Balla et al, 1991). By contrast, Ouali et al (1992) found both
ATj and AT2 binding sites in purified bovine zf cells. In the present chapter, the receptor
subtype mediating All-induced Cortisol secretion from bovine zfr cells has been
characterised using antagonist displacement, Schild and isoelectric focusing analyses.
As shown in Figures 5.1 - 5.3, All-stimulated Cortisol secretion and [3H]phosphoinositol
production were dose-dependently and completely inhibited both by saralasin and
losartan, indicating the involvement of the ATj receptor in All-stimulated
steroidogenesis. Consistent with this hypothesis, the AT2-selective antagonist PD123177
was without effect on either Cortisol secretion or second messenger formation stimulated
by AIL These findings are in agreement with those of Ouali et al (1992), who
demonstrated AT, receptor-mediated Cortisol secretion and PI turnover in bovine zf cells.
This receptor subtype is also known to mediate All-stimulated aldosterone secretion from
cultured bovine zg cells (Balla et al, 1991) and from freshly isolated rat adrenal capsular
cells (Chang & Lotti, 1989).
Closer examination of the inhibition curves shown in Figures 5.1 and 5.2 reveal two
additional points requiring consideration. Firstly, while the curves for the antagonism of
All-stimulated Cortisol secretion and [3H]phosphoinositol production by saralasin were of
the classical steep sigmoid shape, those for losartan were flatter, covering a larger
antagonist concentration range (3-4 log units), possibly indicating complex antagonistic
effects of losartan. Secondly, the potency of losartan in inhibiting the steroidogenic and
second messenger responses to All was lower than expected: transformation of the ID50
values for losartan according to the Cheng-Prusoff relationship (Cheng & Prusoff, 1973)
would produce K; values in the region of 10~7M, while previous binding studies in other
tissues reported Kj values for losartan of 10~9 - 10"8M (see Timmermans et al, 1993). For
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these reasons, the antagonism of All-stimulated Cortisol secretion by saralasin and
losartan was further characterised by Schild analysis.
Saralasin produced parallel shifts of the All dose-response curve without depressing the
maximum response attainable by All, consistent with competitive antagonism. The
extrapolated pA2 for saralasin (8.79) agreed well with previous reports in other systems
(Table 5.1). Peptide analogues of All have previously been reported to exhibit partial
agonist properties, and saralasin has also been described as a non-competitive antagonist
of All-stimulated responses both in vitru (Wong et al. 1990; Freer et al, 1980) and in vivo
(Chiu et al. 1988), as indicated by its non-parallel shifts of the dose response curve and
depression of the upper asymptote. No such activity was observed for the antagonism of
All-stimulated Cortisol secretion from bovine zfr ceils. It is possible that the doses of
saralasin employed (10 nM - 0.33 pM) were insufficient for partial agonism to be
detected. However, depression of the maximum response to All-induced contraction of
rabbit aorta by saralasin is apparent at 3 nM saralasin (Wong et al, 1990). As reported by
others (Liu et al, 1992), the slope of the Schild regression for saralasin was significantly
lower than unity. This may be indicative of a saturable agonist uptake process which
would result in underestimation of the dose ratios and produce a Schild regression of
slope less than unity (Kenakin, 1985). Indeed, uptake of All by cultured bovine
adrenocortical cells has been reported, with All internalisation occurring with a half-time
of 10 min (Crozat et al, 1986). A further possibility is that saralasin acts in a non¬
competitive manner as reported by Wong et al (1990). In tissues with a large receptor
reserve this would result in parallel shifts of the dose response curve without depression
of the maximal response at low antagonist concentrations.
Consistent with previous reports (Liu et al, 1992; Chiu et al, 1990), losartan appeared to
act as a classical competitive antagonist, producing parallel shifts of the dose response
curve to All without depressing the maximum response. Moreover, the resultant Schild
regression was linear with slope not significantly different from unity. However, the
extrapolated pA2 value for losartan (7.02) corresponds to an affinity some 30 times lower
than that previously reported for the antagonism of All-mediated contraction of rabbit
aorta (pA2 = 8.48, Table 5.1). This observation is in agreement with the low IC50 values
obtained for losartan (Figures 5.1 and 5.2). Although differences in assay conditions
might be expected to lead to a small difference in pA2 values for the same receptor, pA2
measurements are generally in close agreement between laboratories (Schild, 1949).
It seems likely that this discrepancy between the pA^ values for losartan in bovine zff
cells compared with rabbit smooth muscle represents a true difference since a reduced
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potency of losartan in bovine adrenal cortex has been reported in previous binding
studies: losartan was around ten-fold less potent in inhibiting 125I-AII binding to bovine,
than to rat, adrenocortical AT, receptors (Balla et al, 1991). A similarly low K, for
losartan was reported in cultured bovine zf cells (Ouali et al, 1992). It is unlikely that
this difference can be accounted for by differences in the AT, receptor microenvironment
between species: comparison of the 125I-AII displacement curves in membrane fractions
of COS-7 cells transfected with AT, receptor cDNA from bovine adrenal cortex (Sasaki
et al, 1991) or rat vascular smooth muscle (Murphy et al, 1991) reveal a reduced potency
of losartan at the adrenal (IC50 = 3xlO"7M) compared to the vascular (IC50 2 5xlO"9M)
receptor. Although this difference has been attributed to differences in the assay
conditions between laboratories (Catt & Abbot, 1991), the pA2 values obtained in the
present study, together with the binding data discussed above, raise the possibility that
losartan may recognise a distinct subtype of AT, receptor in bovine adrenal cortex with
different pharmacological characteristics to those AT, receptors previously described.
This hypothesis would accord with previous functional studies in adrenal and vascular
tissues: although All acts via the AT, receptor in both bovine adrenal cortex and rat
vascular smooth muscle (Balla et al, 1991; Ouali et al, 1992; Chiu et al, 1991), the All
peptide analogues (sar)5-AII and (pro)3-AII were weak agonists/partial antagonists of All-
mediated responses in bovine adrenocortical cells, but acted as full antagonists in rat
aortic smooth muscle cells (Capponi et al, 1991).
Although several subtypes of losartan-sensitive All receptors have been cloned (section
1.6.5), the receptor mediating All-induced Cortisol secretion from bovine zfr cells does
not appear to resemble any previously characterised receptor. The cloned ATia and AT,B
receptor subtypes isolated from rat (Kakar et al, 1992) and murine (Sasamura et al, 1992)
tissues bound losartan with equal and high (low nanomolar) affinity. Moreover, the novel
All receptor recently isolated from from the rat adrenal glomerulosa does not resemble
the bovine zfr recepor since this subtype (termed AT3) exhibited a higher affinity for
losartan than the previously characterised AT, receptors (Sandberg et al, 1992).
In an attempt to further characterise the bovine zfr All receptor, membrane fractions from
zfr cells were labelled with 125I-All, fractionated by isoelectric focusing, and the bound
label visualised by autoradiography. This technique, which separates proteins according
to differences in charge rather than molecular wight, has previously been shown to
separate multiple isoforms of oestrogen receptor (Baker et al, 1992), epidermal growth
factor receptor (Wenisch et al, 1992), as well as DTT-sensitive and -insensitive (ie. AT,
and AT-,) binding proteins from rat tissues (Jimenez et al, 1991). Following isoelectric
focusing, two distinct bands were visible, migrating to isoelectric points (p/) of 7.3 and
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7.6. Jimenez et al (1991) resolved up to four separate All binding proteins in rat tissues
by isoelectric focusing, of p/ between 6.3 and 6.8. Thus the receptor isoforms identified
in bovine zfr cells do not appear to correlate with those present in the rat. Although the
focusing conditions used in the present study were similar to those of Jimenez et al with
respect to time, voltage and current, these authors did not state whether such condidons
were sufficient to allow ensure migration to the true pi, or whether they simply allowed
separation of the different receptor isoforms. Furthermore, a number of differences exist
between the two methodologies with respect to the carrier ampholyte used (pharmalyte vs
ampholine), method of gel polymerisation (ammonium persulphate vs riboflavin/UV
light), electrode solutions and focusing temperature. Since all of these conditions are
known to affect the apparent equilibrium pi (Crambach & Baumann, 1976), comparison
of the pi values obtained in this study with those of Jimenez et al may not be valid. It
should also be noted that while the present study utilised membrane fractions prepared
from a purified zfr cell preparation, the study of Jimenez et al identified All binding
proteins using membranes prepared from a whole gland homogenate. It is likely that this
preparation contained membrane particles from a variety of cell types such as vascular
tissue, red blood cells and mast cells, all of which may contain All receptors.
In an attempt to identify the two 125I-AII binding proteins present in bovine zfr cells,
incubations were performed in the presence of selective displacing agents. Binding of
125I-AII to both proteins was inhibited in the presence of losartan, but was not affected by
PD123177. The absence of PD123177-displaceable binding is in agreement with
previous binding studies which either failed to detect AT2 binding sites (Balla et al,
1991), or found a very low density of AT2 sites (Ouali et al, 1992), in bovine
adrenocortical cells. While it is tempting to speculate that the two losartan-sensitive
bands represent distinct subtypes of AT, receptor, a number of possibilities could account
for their presence. It is possible that one of the bands represents a proteolytic breakdown
product of the AT, receptor, although whether such a molecule would retain its 125I-AII
binding properties is doubtful. Alternatively, the two bands may represent glycosylated
and de-glycosylated forms of the same receptor: sequence analysis of the cloned AT,
receptor from bovine adrenal cortex showed three potential N-gycosylation sites (Sasaki
et al, 1991). Furthermore, the purified rat liver AT, receptor was shown to be heavily
glycosylated (Desarnaud et al, 1993). This possibility seems unlikely however, since the
purified All receptor from various tissues has a molecular weight corresponding to the
glycosylated form of the receptor (ca. 65 kD) (Guillemette et al, 1987; Guillemette &
Escher, 1983; Desarnaud et al, 1993), and deglycosylation of purified AT, receptors
required quite harsh chemical or enzymatic procedures (Desarnaud et al, 1993). Thirdly,
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the bands may represent phosphorylated and de-phosphorylated forms of the receptor, or
sulphydryl-oxidised/reduced forms.
The possibility that bovine zfr cells contain two distinct subtypes of AT, receptor,
analogous to other All target tissues (Kakar et al, 1992; Iwai & Inagami, 1992; Sandberg
et al, 1992), would accord with the reported differential potency of losartan in inhibiting
All-stimulated responses in these cells. Losartan was around 60-fold more potent in
inhibiting All-stimulated [3H]thymidine incorporation into bovine zfr cells than in
inhibiting the steroidogenic response to All (Clyne et al, 1993).
Although the present results are clearly insufficient to confirm or exclude this possibility,
such a hypothesis would be in agreement with the available data. The presence of two
distinct AT, receptors, each subserving the same response (ie. linked to PLC) but with
different affinities for losartan, would be expected to result in a biphasic antagonist
inhibition curve. However, if the affinities of the two receptors for losartan were not
greatly different (ca. 1 log unit difference), then the two phases of the inhibition curve
would appear to merge, forming a more shallow monophasic curve such as those
presented in Figures 5.1 and 5.2. By contrast, saralasin, which exhibits equal affinity for
all known All receptors (Timmermans et al, 1991), would produce a steep classical
monophasic inhibition curve. Moreover, such a situation would not necessarily be
evident from Schild analysis, which could produce a linear Schild regression of unit slope
for losartan (Kenakin, 1985). This hypothesis should be open to experimental testing,
since in the situation described above, the antagonism of a heterogenous receptor
population by losartan would be expected to result in agonist-dependent Schild
regressions (Kenakin, 1985). Furthermore, the densitometric analysis of the effect of
increasing concentrations of losartan on the All binding proteins separated by isoelectric
focusing would provide estimates of the affinity of losartan for each binding site.
In conclusion, the results presented in this chapter establish that All-stimulated Cortisol
secretion from bovine zfr cells occurs through activation of the AT, receptor. However,
this receptor appears to exhibit different characteristics from the previously characterised
AT, receptor in other tissues, based on the low potency of losartan in zfr cells. In
addition, isoelectric focusing experiments have raised the possibility that bovine zfr cells
contain two distinct AT, receptors, and the address of this question should prove a fruitful
area of future research.
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CHAPTER 6
HORMONE-SENSITIVE AND -INSENSITIVE POOLS OF
PHOSPHOINOSITIDES IN BOVINE ZFR CELLS STIMULATED WITH
ACETYLCHOLINE AND ANGIOTENSIN II
6.1 INTRODUCTION
Over the past thirty years considerable advances have been made in the understanding of
receptor-mediated Ptdlns metabolism. One area which still remains controversial,
however, is the concept that discrete pools of inositol phospholipid may be involved in
signal transduction, ie. that cells may contain hormone-sensitive and -insensitive pools of
phosphoinositides. That only a small proportion of total cellular lipid is accessible to
hormone-stimulated catabolism was first suggested by Hokin and Hokin (1964), based on
their studies of 32P metabolism in the avian salt gland. Subsequent studies have largely
been conducted using the rat mammary tumour (WRK-1) cell line. Thus Monaco (1982)
found that vasopressin could stimulate loss of 32P from Ptdlns fractions of 32P labelled
WRK-1 cells if, and only if, vasopressin was itself included during the 32P labelling
period. This vasopressin-sensitive pool of phosphoinositides was shown to account for
around 17% of total cellular Ptdlns (Monaco, 1982). Subsequent studies designed to
characterise the hormone-sensitive pool of phosphoinositides in WRK-1 cells found that
it was discrete, in that no transfer of Ptdlns between hormone sensitive and -insensitive
pools occurred (Monaco & Woods, 1983). Furthermore, PtdIns(4,5)P2 derived from
hormone-sensitive Ptdlns was itself accessible for signal transduction, whereas that
derived from hormone-insensitive Ptdlns was not (Koreh & Monaco, 1986).
A variety of cells from different tissues/species have now been proposed to contain
multiple pools of phosphoinositides, including rabbit and horse platelets (Vickers &
Mustard, 1986; Billah & Lapetina, 1982), rat liver, pancreas and brain (Putumraj &
Slaby, 1982; Rana et al, 1986; LaBarca et al, 1985), rabbit kidney (Schwartzman et al,
1981) and human neutrophils and erythrocytes (Muller et al, 1986; Cockcroft & Allan,
1984; King et al, 1987).
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The possible occurance of distinct subpools of phosphoinositides in adrenocortical cells
has been little studied. However, Bird et al (1992c) obtained evidence for the presence of
two metabolically distinct hormone-sensitive phosphoinositide pools in [3H]inositol
labelled bovine zfr cells. When stimulated with All, [3H]inositol phosphate production
occurred through turnover of a small (30%) pool of [3H]phosphoinositides maintained
through utilisation of cytosolic [3H]inositol for up to 30 min. After this time, when
cytosolic [3H]inositol became depleted, a second (45%) pool of phosphoinositides was
metabolised until it too became depleted after a further 60 min (Bird et al, 1992c).
Given this evidence for multiple phosphoinositide pools in bovine zfr cells, an important
question is whether a common pool is broken down in response to different agonists, or
whether different agonists stimulate the catabolism of discrete subpools of
phosphoinositides. In this chapter, evidence is presented to suggest that in bovine zfr
cells, ACh and All stimulate the breakdown of a common phosphoinositide pool.
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6.2 RESULTS
6.2.1 Correlation between acetylcholine- and angiotensin Il-stimulated Cortisol
secretion and PLC activity
Figures 6.1 and 6.2 show dose response curves for the secretion of Cortisol and
production of [3H]phosphoinositols (in cells labelled to steady state with [3H]inositol) in
response to ACh and All respectively. For both ACh and All, the dose-response curves
for Cortisol secretion and phosphoinositol production fell in a similar dose range (107 -
104M for ACh (Figure 6.1), 3 x 1011 - 3 xlO"9M for All, Figure 6.2). In addition, the
EC50 values for each response were similar: ACh stimulated Cortisol secretion and
phosphoinositol production with EC50 values of 1.81 x 10~6M and 1.06 x 10"6M
respectively, while the EC50 values for All-stimulated steroidogenesis and second
messenger formation were 1.3 x 10"10M and 2.45 x 10"10M. Plotting the magnitudes of
the Cortisol and phosphoinositol responses as a function of each other revealed a highly
significant correlation between PLC activation and Cortisol secretion for each agonist
(Figure 6.3): the correlation coefficients (r) for ACh and All were 0.972 and 0.964
respectively (both p<0.01). Moreover, the gradients of the two regression lines were not
significantly different (8.32 + 1.21 for ACh and 8.34 + 1.07 for All)
6.2.2 Partial additivity of acetylcholine- and angiotensin Il-stimulated Cortisol
secretion and phosphoinositolproduction
In order to determine if any additivity of effect occurred on co-addition of ACh and All,
the effect of submaximal (10"9M) and maximal (10"7M) doses of All on ACh-stimulated
phosphoinositol production and Cortisol secretion was investigated. Examples of such
experiments are shown in Figures 6.4 and 6.5. Responses were termed "additive" if the
incremental response to ACh was the same magnitude in the presence and absence of AIL
In five out of eight experiments, ACh (10"6M) stimulated a significant (P<0.05) increase
in phosphoinositol production over basal levels in cells pre-labelled to steady state with
[3H]inositol, while phosphoinositol production in the presence of ACh (KHM) was
significantly increased (p<0.01) in all experiments (n=8) (Figure 6.4, upper panel).
When repeated in the presence of All (109 M) the effects of ACh (KHM) on
phosphoinositol production were partially additive. The extent of additivity ranged from
0% to 100% between experiments (0% additivity representing no effect of ACh over the
All response, 100% additivity representing an equal incremental increase in the
phosphoinositol response to ACh in the presence and absence of All). In two out of eight
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FIGURE 6.1 : Dose response curves for acetylcholine-stimulated Cortisol secretion (■)
ind phosphoinositol production (A) from bovine zfr cells. Data points are the mean +
SD of triplicate measurements from one experiment. Significant stimulation relative to
:ontrol values is indicated at *p<0.05, **p<0.01.
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FIGURE 6.2
FIGURE 6.2 : Dose response curves for angiotensin II-stimulated Cortisol secretion (■)
and phosphoinositol production (A) from bovine zfr cells. Data points are the mean ±
SD of triplicate measurements from one experiment. Significant stimulation relative to
control values is indicated at *p<0.05, **p<0.01.
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FIGURE 6.3
FIGURE 6.3 : Correlation between acetylcholine- and angiotensin Il-stimulated Cortisol
secretion and phosphoinositol production in bovine zfr cells. Cortisol secretion and
phosphoinositol production were measured in response to acetylcholine (10"9-10"3M) (A)
and angiotensin II (10"u- 10"7M) (•). Results are expressed as n-fold stimulation ratios
and show the linear relationship between Cortisol secretion and phospholipase C activity
(as measured by the accumulation of total labelled phosphoinositol headgroups) for both
agonists. Each data point represents the mean + s.e.m. of data from 3-6 experiments,
each performed in triplicate.
140
in five out of eight experiments the effect of both agonists on phospholipase C activity
was greater than the effects of either agonist alone (p<0.05) (ie. partially additive), while
in one experiment, no further increase in phosphoinositol production over the All
response was observed in response to ACh.
The effects of ACh and All on Cortisol secretion were also assessed (Figure 6.4, lower
panel). As before, variable results were obtained, with additivity ranging from 0%-
100%. Full additivity in the responses to ACh (ICHM) and All (109M) occurred in two
out of eight experiments, partial additivity in three out of eight experiments, and in the
remaining three experiments, no further increase in Cortisol secretion over the response to
All occurred in response to ACh.
The effects of ACh on phospholipase C activity and Cortisol secretion stimulated by a
maximal dose of All (10"7M) were also studied (Figure 6.5). In eight out of eight
experiments, no significant increase in PLC activity stimulated by All (107M) occurred
on co-administration of ACh (106M, ICHM). Similarly, in seven out of eight
experiments in which Cortisol secretion was measured as the end response, no effect of
ACh on All (107M)-stimulated Cortisol secretion was observed. In one experiment, the
effects of ACh (HHM) and All (KHM) were partially additive (p<0.05).
6.2.3 Effects of acetylcholine and Mn2+ pre-incubation on All-stimulated
redistribution of radioactivity between phosphoinositides, phosphoinositols and free
inositol
Cells were labelled for 6 h with [3H]inositol in the presence or absence of ACh (KHM)
or MnCl2 (103M) (see section 2.2.5ii), and subsequently challenged with All (10"7M) in
the presence of lithium for 15 min or 2h. The resultant distribution of radioactivity
between phosphoinositide, free inositol and phosphoinositol fractions in such cells is
shown in Figures 6.6 and 6.7 respectively. Previous studies have shown that under these
labelling conditions, the majority of the radiolabel is found in the free inositol fraction
(Bird et al, 1992c).
In control cells (no prestimulation during the labelling period), subsequent acute (15 min)
stimulation with All resulted in increased turnover of the phosphoinositides. This was
apparent from the increased accumulation of label in both the [3H]phosphoinositide and
[3H] phosphoinositol fractions, and corresponding decrease in free [3H]inositol (all
p<0.01) (Figure 6.6). Labelling in the presence of ACh (KHM) for 1 h increased the
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FIGURE 6.4 : Effect of acetylcholine on phosphoinositol production (upper panel) and
Cortisol secretion (lower panel) from bovine zfr cells either alone (open bars) or in
combination with a sub-maximal (10'9M) dose of angiotensin II (solid bars). Data are the
mean + SD of triplicate determinations from a single expenment which was repeated on
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FIGURE 6.5 : Effect of acetylcholine on phosphoinositol production (upper panel) and
Cortisol secretion (lower panel) from bovine zfr cells either alone (open bars) or in
combination with a maximal (10"7M) dose of angiotensin II (solid bars). Data are the
mean + SD of triplicate determinations from a single experiment which was repeated on
eight occasions with similar results.
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such ACh-pretreated cells were subsequently stimulated with All (107M), the maximal
incorporation of label into [3H]phosphoinositides was not significantly different from that
observed in control cells, indicating that the same steady state was achieved on acute (15
min) stimulation with All whether cells had previously been stimulated with ACh or not.
Furthermore, the magnitude of the [3H]phosphoinositol response to All was not
significantly different in control and ACh-pretreated cells (Figure 6.6, lower panel)
Cells which had been pre-labelled with [3H]inositol in the presence of MnCl2 exhibited an
increased incorporation of label into the [3H]phosphoinositide fraction and a
correspondingly reduced labelling of the free [3H]inositol fraction compared with control
cells (both p<0.05). However, on subsequent acute stimulation with All, the incremental
increases in the labelling of the [3H]phosphinositides and [3H]phosphoinositols, and the
incremental loss of [3H]inositol, were not significantly different from those measured in
control cells.
The effects of ACh and MnCl2 pre-treatment were also investigated in cells subsequently
stimulated chronically with All (107M, 2 h) (Figure 6.7). In control cells (no pre-
treatment during labelling), chronic (2 h) stimulation with All (lCFM) resulted in a loss
of radioactivity from the [3H]phosphoinositide and free [3H]inositol fractions (both
p<0.05). As would be expected on prolonged stimulation in the presence of LiCl, a
correspondingly large increase in the level of [3H]phosphoinositols occurred on chronic
All stimulation (PcO.Ol). Labelling in the presence of ACh increased the incorporation
of label into the [3H]phosphoinositide fraction (p<0.01). However, the levels to which
[3H]phosphoinositide labelling and free [3H]inositol levels dropped on subsequent
chronic stimulation with All were unaffected by ACh pre-treatment. In addition, the
magnitide of the [3H]phosphoinositol response to All was not significantly different in
control and ACh-pre-treated cells (Figure 6.7, lower panel). In contrast, when MnCI2
pre-treated cells were subsequently subjected to chronic (2 h) stimulation with All, the
elevated level of [3H]phosphoinositide labelling was decreased by the same increment,
but not to the same level, as that observed in control cells. In addition, the magnitude of
the [3H]phosphoinositol response to All was reduced in MnCl2 pre-treated cells compared
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FIGURE 6.6 : Effect of acetylcholine and manganese pre-stimulation on subsequent
acute angiotensin II-stimulated redistribution of radioactivity between
[3H]phosphoinositide, [3H]inositol and [3H]phosphoinositol fractions of pre-labelled
bovine zfr cells. Cells were labelled with [3Hlinositol for 6 h in the presence of MnCl2
(10"3M) or acetylcholine (10'4M) as described in section 2.5.1, and subsequently
incubated in the presence or absence of angiotensin II (10"7M) for 15 min (in medium
containing LiCl, lOmM). The distribution of radioactivity between the three [3H]inositol-
labelled fractions is shown. Values are the mean + SD of triplicate determinations from
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FIGURE 6.7 : Effect of acetylcholine and manganese pre-stimulation on subsequent
chronic angiotensin II-stimulated redistribution of radioactivity between
[3H]phosphoinositide, [3H]inositol and [3H]phosphoinositol fractions of pre-labelled
bovine zfr cells. Cells were labelled with f3H]inositol for 6 h in the presence of MnCl2
(10"3M) or acetylcholine (10"4M) as described in section 2.5.1, and subsequently
incubated in the presence or absence of angiotensin II (10"7M) for 2 h (in medium
containing LiCI, lOmM). The distribution of radioactivity between the three [3H]inositol-
labelled fractions is shown. Values are the mean ± SD of triplicate determinations from
one representative experiment of three similar experiments.
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6.3 DISCUSSION
Previous studies have demonstrated many similarities in the cellular effects and
mechanisms of action of ACh and All in bovine adrenocortical zfr cells. Neither agonist
has any acute effect on cAMP levels, whereas both stimulate a hormone-sensitive
phospholipase C (Walker et al, 1990; Bird et al, 1989). ACh and All also stimulate dose-
dependent increases in intracellular calcium concentration, and both agonists appear to
mobilise a common intracellular calcium pool (Walker et al, 1991). These similarities
would suggest that ACh and All stimulate steroidogenesis through a common mechanism
in bovine zfr cells. It is not clear, however, whether ACh and All receptors are coupled
to distinct subpools of PLC, which in turn may act on separate subpools of
phosphoinositides, or whether a single pool of enzyme acts on a common pool of
phosphoinositides. This is particularly relevant given the existence of at least two distinct
hormone-sensitive pools of phosphoinositides in these cells (Bird et al, 1992c).
For measurement of PLC activity, cells were prelabelled with [3H]inositol for 48 h.
Previous studies have established that the phosphoinositides of bovine zfr cells label to
steady-state by this time. Therefore, any increase in [3H]phosphoinositol production in
the presence of lithium is a reflection of PLC activity (Bird et al, 1989,1990b). Figures
6.1 and 6.2 illustrate the close correspondence between ACh- and All-stimulated PLC
activity and Cortisol secretion. Both agonists stimulated [3H]phosphoinositol production
and Cortisol secretion with similar dose dependencies. A strong correlation between these
two responses was revealed (Figure 6.3). Moreover, the gradients of the regression lines
for ACh and All were near identical (8.32 +1.21 and 8.34 + 1.07 respectively). Thus the
relationship of PLC activation to Cortisol secretion for each agonist appears to be
identical, consistent with a common mechanism of action.
Bird et al (1990a) suggested that ACh and All activate the same PLC in bovine zfr cells,
based on the relationship between phosphoinositol labelling in response to ACh and All
in normal and low calcium media. In order to confirm this hypothesis, the possible
additive effects of ACh and All on PLC activity and Cortisol secretion were examined. If
both agonists share a common mechanism of action, but stimulate separate pools of PLC,
then the effects of both sub-maximal and maximal doses of each agonist would be
expected to be additive. If however a single pool of enzyme is stimulated by both
agonists then there are two possible outcomes. In the event that All receptors are
available in excess and can fully stimulate the available PLC, then ACh would be
expected to have no further effect on PLC activity or Cortisol secretion stimulated by a
maximally effective dose of AIL Alternatively, if All receptors are limiting, then the
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effects of ACh and All may still be additive at maximal doses of AIL That All-
stimulated steroidgenesis is unimpaired by a substantial loss of All receptors (Penhoat et
al, 1988) suggests that All receptors are present in excess over the available PLC.
Therefore, if both agonists stimulate a common pool of enzyme, then their effects would
be expected to be additive at sub-maximal, but not maximal, doses of AIL
The situation in bovine zfr cells appeared to be more complex than that described above,
in that full additivity was rarely observed at submaximal doses of AIL In most
experiments, for both PLC activity and Cortisol secretion, the effects of ACh and All
were only partially additive. The interpretation of these results are probably complicated
by the rapid desensitisation of the ACh response. Pre-incubation with ACh (1CHM) for
30 min significantly reduced, and, in some experiments, completely abolished subsequent
responses to ACh (Chapter 4). Although it is not known if the ACh and All responses
are subject to heterologous desensitisation, such a phenomenon has been reported to
result in partial additivity of bradykinin and vasopressin responses in WRK-1 cells
(Monaco et al, 1990). Thus, the possibility of heterologous desensitisation in zfr cells
cannot be discounted.
The effects of ACh and All at maximal doses were not additive with respect to PLC
activity and Cortisol secretion (Figure 6.5). However, two points require consideration.
Firstly, if heterologous desensitisation does occur, as suggested above, then the
desensitising effects would be expected to be greater at maximal agonist concentrations
than at submaximal doses. This could result in a lack of additivity even if separate pools
of PLC were stimulated by ACh and AIL Secondly, the standard deviations of the PLC
and Cortisol responses to All (107M, Figure 6.5) were of a similar magnitude to the
incremental increases in response to ACh. Thus, the inherent variability of the cell
preparation could mask any further effects of ACh at maximal concentrations of AIL
Thus, although the additivity data is not inconsistent with the stimulation of a common
pool of PLC by ACh and All, firm conclusions cannot be drawn from the data set.
In order to investigate the phosphinositide pools labelled in response to ACh and All,
[3H]phosphoinositide breakdown and resynthesis were examined in cells pre-labelled
with [3H]inositol for 6 h. Zfr cells labelled in this way contain large reserves of
[3H]inositol in the cytosol, but incorporate only small amounts of label into the
phosphoinositides (Bird et al, 1992c). Since cells are not labelled to isotopic equilibrium,
resynthesis of phosphoinositides (as a consequence of agonist stimulated
phosphoinositide turnover) results in increased labelling of the phosphoinositide pool. In
the presence of LiCl, which prevents phosphoinositol recycling into inositol, All
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stimulates incorporation to a new steady state within 15 min. After 30 min of stimulation
in the presence of Li, depletion of cytosolie f3H]inositol results in the breakdown of
newly synthesised phosphinositides without resynthesis. Thus, at stimulation times
longer than 30 min, breakdown of this newly synthesised lipid can be observed (Bird et
al, 1992c).
The effect of ACh and MnCL pre-stimulation on the redistribution of label in response to
subsequent acute (15 min) All stimulation (Figure 6.6) shows that although pre-
stimulation with ACh increased [3H]phosphoinositide labelling, the maximal
incorporation of label into the phosphoinositide pool was unaffected by ACh pre-
treatment. This is consistent with the stimulation by ACh of incorporation of [3H]inositol
into the same hormone-sensitive phosphoinositide pool as that stimulated by AIL If ACh
had stimulated labelling of a different pool than that labelled in response to All, then the
label incorporation into phosphoinositides would be greater with ACh preincubation than
without. Consistent with this hypothesis, the magnitude of the phosphinositol response to
acute All stimulation was unaffected by ACh pre-stimulation during labelling.
The effects of [3H]inositol labelling were also studied in the presence of MnCl2. Mn2+
treatment has been shown in other cells to stimulate labelling by both Ptdlns synthase
activity and by inositol headgroup exchange (Agranoff et al, 1958; Paulus & Kennedy,
1960; Jungalwala, 1973). However, this process stimulates the labelling of a hormone-
insensitive pool of inositol phospholipid (LaBarca et al, 1985). Pre-labelling cells with
[3H]inositol in the presence of MnCL increased the incorporation of label into the
phosphoinositides, and reduced free [3H]inositol levels. However, unlike ACh pre-
stimulation, subsequent acute All stimulation resulted in a significant increase in the
maximum phosphoinositide labelling, though the incremental increase in
phosphoinositide and phosphoinositol labelling, and the loss of [3H]inositol, were
unaffected by MnCl2 pre-treatment. This suggests that MnCl2, unlike ACh, stimulated
the labelling of a phosphoinositide pool distinct from that labelled by AIL
ACh pre-stimulation had no effect on the levels to which phosphoinositide labelling and
free [3H]inositol levels dropped in response to subsequent chronic (2 h) stimulation by
AIL Furthermore, this treatment had no effect on the accompanying phosphoinositol
response to All (Figure 6.7). This suggests that the lipid synthesized in response to ACh
pre-stimulation was accessible to the PLC activated in response to All, and must
therefore have been in the same hormone-sensitive pool. In contrast, when cells pre-
labelled in the presence of MnCL were subsequently stimulated for 2 h with All, the pool
of phosphoinositide labelled in response to MnCL remained inaccessible to the AII-
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stimulated PLC. Cells pre-treated with MnCL showed the same incremental decrease in
phosphoinositide labelling in response to chronic All stimulation as did control cells, but
showed a significantly reduced phosphoinositol response to All. These data also suggest
that, as in other cells, MnCl2 stimulated the labelling of a hormone-insensitive pool of
phosphoinositide.
It is possible that the hormone-insensitive pool of inositol phospholipid labelled in the
presence of manganese represents labelling of 3-phosphorylated phospholipids.
However, HPLC analysis of the phosphoinositol species formed in response to All in
bovine zfr cells indicates that 3-phosphate derivatives of the phosphoinositides are not
formed (Bird et al, 1992d). Even if 3-phosphorylated phosphoinositides are not
substrates for PLC activity (Fisher et al, 1992), FPLC and HPLC studies of the
deacylated phosphoinositides from bovine zfr cells have also failed to detect multiple
isomeric forms of phosphatidylinositol bisphosphate (Dr. I.M. Bird, personal
communication).
In conclusion, the data presented in this chapter suggest that ACh and All share a
common mechanism of action in bovine zfr cells, and in addition stimulate the
breakdown and resynthesis of a common hormone-sensitive pool of phosphoinositides
which is distinct from the hormone-insensitive pool labelled by manganese. A similar
situation appears to occur in rat adrenal zg cells stimulated with All and vasopressin
(Enyedi et al, 1988), and in the WRK-1 cell line stimulated with bradykinin and
vasopressin (Monaco et al, 1990). The coupling of two or more receptors to a common
pool of phosphoinositides in the same cell has important implications to the possible
modulation of the effects of one agonist by another. Homologous desensitisation or
sensitisation to either agonist must therefore occur at the levels of the receptor, whereas




EFFECTS OF ACETYLCHOLINE AND ANGIOTENSIN II ON
INTRACELLULAR CALCIUM CONCENTRATION IN INDIVIDUAL BOVINE
ZFR CELLS
7.1 INTRODUCTION
It is now well established that intracellular Ca2+ plays a pivotal role in the steroidogenic
actions of All and ACh in adrenocortical zg cells. Studies of 45Ca2+ efflux from
superfused rat zg cells, and measurement of ICa2*], in aequorin-loaded rat zg cells have
shown that All stimulates a rapid and sustained rise in [Ca2+],, with a dose-dependency
correlating well with the aldosterone-stimulating action of the peptide (Balla et al, 1985a;
Braley et al, 1984,1986). Similar results have been obtained in zg cells from bovine
adrenal cortex (Kojima et al, 1985a,b,d). The initial sharp increase in [Ca2+]i in response
to All occurs through the Ins(l,4,5)P3-mediated release of Ca2+ from intracellular stores
(Barret et al, 1986a; Gupta et al, 1992; Kojima et al, 1984; Balla et al. 1989), while the
sustained phase of the All [Ca2+]1 response is maintained through influx of extracellular
Ca2+ (Capponi et al, 1984). The importance of this Ca2+ influx is evident from the
inhibitory effects of Ca2+ channel blockers such as lanthanum on All-stimulated
aldosterone secretion (Fakunding & Catt, 1980), and recent studies have proposed a
dominant role of non-dihydropyridine-sensitive Ca2+ channels in All-stimulated Ca2+
influx in bovine zg cells (Ambroz & Catt, 1992). Although less study has been made of
ACh effects on zg cell [Ca2+]j, it is clear that ACh does promote a rapid elevation of
[Ca2+]j in aquorin-loaded bovine zg cells (Kojima et al, 1986a).
The effects of All and ACh on [Ca2+]j in zfr cells has received comparatively less
attention. That All has no effect on 45Ca2+ efflux or [Ca2+)1 in rat zfr cells (Williams et al,
1981; Braley et al, 1986) is in agreement with the reported lack of effect of the peptide on
rat zfr cell steroidogenesis (Whitley et al, 1982). By contrast, both All and ACh
stimulate rapid dose-dependent increases in [Ca2+]| in populations of fura-2 loaded bovine
zfr cells (Walker et al, 1990,1991), and it has been proposed that in this preparation. All
and ACh mobilise a common intracellular pool of Ca2+ (Walker et al, 1991), despite
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evidence suggesting the existence of at least three distinct Ca2+ pools in bovine adrenal
cortex (Guillemette etal, 1991).
The measurement of [Ca2+]( in cell populations (as in the above studies) produces a
population average Ca2+ signal, and thus provides no information regarding the [Ca2+]1
responses of individual cells. It is known that in individual rat and bovine zg cells, All
stimulates oscillations in [Ca2"^ (Johnson et al, 1989; Quinn et al, 1988). That the
frequency of such oscillations was dependent on the concentration of All used raises the
possibility that in zg cells, aldosterone secretion may be regulated by a Ca2+ signal that is
frequency, rather than amplitude, encoded. Since no information is available regarding
the effects of All or ACh on fCa2+11 in individual zfr cells from any species, the
experiments described in this chapter were performed in order to investigate the [Ca2+]i
responses of single fura-2 loaded bovine zfr cells to these agonists.
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7.2 RESULTS
7.2.1 Cellular loading and calibration offura-2
In order to investigate the kinetics and concentration dependence of fura-2 uptake into
bovine zfr ceils, cultured cells were exposed to fura-2 AM under various experimental
conditions, and the internalised dye quantified by spectrofluorimetry. Following
thorough washing of loaded cells, cells were sonicated to release intracellular dye, and
the fluorescence intensity emitted on excitation at 362 nm recorded. This wavelength
represents the isosbestic point of fura-2 (Figure 2.1), and therefore fluorescence
measurements made at 362 nm are proportional to the absolute amount of dye present,
and unaffected by any changes in free Ca2+ concentration.
As shown in Figure 7.1, fura-2 uptake was concentration dependent. Uptake increased
linearly over the concentration range 1-10 |lM, reaching a plateau at higher dye
concentrations. A time-dependent increase in fura-2 uptake was also observed (Figure
7.2). Uptake was maximal following 60 min exposure to the dye, and this maximal level
of uptake was maintained at loading times of at least 2 h.
In order to relate changes in the fluorescence ratio F34O/F3g0 obtained from fura-2 loaded
cells to changes in intracellular Ca2+ concentration, the fluorescence ratios obtained from
solutions of known free Ca2+ concentration in the presence of 0.1 (iM fura-2 free acid
were recorded, and used to construct a calibration curve (Figure 7.3). The experimental
conditions under which measurements were made from standard solutions were designed
to mimic as closely as possible measurements made from cells: the magnification, and
the aperture size through which emitted light was recorded were the same for cell and
calibration measurements. Furthermore, the absolute intensity of light emitted at the two
excitation wavelengths was of a similar order of magnitude for both cell and calibration
measurements (ca. 105 photons/sec). As shown in Figure 7.3, a linear relationship existed
between free Ca2+ concentration (50-800 nM) and the fluorescence ratio F34O/F3g0. The
ratios obtained were relatively constant between different batches of standards up to 400
nM free Ca2+. However, larger variation in ratios was encountered both between and
within separate batches at free Ca2+ concentrations of 600-800 nM, reflecting the upper
limit of sensitivity of fura-2, which becomes saturated at Ca2+ concentrations approaching




FIGURE 7.1 : Concentration dependence of fura-2 uptake into bovine zfr cells in
monolayer culture. Cells were incubated with fura-2 at the concentrations indicated for
60 min. Following extensive washing, cells were scraped from the culture plastic and
sonicated to release intracellular dye. The fluorescence signal was recorded at 510 nm
with an excitation wavelength of 362 nm. Values are corrected for autofluorescence
recorded from cells loaded with vehicle only, and represent the mean ± SD of triplicate





FIGURE 7.2 : Time course of fura-2 uptake by cultured bovine zfr cells. Cells were
loaded with fura-2 (10 p.M) for the times indicated and processed as in Figure 7.1.
Values represent the mean ± SD of triplicate determinations from a representative




FIGURE 7.3 : In vitro calibration showing the relationship between the fluorescence
ratio F34(/F3g0 for fura-2 as a function of free Ca2+ concentration. Measurements were
carried out at 37°C through the optics of a Nikon Diaphot inverted microscope using 500
p.1 of Kreb's buffer of defined free Ca2+ concentration containing fura-2 free acid (0.1
(iM) Data points are the mean + s.e.m. of triplicate determinations from three sets of
standard solutions prepared on different occasions. The correlation coefficient of
regression was 0.997.
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7.2.2 Effect of acetylcholine on intracellular Ca2+ concentration in single bovine zfr
cells.
Cells were loaded with f'ura-2 (10 pM) for 1 - 2 h at 37°C. Following removal of
extracellular fura-2, fluorescence measurements were made from individual zfr cells as
described in section 2.6.2. ACh (10"6 - 10 4M) was presented to the cells as a continuous
perfusion. A total of 38 cells from at least eight separate cell preparations were analysed
in this way. Representative experiments are shown in Figures 7.4 - 7.8.
Mean resting F34C/F3g0 ratio was 0.57, corresponding to an intracellular free Ca2+
concentration of 69 nM. This value is very close to the resting [Ca2+]j previously
determined in single fura-2 loaded bovine zg cells (61.2 nM, Johnson et al, (1989)). On
stimulation with ACh, 82% of cells responded with an increase in fCa2+]1. All cells which
responded to ACh showed an initial sharp increase in [Ca2+]j- Although the magnitude of
this initial response was extremely variable between cells, a dose-dependent trend was
evident. At ACh concentrations of 10'6, 10~5 and 10~4M, the mean initial peak [Ca2+]i
levels were 370 nM (range 233 - 589 nM), 470 nM (range 188 - 1077 nM) and 613 nM
(range 461 - 734 nM) respectively. Following this initial increase in [Ca2+]j, the
characteristics of the fluorescence signal were variable, with cells showing either
oscillatory or non-oscillatory responses. Considering Firstly those cells which showed
non-oscillatory responses, the nature of the Ca2+ signal again appeared to be dose-
dependent. At 10"6M ACh, the fluorescence ratio decayed exponentially, returning to the
original resting value within 5 - 10 min (Figure 7.4). At 105 and 10"4M ACh, the
fluorescence signal decayed to a new elevated level which was sustained for several
minutes (Figures 7.5 and 7.6 respectively). The mean plateau [Ca2+]j was 231 nM at 10'5
M ACh and 252 nM at 10"4M Ach. 100% of cells stimulated with 10"6M ACh behaved in
this way, while 60% of cells stimulated with 10"5M ACh, and 75% of cells stimulated
with 10 4M ACh showed this pattern of responsiveness.
The remaining 40% and 25% of cells stimulated with 10"5 and 10"4M ACh showed
oscillatory responses following the initial sharp increase in [Ca2+];. No oscillations in
[Ca2+], were observed in response to 10"6M ACh. When stimulated with 10"5M ACh,
however, following the initial sharp increase in [Ca2+]j, the level of Ca2+ decreased to
basal levels with sharp oscillations in [Ca2+]j superimposed over the falling signal (Figure
7.7). [[Ca2+]1 then oscillated between basal and stimulated levels for up to 10 min. The
average amplitude of the individual spikes was 436 nM (range 188 - 734 nM), and the
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FIGURE 7.4 : Effect of acetylcholine (10"6M) on the intracellular Ca2+ concentration of a
single fura-2 loaded bovine zfr cell. Acetylcholine was delivered as a continuous
perfusion, indicated by the horizontal bar. The change in fluorescence ratio F340/F3g0 over
time is indicated on the left vertical axis, and the corresponding free Ca2+ concentration is




FIGURE 7.5 : Effect of acetylcholine (10 5M) on the intracellular Ca2_t concentration of a
single fura-2 loaded bovine zfr cell. Acetylcholine was delivered as a continuous
perfusion, indicated by the horizontal bar. The change in fluorescence ratio F34C/F3g0 over
time is indicated on the left vertical axis, and the corresponding free Ca2+ concentration is




FIGURE 7.6 : Effect of acetylcholine (10'4M) on the intracellular Ca2+ concentration of a
single fura-2 loaded bovine zfr cell. Acetylcholine was delivered as a continuous
perfusion, indicated by the horizontal bar. The change in fluorescence ratio F34C/F3g0 over
time is indicated on the left vertical axis, and the corresponding free Ca2+ concentration is
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FIGURE 7.7 : Effect of acetylcholine (10"5M) on the intracellular Ca2+ concentration of a
single fura-2 loaded bovine zfr cell. Acetylcholine was delivered as a continuous
perfusion, indicated by the horizontal bar. The change in fluorescence ratio F34(/F3g0 over
time is indicated on the left vertical axis, and the corresponding free Ca2+ concentration is




FIGURE 7.8 : Effect of acetylcholine (104M) on the intracellular Ca2+ concentration of a
single fura-2 loaded bovine zfr cell. Acetylcholine was delivered as a continuous
perfusion, indicated by the horizontal bar. The change in fluorescence ratio F340/F380 over
time is indicated on the left vertical axis, and the corresponding free Ca2+ concentration is
indicated on the right.
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FIGURE 7.9
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FIGURE 7.9 : Acetylcholine (10"5M)-stimulated oscillations in [Ca2+]l (upper panel), and
the corresponding fluorescence intensities emitted by the cell when excited alternately at




FIGURE 7.10 : Effect of atropine (10'6M) on acetylcholine- induced oscillations in
[Ca2+], of a single fura-2 loaded bovine zfr cell. Test substances were delivered as
continuous perfusions, indicated by the horizontal bars. The change in fluorescence ratio
F34o/F3go over time is indicated on the left vertical axis, and the corresponding free Ca2+
concentration is indicated on the right.
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were of very high frequency, oscillating around an elevated level of [Ca2"1"],, before
beginning to decay (Figure 7.8).
These oscillations in [Ca2*], could be distinguished from random spikes due to electrical
noise which occasionally occurred during experiments by analysis of the raw photon
counts at 340 and 380 nm excitation wavelength (Figure 7.9). The traces for each
excitation wavelength are in theory perfectly antiparallel. It can be seen from Figure 7.9
that true transient increases in fCa2"1"^ were associated with antiparallel peaks in the two
traces, while for random noise spikes the peaks in each channel were in the same
(upwards) direction.
The effects of the (non-selective) muscarinic antagonist atropine on ACh-induced Ca2+
oscillations are shown in Figure 7.10. A cell in which [Ca2+]; was oscillating in response
to ACh (10°M) was then co-perfused with atropine (10"6M). Oscillations ceased almost
immediately in the presence of atropine. A similar result was obtained in a second
experiment in which the effect of atropine was investigated
7.2.3 Effect of angiotensin II on intracellular Ca2+ concentration in single bovine zfr
cells.
In a further series of experiments cells treated with fura-2 as above were stimulated by
continuous perfusion of All (109 - 10_7M). A total of 27 individual cells from five
separate experiments were studied. Representative experiments are shown in Figures
7.11-7.13. In contrast to the [Ca2"1"], signals observed in response to ACh, those [Ca2+]i
responses to All were relatively homogeneous, and no oscillations in [Ca2"1"]; were
observed at any concentration of AIL 76% of cells responded to All with an increase in
[Ca2+]1. As was observed in response to ACh, the Ca2+ signal showed an initial rapid rise
in response to AIL The mean peak [Ca2+]i values in response to 10'9, 10~8 and 10"7M All
were 313 nM (range 192 - 825 nM), 408 nM (range 208 - 734 nM) and 387 nM (range
192 - 1293 nM) respectively. The subsequent changes in [Ca2+]i in response to All
appeared to be dose-related. At 10"9M, the peak fCa2+]i invariably decayed rapidly,
reaching resting levels within 1 - 2 min (Figure 7.11). At 10"8M All, the Ca2+ signal
again decayed exponentially to resting levels, but with a longer half-time (resting levels
were reached within 4 - 6 min). When stimulated with 10"7M All, the initial peak [Ca2+]j
signal decayed exponentially before settling at a new elevated level (mean plateau level
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FIGURE 7.11 : Effect of angiotensin II (10 9M) on the intracellular Ca2+ concentration of
a single fura-2 loaded bovine zfr cell. Angiotensin II was delivered as a continuous
perfusion, indicated by the horizontal bar. The change in fluorescence ratio F34(/F3g0 over
time is indicated on the left vertical axis, and the corresponding free Ca2+ concentration is



















100 200 300 400
time (sees)
500 600
FIGURE 7.12 : Effect of angiotensin II (10~8M) on the intracellular Ca2+ concentration of
a single fura-2 loaded bovine zfr cell. Angiotensin II was delivered as a continuous
perfusion, indicated by the horizontal bar. The change in fluorescence ratio F34C/F380 over
time is indicated on the left vertical axis, and the corresponding free Ca2+ concentration is











FIGURE 7.13 : Effect of angiotensin II (10 7M) on the intracellular Ca2+ concentration of
a single fura-2 loaded bovine zfr cell. Angiotensin II was delivered as a continuous
perfusion, indicated by the horizontal bar. The change in fluorescence ratio F340/F3g0 over
time is indicated on the left vertical axis, and the corresponding free Ca2+ concentration is
indicated on the right.
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7.3 DISCUSSION
Fura-2 has now become the most widely used indicator of [Ca2+]1. The use of this
indicator, combined with dual excitation fluorescence microscopy and digital imaging
techniques has revealed complex spatio-temporal Ca2+ responses in single cells from
many tissues/species not apparent from population studies (reviewed in Berridge &
Irvine, 1989; Fewtrell, 1993). While oscillatory [Ca2"1"], behaviour has been reported in
single rat (Quinn et al, 1988) and bovine (Johnson et al, 1989) adrenocortical zg cells
stimulated with All, the [Ca2+]| responses of single zfr cells to All have not been studied.
Neither have the effects of ACh on [Ca2+]; in single adrenocortical cells been
investigated. The present results extend previous studies of All and ACh effects on
[Ca2+]j in bovine zfr cells populations (Walker et al, 1990,1991), and reveal a
heterogeneity of response of individual cells to these agonists.
Despite its widespread use, there are a number of problems associated with the loading
and calibration of fCa2+]i using fura-2. Different cell types differ in their ability to take
up and de-esterify fura-2 AM (Malgaroli et al, 1988), and it was necessary therefore to
optimise the conditions under which the dye is loaded. As shown in figures 7.1 and 7.2,
fura-2 uptake was both time and concentration dependent. The loading conditions chosen
(10 (iM, 1-2 h) were sufficient to allow a high signaknoise ratio, while presumably
maintaining relatively low intracellular concentrations of the dye. This is desirable since
at high fura-2 concentrations, buffering of intracellular Ca2+ can occur (Moore et al,
1990). Although the absolute concentration of fura-2 was not known, that adequate levels
of loading were achieved at micromolar concentrations of the dye, together with the
known sensitivity of fura-2 (Grynkiewicz et al, 1985), suggest that buffering of [Ca2+]j
did not occur. This is further supported by the relatively low fCa2+]j measured under
resting conditions (69 nM).
A further problem associated with the use of fura-2 is the method of calibration chosen to
relate ratio measurements to intracellular free Ca2+ concentrations. Two approaches are
in widespread use, the in vitro and in situ methods, which may produce significantly
different results (Aimers & Neher, 1985; Tsein et al, 1985). The in situ method involves
equilibrating cells with buffers of known free Ca2+ concentration in the presence of an
ionophore, and recording the ratios obtained from such cells. The free [Ca2+]i is
calculated according to Grynkiewicz et al (1985) following estimation of the minimum
and maximum fluorescence ratios measured at zero and saturating concentrations of Ca2+
(^min' ^max)- This method suffers from the problem that ionphores may not fully
equilibrate intra- and extracellular Ca2+, and in addition, fura-2 may leak from ionophore-
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treated cells (Roe et al, 1990). Furthermore, R must be measured in lvsed cells,max
leading to loss of intracellular fura-2. This makes the in situ method unsuitable for use in
single cell measurements, since the dye escapes from the microscope field of view,
precluding accurate measurement of Rmax- While these problems are overcome by the in
vitro method utilised here, ratio measurements made from buffered solutions may not
truly reflect ratios made from fura-2 loaded cells since the intracellular milieu obviously
differs from experimental solutions in terms of viscosity, local ionic strength and polarity,
all of which are known to affect fura-2 ratio measurements (Roe et al, 1990; Poenie,
1990).
Given these considerations, the in vitro method of calibration was used in the present
study (Figure 7.3). Ratio measurements made from standard Ca2+-buffered solutions
were both internally and externally consistent at free Ca2+ concentrations up to 400 nM.
Above this concentration, measurements were subject to much greater variability. This
variability stems from the gradual saturation of fura-2 at free Ca2+ concentrations
approaching 1 jj,M (Grynkiewicz et al, 1985). This is apparent from both Figure 7.3 and
from the Ca2+ titration curve presented in Figure 2.1. This reduced sensitivity of fura-2 to
changes in high [Ca2+] inevitably leads to increased error both in the preparation of
buffered solutions of free [Ca2+] above 400-500 nM, and in the ratio measurements made
from such solutions. For these reasons, both ratio measurements and estimated free Ca2+
concentrations are presented in the individual traces shown in Figures 7.4 - 7.13, and the
errors associated with measurement of high free [Ca2+] must be considered.
The mean resting [Ca2+]1 of individual bovine zfr cells was 69 nM. This value is close to
that previously reported in single bovine (61 nM) and rat (82 nM) zg cells (Johnson et al,
1989; Quinn et al, 1988), and also correlates well with that determined in populations of
bovine zfr cells (75 nM, Walker et al, 1991). However, this resting value is significantly-
lower than that determined in populations of aquorin-loaded bovine (136 nM) and rat (ca.
240 nM) zg cells (Kojima et al, 1986a; Braley et al, 1986). Several factors may
contribute to this discrepancy including, for example, the use of different Ca2+ indicators
between studies. Quantitative differences in [Ca2+]1 measured by fura-2 and aquorin have
been attributed to the Ca2+-binding properties of the two dyes (Quinn et al, 1988). Fura-2
is a linear indicator of [Ca2+]i (Grynkiewicz et al. 1985), whereas the fluorescence signal
emitted by aquorin is a function of the cube of the Ca2+ concentration. A further
possibility is that spontaneous oscillations in resting fCa2+]i contribute to the population
average [Ca2+]j. Johnson et al (1989), observing spontaneous Ca2+ oscillations in
individual bovine zg cells, suggested that this factor must have resulted in over-
estimation of resting [Ca2+]| in zg cell populations. Spontaneous oscillations in the
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resting [Ca:+]1 were not observed in bovine zfr ceils in the present study, and it is likely
that this stability in zfr cell resting tCa2+)i explains the good agreement between single
cell and population determinations of resting [Ca2+]j in bovine zfr cells (69 nM vs 75 n.M)
compared with bovine zg cells (61 nM vs 136 nM).
When stimulated with ACh, bovine zfr cells showed a heterogeneous pattern of
responsiveness. Following an initial rapid increase in [Ca2+]1 observed in all cells which
responded to ACh, cells could be divided into those that showed agonist-induced
oscillations in [Ca2+]1, and those that did not. It is unlikely that this heterogeneity of
response can be explained by the presence of contaminating cell types. The Sephadex
column filtration method for zfr cell purification employed in this study is known to
produce an extremely pure cell preparation from which secretion of aldosterone and
androstenedione is undetectable (Williams et al, 1989). Furthermore, a similar
heterogeneity of rCa2+]j response has been observed in single cells from a homogeneous
population of clonal pancreatic insulinoma cells stimulated with a single agonist (Prentki
et al, 1988). The reasons underlying this heterogeneity of responsiveness are at present
unknown. It cannot be explained by differences in the cell cycle between test cells since
heterogeneous responses were also observed between individual daughter cells from a
smooth muscle cell line immediately on completion of cell division (Ambler et al, 1988).
An interesting feature of this cell-specific heterogeneity of response is that insulinoma
cells responded in exactly the same way when restimulated with agonist. This
phenomena was termed the Ca2+ fingerprint of the cell (Prentki et al, 1988), and has also
been observed in vasopressin-stimulated hepatocytes (Rooney et al, 1989). It is unknown
whether bovine zfr cells show a similar Ca2+ fingerprint since cells were completely
unresponsive to subsequent further challenge, even at high agonist concentrations (data
not shown).
Agonist-induced oscillations in [Ca2+]j are a well documented feature in non-excitable
cells. The characteristics of the oscillations vary greatly between different cell types, and
in some cells these characteristics appear to be dependent on the agonist used to elicit the
response (reviewed in Fewtrell, 1993). The oscillations observed in the present study in
response to ACh were characterised by an extremely rapid rise in [Ca2+]i followed by an
equally rapid decline to basal levels (Figure 7.7). This regular spiking behaviour is very
similar to that observed in vasopressin-stimulated hepatocytes (Rooney et al, 1989;
Woods et al, 1986), histamine-stimulated endothelial cells (Jacob et al, 1988), and both
pancreatic acinar and avian salt gland cells stimulated by cholinergic agonists (Jacob et
al, 1988; Tsunoda et al, 1990). Further, ACh-stimulated [Ca2+]l oscillations in bovine zfr
cells closely resemble those seen in All-stimulated bovine zg cells (Johnson et al, 1989),
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but are markedly different from All-stimulated responses in rat zg cells (Quinn et al,
1988). The Ca;T transients in the latter preparation were highly asymmetric, with an
initial sharp increase in [Ca2+]t followed by a much slower decay during which the next
oscillation occurred (Quinn et al, 1988).
The frequency of ACh-induced [Ca2+]j oscillations appeared to be dose-related. No
oscillatory behaviour was observed at low (lO^M) concentrations of ACh. At 10"5M
ACh oscillations were clearly discernible, with an average period of around 30 sec, while
at 10~4M ACh, oscillations appeared to fuse together, with very rapid changes in [Ca2+]j
superimposed over an elevated baseline. Although insufficient data were available for a
rigorous statistical analysis, a dose-dependent trend is clearly evident. This dose-
dependent frequency modulation appears to be a general feature of those cell types
exhibiting sharp Ca2+ spiking behaviour, but is rarely seen in cells in which Ca2+
oscillations are more sinusoidal in shape (Fewtrell, 1993).
In contrast to the [Ca2+]! spiking behaviour induced by ACh, All-stimulated [Ca2+]i
responses in bovine zfr cells were more homogeneous, and fCa2+]| oscillations were not
observed at any All concentration. This was surprising, since All is known to stimulate
Ca2+ oscillatory behaviour in individual rat (Quinn et al, 1988) and bovine (Johnson et al,
1989) zg cells. In common with ACh, however, a dose-dependent trend in the pattern of
the [Ca2+]i response to All was observed, with higher doses of All resulting in more
sustained elevations of [Ca2+];. It is possible that the doses of All used in the present
study were not low enough to induce [Ca2+]j oscillations; it has been shown that in
individual rat zg cells, [Ca2+]; oscillations only occur at low doses of All (picomolar),
while higher (nanomolar) concentrations of All produce Ca2+ responses similar to the
profiles observed here (Quinn et al, 1988). This suggests that [Ca2+]t oscillations in zg
cells are regulated by the degree of receptor activation, and could explain the failure of
All to induce fCa2+]i oscillations in the present study.
Studies of All effects on [Ca2+]j in individual bovine zg cells have established that the
initial increase in [Ca2+]| in response to All occurs through the mobilisation of
intracellular Ca2\ while the subsequent sustained Ca^+ increase (and [Ca2+]; oscillations)
is dependent on the presence of extracellular Ca2+ (Johnson et al, 1989). In populations
of bovine zfr cells stimulated with All, this 'late' Ca2+ response was rr.uch reduced in the
absence of extracellular Ca2+ (Walker et al, 1991). It is possible therefore that the dose-
dependency of the fCa2^]; response to All observed in the present study reflects dose-
dependent effects of All on Ca2+ influx. This could occur through the PKC-mediated
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phosphorylation of plasma membrane Ca2+ channels or potentially by direct effects of
inositol phosphates on Ca2r influx (Irvine & Moor, 1986).
The mechanism of agonist-induced [Ca2+]1 oscillations is unknown at present, and various
different theories have been proposed. While such theories are generally consistent with
the behaviour of one or two cell types, the wide variety of oscillation patterns observed in
different cells has precluded the formation of a unifying model. The model proposed by
Meyer and Stryer (1988) assumes that [Ca2+]i oscillations result from the periodic release
of intracellular Ca2+ due to fluctuations in the level of Ins(l,4,5)P3. This is proposed to
occur via a positive feedback by Ca2+, released by Ins(l,4,5)P3, on PLC. This positive
feedback system results in a sharp increase in [Ca2+lj, which is terminated by
sequestration of intracellular Ca2+ into an Ins(l,4,5)P3-insensitive store. The next
oscillation then occurs after replenishment of the Ins(l,4,5)P3-sensitive store. Another
popular model (Berridge & Galione, 1988) holds that fluctuations in [Ca2+]1 occur over a
constant non-oscillating level of Ins(l,4,5)P3. Ins(l,4,5)P3 is thought to stimulate a
constant release of Ca2+ from intracellular stores, which are constantly replenished by
influx of extracellular Ca2+. The Ca2+ released into the cytosol is sequestered into a Ca2+-
sensitive store, and thus [Ca2+]j remains stable. However, when this Ca2+-sensitive store
is full, then [Ca2+]j rises sharply producing a sharp peak in [Ca2+]; which begins to decline
when the Ca2+-sensitive store is depleted. The next oscillation occurs on replenishment
of this store.
In the present study, the frequency of ACh-induced [Ca2+], oscillations appeared to be
dose-related. Both models discussed would allow for dose-dependent oscillation
frequency modulation by the degree of receptor activation. Although both models
propose intracellular Ca2+ as the source of Ca2+ for oscillations, the Ca2+-induced Ca2+
release model requires that extracellular Ca2+ replenish the Ins(l,4,5)P3-sensitive store
(Berridge & Galione, 1988). If this were true, ACh-induced oscillations in bovine zfr
cells would be expected to show a requirement for extracellular Ca2+. In fact, ACh-
induced [Ca2+l1 oscillations cease immediately on removal of extracellular Ca2+
(Williams, Gillespie, Skimming, Davies, Clyne, Kelly, Walker and Bird, unpublished
observations). A similar effect has been reported in All-stimulated zg cells (Johnson et
al, 1989).
It is unknown at present why some agonists induce [Ca2+]| oscillations and others do not.
A model in which agonist receptors themselves regulate Ca2+ spiking activity has been
proposed (Cobbold et al, 1991; Cuthbertson & Chay, 1991). This model proposes that
PLC is only activated once a certain threshold of G protein activation has been reached,
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resulting in a sudden burst of PLC activity, Ins(l,4,5)P3 release, and consequent sharp
increase in [Ca2""],. Activation of PKC by Ca2+ and DAG is thought to lead to negative
feedback on the earlier activation steps, leading to termination of the Ca2+ spike.
Consistent with this hypothesis is the observation that inhibition of PKC in hepatocytes
results in a longer half-time of decay of the Ca2+ spike (Woods et al, 1986). Phorbol ester
treatment, which would therefore be expected to increase to half-time of spike decay,
actually results in inhibition of [Ca2"1"], oscillations, and this has been interpreted as
reflecting deactivation of agonist receptors and/or G proteins (Cobbold et al, 1991). This
model therefore provides a mechanism by which a relatively weak agonist in bovine zfr
cells, such as ACh, can initiate Ca2+ oscillations, whereas a stronger more efficacious
agonist such as All cannot.
In conclusion, the results presented in this chapter demonstrate different profiles of
[Ca2+], behaviour in response to All and ACh, with oscillations in [Ca2"1"], being described
for the first time in adrenocortical inner zone cells. The relationship between oscillation
frequency and steroid output, and the mechanisms by which oscillations are generated,
remain to be established. Likewise, the physiological role of [Ca2+]j oscillations in
adrenocortical cells is unknown. Clearly, at low agonist concentrations, the generation of
[Ca2+]j oscillations would represent a significant improvement in signalinoise ratio





Contrary to the earlier view that Cortisol and aldosterone secretion from the adrenal
cortex is controlled exclusively by the peptide hormones ACTH and All respectively, it is
now clear that many different agonists are capable of modulating steroid secretion from
experimental adrenocortical .preparations. These agonists may represent classic
autonomic neurotransmitters, such as acetylcholine or noradrenaline, peptidergic
transmitters such as vasoactive intestinal peptide, endocrine hormones such as insulin or
All, or cytokines such as the interleukins or transforming growth factors. In general
terms, significantly more information is available regarding agonist effects on zg cell
function than on zfr cell function, and this probably reflects the importance of the renin-
angiotensin-aldosterone system in the control of salt and water balance, and pathogenesis
of hypertension and heart failure (reviewed in Hall et al, 1990; Schelling et al, 1991;
Lindpainter & Ganten, 1991; Tan et al, 1991). However, given the crucial importance of
glucocorticoids in the stress response and the maintenance of normal
protein/carbohvdrate metabolism and immune function, a fuller understanding of the
mechanisms regulating Cortisol secretion is clearly important. The potential effects of
All on inner zone cells are especially important in light of recent developments in the
pharmacology of non-peptide All antagonists, which are currently being developed as
therapeutic agents for the treatment of hypertension and congestive heart failure
(Timmermans et al, 1993). It will be important not to overlook possible effects of such
antagonists on glucocorticoid secretion. The aim of this thesis was to compare and
contrast the cellular mechanisms involved in the stimulation of zfr cell steroidogenesis by
two different adrenoconical agonists, ACh and All. As discussed in sections 1.5 and 1.6,
both agonists have been shown to stimulate Cortisol secretion in various species, and both
have the potential to regulate steroidogenesis in the inner zones in vivo, although they
may access the steroidogenic cells by different mechanisms. ACh is thought to be
released from cholinergic nerve terminals within the cortex, while All is formed via the
renin-angiotensin system, either outwith the adrenal gland, or locally within the gland
itself (section 1.3.4).
The model chosen for this study was a primary culture of bovine adrenocortical zff cells.
The reasons for this choice were three-fold. Firstly, the ease of obtaining fresh abattoir
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material, coupled with the clear zonation of the bovine adrenal gland, allow the isolation
of zfr cells at extremely high yield and purity. Secondly, this model has previously been
well characterised with respect to ultrastructure and serum requirement, and shown to
retain the steroidogenic responsiveness of freshly isolated cells to ACh and All (Williams
et al, 1989: Walker et al, 1990). Thirdly and most importantly, the available evidence
suggests that cultured bovine zfr cells may be a more relevant model of the human inner
adrenocortical zone compared with other commonly used preparations, at least with
regard to All: both bovine and human zfr cells respond to All with an increase in Cortisol
secretion (Hadjian et al, 1984a; McKenna et al, 1978), and this effect can be mimicked
by a combination of phorbol ester and calcium ionophore suggesting the involvement of
the calcium messenger system in both species (Bird et al, 1992a; Laird et al, 1991). By
contrast, rat and ovine zfr cells do not respond steroidogenically to All, although both
species show a clear stimulation of Ptdlns hydrolysis in response to All (Whitley et al,
1982; Viard et al. 1990). The effects of ACh in isolated human adrenal zfr cells have not
been studied, although evidence exists to support a role of ACh in regulating human
adrenocortical steroidogenesis in vivo (Stem et al, 1989).
In characterising this bovine zfr cell model, the steroidogenic responsiveness of cells to
ACh and All was examined on each day of primary culture (Chapter 3). This
investigation was carried out in order to find the time of peak responsiveness of cells to
ACh and All, since previous studies have found that the ability of cultured adrenocortical
cell preparations to respond steroidogenically to agonists varies according to culture time
(Walker et al, 1988; Kawamura et al, 1984; Williams et al, 1989). Although the
steroidogenic and second messenger responses to all agonists studied (All, ACh, ACTH
and adrenaline) were maximal following 48 - 72 h of primary culture, a clear difference
in the ability of cells to respond to these agents was observed on day 2 of culture. While
increased steroidogenic and second messenger responses to the adenylate cyclase agonists
ACTH and adrenaline were observed at this time, the phospholipase C agonists All and
ACh were generally unable, or only weakly able, to stimulate Cortisol secretion on culture
day 2, even though enhanced second messenger (phosphoinositol) responses were
observed at this time. Thus, bovine zfr cells appear to reversibly uncouple
steroidogenesis from the activation of PLC in response to All and ACh following 24 h in
primary culture. Evidence was presented that this temporary loss of steroidogenic
responsiveness to PLC agonists may be due to a defect in the protein kinase C-mediated
transduction of the second messenger signals to the activation of steroidogenesis.
Although uncoupling of agonist receptor-PLC interactions is a well documented
phenomenon, implicated in the mechanism of desensitisation, the uncoupling observed in
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the present study was more unusual, in that the receptor-PLC interaction was preserved,
but the second messengers formed were unable to stimulate steroidogenesis. The defect
was selective for PLC agonists, since the steroidogenic and second messenger responses
to ACTH and adrenaline were enhanced on day 2. There are several implications of this
observation. Firstly, these results highlight the need for a careful optimisation of any new
cell culture system. In this case, experiments performed on day 2 of primary culture
would give erroneous results, and could lead to the conclusion that PLC agonists are not
steroidogenic in this system. Secondly, the demonstration that steroidogenesis can
become uncoupled from PLC activation may explain apparently anomalous results from
other in vitro adrenocortical preparations. Ovine zfr cells in primary culture responded to
All with an increase in PLC activity, 45Ca2+ uptake and [Ca2+]|, but do not respond
steroidogenically to the peptide (Viard et al, 1990). As was the case for bovine zfr cells,
treatment with PMA and A23187 failed to stimulate steroidogenesis in ovine zfr cells.
Since these experiments were performed using day 4 primary cultured cells only, the
possibility is raised that All could stimulate steroidogenesis in ovine zfr cells following
different periods of primary culture. Similar uncoupling of steroidogenesis from PLC
activation has been demonstrated in 3-day primary cultured rat zfr cells stimulated with
the PLC agonist vasopressin (Gallo-Payet et al, 1986). Again, investigation of agonist
effects on different experimental days may produce different results.
The data presented in chapter 3 are clearly insufficient to determine whether reversible
uncoupling in bovine zfr cells occurs in vivo, or is simply a cell culture artifact. Neither
do these results provide any indication of the physiological significance, if any, of this
dissociation. To speculate, the ability of bovine zfr cells to uncouple PLC activation from
stimulation of steroidogenesis may represent a mechanism whereby the stimulatory
effects of PLC agonists can be diverted from the steroidogenic pathway to stimulation of
some other cell function, for example, cell growth. All is known to stimulate
[3H]thymidine incorporation into unpurified cultured bovine adrenocortical cells (Gill &
Simonian, 1977; Simonian & Gill, 1979a) and purified bovine zfr cells in primary culture
(Clyne et al, 1993), although no information is available regarding the possible mitogenic
effects of ACh in these cells.
A major component of this thesis comprised the classification of the bovine zfr cell
receptors for ACh and All (Chapters 4 and 5). Estimation of the affinity of a number of
selective antagonists of ACh and All by Schild analysis provided evidence to suggest that
ACh and All stimulate Cortisol secretion from bovine zfr cells via activation of M3
muscarinic and AT, receptors respectively. However, while the pA2 values for
muscarinic antagonists were typical of previously characterised M3 receptors, evidence
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was presented to suggest that the bovine zfr All receptor differs from previously
characterised All receptors. The selective inhibition of All-stimulated Cortisol secretion
and [3H]phosphoinositol production by losartan clearly indicates involvement of the AT,
receptor (Bumpus et al, 1991). However, since losartan was significantly less potent in
zfr cells than at AT, receptors in other systems, it was suggested that the bovine zfr
receptor may represent a distinct subtype of AT, receptor, or a mixture of different AT,
receptor subtypes with different affinities for losartan. The latter possibility was
supported by the demonstration of two distinct losartan-sensitive 125I-AII binding proteins
in zfr cell membranes fractionated by isoelectric focusing. It would clearly be of interest
therefore to compare the ability of losartan to displace 125I-AII binding to each All
binding protein.
Although AT, receptor subtypes exist in rat and mouse tissues (Iwai & Inagami, 1992;
Sasamura et al, 1992), similar investigations of AT, receptor heterogeneity have not yet
been performed in bovine species. The rat AT, receptor subtypes appear to show a ten¬
fold difference in their ability to bind angiotensin I (Kakar et al, 1992), although it is not
clear at present if AT,a and AT,,, receptors differ in their affinity for losartan
(Timmermans et al, 1993). However, in relation to the situation in bovine species,
binding studies from several laboratories have demonstrated a reduced potency of
losartan in inhibiting 125I-All binding to bovine adrenal cortex preparations (Balla et al,
1991; Ouali et al, 1992; Sasaki et al, 1991). The results presented in chapter 5 confirm
these observations, and show that this reduced binding affinity of losartan in the bovine
adrenal cortex is reflected by a reduced potency in functional assays.
If, as has been suggested above, bovine zfr cells contain two distinct AT, receptors with
unequal affinity for losartan, then the possibility arises that these subtypes may be
coupled to different cellular responses, which may therefore be expected to be
differentially inhibited by losartan. In fact, losartan was around two orders of magnitude
more potent in inhibiting the mitogenic response to All in cultured bovine zfr cells (ID50
= 5 x 10"8M) than the steroidogenic response (ID50 = 3.1 x 10~6M) (Clyne et al, 1993).
Thus, the bovine zfr cell preparation utilised here may prove a useful model for future
investigations of AT, receptor heterogeneity.
Having identified the receptor subtypes through which ACh and ACH stimulate Cortisol
secretion, the effects of these agents on Ptdlns hydrolysis and [Ca2+], mobilisation were
assessed. Previous studies have suggested that ACh and All stimulate a common PLC
enzyme (Bird et al. 1990a), leading to mobilisation of calcium from a common
intracellular pool (Walker et al, 1991). The data presented in Chapter 6 extend these
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observations, establishing that a common pool of Ptdlns is metabolised in response to
both ACh and AIL Although this is consistent with a common mechanism of action for
ACh and All in zfr cells, attempts to confirm this hypothesis through investigation of the
possible additive effects of ACh and All were unsuccessful: their effects in combination
were only partially additive with respect to both Cortisol secretion and PLC activity. This
could reflect a heterologous desensitisation effect, as previously reported to result in
partial additivity of bradykinin and vasopressin responses in WRK-1 cells (Monaco et al,
1990). However, the demonstration that ACh and All stimulate the breakdown of a
common Ptdlns pool, coupled with the very close correlation between ACh- and All-
stimulated Cortisol secretion and PLC activity (Figure 6.3), lend support to the hypothesis
of a common mechanism of action in bovine zfr cells.
The final experimental section of this thesis compared the abilities of ACh and All to
elevate [Ca2+]; in zfr cells. The main conclusions to emerge from this work were as
follows:
(i) ACh is capable of inducing oscillations in [Ca2+]1 in bovine zfr cells.
(ii) The frequency of ACh-induced [Ca2+], oscillations appeared to be
concentration-dependent.
(iii) All does not stimulate [Ca2+]1 oscillations in bovine zfr cells.
As discussed in Chapter 7, several contradictory models have been proposed to explain
the mechanisms of agonist-induced [Ca2+]i oscillations. The data presented in the present
study appears to be most consistent with the receptor-controlled oscillator model
(Cobbold et al, 1991), which predicts that sustained PLC activity inhibits the generation
of Ca2+ spikes. This model could therefore explain the failure of All to induce [Ca2*^
oscillations, since the concentrations of All used here were somewhat higher than those
reported to stimulate oscillatory activity in adrenocortical zg cells (Quinn et al, 1988;
Johnson et al, 1989). Further study will be required to resolve this question.
The bovine zfr cell model used in this study is clearly a useful preparation for the
investigation of adrenocortical agonist receptors and effectors. Data presented in this
thesis has extended knowledge of ACh and All effects on the bovine adrenal cortex at the
cellular level. An important question, however, concerns the physiological relevance of
these agonists in the adrenal. Under which conditions may ACh and All gain access to
the cortex, and what are the likely effects of their release within the gland? Perhaps more
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importantly, how do intra-adrenal ACh and All interact, both with each other, and with
other stimulatory factors? Under conditions of stress, ACTH is released from the
hypothalamus, and the sympathetic nervous system is activated. Sympathetic splanchnic
nerve stimulation results in release of ACh within the medulla, although it is not known
as yet if release of ACh within the cortex occurs. This seems likely, however, given the
presence of cholinergic nerve terminals, derived from the splanchnic nerve, within the
cortex (Charlton et al, 1991), and the observation that adrenal responses to splanchnic
nerve stimulation in cattle are very similar to those in response to infusion of ACh
(Edwards & Jones, 1987; Jones et al, 1991). Although All can reach the adrenal cortex
through the action of renin secreted from the kidney, the evidence for an intra-adrenal
renin-angiotensin system reviewed in section 1.3.4. suggests that All may also be formed
locally within the gland. Since renin activity in cultured bovine zg cells is potently
stimulated by catecholamines (Gupta et al, 1992), it is possible that catecholamines,
released within the cortex on splanchnic nerve stimulation (Charlton et al, 1992; Gilchrist
et al, 1993), may stimulate adrenocortical All formation. The juxtaposition of medullary
and cortical cells in several species (section 1.1.4) raises the possibility of an indirect
stimulation of adrenocortical All formation by ACh: medullary catecholamines formed
on splanchnic nerve stimulation may reach the cortex and stimulate renin. Thus,
evidence exists to support the formation of both ACh and All within the adrenal cortex
under conditions of increased splanchnic nerve activity.
The effects of ACh infusion on adrenal gland function in cattle in vivo have been studied
by Jones et al (1991). These included an decrease in adrenal vascular resistance,
indicating vasodilatory effects of ACh which could enhance the delivery of other
adrenocortical agonists, such as All, to the steroidogenic cells. Medullary responses
included release of catecholamines, CRF and enkephalins, all of which could potentially
modify steroid output if they were able to reach the cortical cells. The authors also
suggested that since adrenal responses to ACh infusion differed subtly from those in
response to splanchnic nerve stimulation, other (as yet unidentified) neurotransmitters are
likely to be released from splanchnic nerve terminals. Thus, while it is clear that both
ACh and All are capable of stimulating steroid secretion in many species, it seems
probable that the physiological relevance of these agents in the adrenal cortex may
depend on complex interactions with other agonists.
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ABSTRACT
Inner zone cells, isolated from bovine adrenal cortex,
secrete Cortisol in response to both adrenergic and
cholinergic agonists.
The response to adrenaline (and other catecholamines)
appears during culture, is evident by 24 h and reaches a
maximum by 48-72 h, but is absent in freshly isolated
cells. Pre-incubation of cultured cells with adrenaline
leads to homologous desensitisation; the possibility
that this may explain the absent response in freshly
isolated cells is discussed. Cells show a dose-dependent
cyclic AMP response but no increased membrane
phosphoinositide turnover. In agreement, Cortisol
secretion is blocked by |3-receptor, but not a-receptor,
antagonists. Schild analysis established that the
response occurs through binding to a (3,-receptor subtype,
consistent with adrenergic innervation as opposed to an
effect of circulating catecholamines.
In contrast, Cortisol secretion to AcCh was present in
both freshly isolated cells and those in culture,
reaching a maximum by 48-72 h in culture. The response
was specifically blocked by muscarinic, but not
nicotinic, antagonists. No effect on cyclic AMP formation
was observed, but dose-dependent stimulation of
phosphoinositide turnover occurred. HPLC analysis of the
time-course of appearance of 3H-inositol labelled head
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groups (from cells pre-labelled with 3H-inositol)
confirmed that AcCh activates a phosphoinositidase C.
Intracellular Ca2+ oscillations were also measured from
fura-2 loaded single cells in response to AcCh. Together
with other pharmacological studies, these observations
establish that AcCh acts through a M3 muscarinic receptor
subtype in these cells.
The possible significance of these findings in vivo is
discussed.
Introduction
Although adrenocorticotropic hormone is the
principal regulator of glucocorticoid formation from the
inner zone of the adrenal cortex, both adrenergic and
cholinergic effects have been described.
Adenylate cyclase activity stimulated by catechol¬
amines has been reported in membrane preparations from
rat 494 corticosterone-secreting tumours (1,2) and in
human adrenocortical carcinomas, though not in normal
human adrenal cortex (3). Stimulation of aldosterone
secretion has been reported from capsular explants of rat
adrenal cortex in a perifusion system (4) and from 3-day
cultures of bovine adrenocortical cells (5). Cortisol
production has also been reported from a mixed bovine
adrenocortical cell preparation in primary culture (6).
Only recently has the stimulatory effect of
catecholamines on glucocorticoid secretion, specifically
from the inner zone, been studied (7). Where the second
messenger response has been investigated, steroid
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secretion appears to be mediated by adenosine 3',5'
cyclic monophosphate (cyclic AMP) (6,7).
Cholinergic stimulation of adrenocortical
steroidogenesis has also been found. Acetylcholine, but
net nicotine, stimulated steroid production from the
perfused calf adrenal (8). Cortisol secretion has also
been described from cultured bovine zona
fasciculata/reticularis (zfr) cells in response to
muscarinic, cholinergic agonists (9, 10). Evidence that
membrane phosphoinositide turnover mediates the
cholinergic response in bovine fasciculata/reticularis
cells exists (11). More recently, activation of
phosphoinositidase C by acetylcholine has been shown for
bovine zfr cells (12).
In this article, we describe our recent work on the
catecholaminergic and cholinergic regulation of Cortisol
secretion from inner zone cells of bovine adrenal cortex.
The significance of these results to the situation in
vivo is discussed.
Materials and Methods
The source of materials and details of cell isolation
and primary culture of bovine zfr cells are described in
Williams et al (13). The experimental details and
material sources for the study of Cortisol and cyclic AMP
formation in response to catecholamines are reported in
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Walker et al (7) and for subclassification of the (3-
receptor in Lightly et al (14). For the cholinergic
response, the appropriate experimental methods and the
source of materials is described in Walker et al (12).
Studies of changes in single cell [Ca2+] were
carried out using cells cultured on 2.5 cm diameter glass
coverslips at a density of 150,000 cells/ml. Cells were
loaded with Fura 2-AM (5 uM) for 2 h, and the cover slip
then transferred to the perfusion chamber on the
microscope stage. The chamber was perfused with pre-
warmed (37°C) Krebs Ringer/Hepes buffer (pH7.4 with 2.5
mM CaCl2) , with or without acetylcholine as required.
Cells were alternately excited at 350 and 380 nm, and the
emitted light measured at 520 nm using a Nikon Diaphot
inverted microscope.
Results
Cortisol responsiveness over the first 96 h in culture
Fig.l illustrates the Cortisol secretion of the
bovine zfr cells measured over 1 h on day 1 (freshly
collagenase-dispersed) and at 24 h intervals thereafter
for 96 h in culture. The basal Cortisol output is shown,
together with the corresponding responses to maximally
stimulatory doses of ACTH (10"9M) and adrenaline (10"6M).
Also shown for comparison is the day-by-day response of
the zfr cells to angiotensin II (All) at a concentration
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STEROIDOGENIC RESPONSE OF CELLS FROM DAY OF
PLATING OUT (DAY 1)
DAY
Fig 1: Dav-bv-day responses of bovine zfr cells to ACTH
(—) , All (—) and adrenaline (■-) .
The Cortisol output was measured over 1 h for freshly
isolated cells (day 1) and at 24 h intervals thereafter
for cells in monolayer culture. The basal (no agonist)
response is shown, together with the responses to
maximally stimulatory doses of ACTH (—) , All (--) and
adrenaline (--■). Each point is the mean+S.D. for 3 wells
in a representative experiment.
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Fig 2: The Cortisol and cyclic AMP response of cultured
bovine zfr cells to catecholamines.
In Fig. 2A, the Cortisol secretory response over 1 h
(expressed as pmol.h"1.mg protein"1) is measured at 48 h
in culture (day 3) for the three catecholamines,
isoprenaline, noradrenaline and adrenaline. The basal
response is shown for comparison. In Fig. 2B, the
corresponding cyclic AMP production by the cells is
shown. Each point is the mean+S.D. for 3 wells in a
representative experiment.
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Fig. 2B
of 10"8M; bovine zfr cells show a marked response to this
agonist, which stimulates membrane phosphoinositide
turnover (14) .
Although freshly dispersed cells secrete Cortisol to
both ACTH and All, there is no significant increase above
basal secretion to adrenaline on day 1. After 24 h in
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culture, however, the cells now respond to adrenaline.
The Cortisol secretory response to all three agonists
peaks by 48 h and declines thereafter.
Cortisol and cyclic AMP response to catecholamines
Fig. 2A shows the Cortisol response to increasing
doses of isoprenaline, noradrenaline and adrenaline for
cells after 48 h in primary culture. The mean ED5Q for
adrenaline was found to be 5.0 x 10"8M (range 2.0 - 12.6
x 10"SM; n=3). In Fig. 2B, the dose-dependent increase in
medium cyclic AMP content in response to increasing doses
of the same three agonists is also evident.
The failure of adrenaline to elicit any significant
increase in 3H-inositol-labelled total aqueous head group
production from cells whose membrane phosphoinositides
had previously been labelled to isotopic steady state
with 3H-inositol is shown in Fig. 3. The same figure
uses All as a positive control for the head group assay
and also illustrates the corresponding lack of effect of
All on cyclic AMP formation. The ability of the 0-
receptor antagonist, propranolol, to completely block the
effect of adrenaline on Cortisol and cyclic AMP
production and its lack of effect on the steroid and
second messenger responses to All is also shown.
Homologous desensitisation by adrenaline
Fig. 4 illustrates the effect of pre-incubating the
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Fig 3: Effects of adrenaline, noradrenaline and All on
Cortisol secretion, phosphoinositidase C activity and
cyclic AMP accumulation.
Cells were incubated for 15 min with agonists and, where
relevant, antagonists at the concentrations shown. For
measurement of Cortisol and cyclic AMP responses,
incubation medium was removed at the end of this time and
Cortisol and cyclic AMP (medium) content determined by
radioimmunoassay. Cellular cyclic AMP was also determined
after washing and ethanol extraction. For monitoring
phosphoinositidase C activity, [3H]inositol-prelabelled
cells were used and stimulation was carried out in the
presence of Li* (10 mM) . The total phosphoinositol
fraction was then recovered and its radioactivity
determined. Abbreviations: adrenaline (Adr),
noradrenaline (N.Adr), phentolamine (Phent), propranolol
(Prop). Results shown are the mean+S.D. of triplicate
values from a single experiment
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Fig 4: Homologous desensitisation of the adrenergic
response.
Cells were pre-incubated with, adrenaline (10"7M) after 48
h in culture. At different times thereafter, the
adrenaline was washed out and the cells challenged with
zero (i.e basal), 10"8M or 10"7M adrenaline and the
Cortisol secretion over a 1 h period measured. Each bar
is the mean+S.D. for 3 wells in a representative
experiment (the error bar only being shown when
sufficiently large to appear on the scale used). The xO'
time response relates to cells which have not been
previously exposed to adrenaline. Protein content of the
wells was not affected by the pre-incubation.
time on a subsequent challenge to zero (basal), 10"8M or
10"7M adrenaline. A time-dependent homologous
desensitisation of the Cortisol response is evident.
Characterisation of the adrenergic receptor
Experiments with |3- and a-receptor antagonists were
consistent with adrenergic stimulation occurring through
REGULATION OF CORTISOL SECRETION 247
Log 10 [AGONIST]
Fig 5: Dose response curves for Cortisol secretion to
different catecholaminergic agonists.
The Cortisol response over 1 h was measured for cells at
48 h (day 3) in response to isoprenaline (O ),
noradrenaline (»), dobutamine (A), salbutamol (A) and
BRL37344A (Q) . B=basal Cortisol production. Each point is
the mean+S.D. for 3 wells.
a 0-receptor in the bovine zfr cells (Fig. 3., see also
(7)). Dose-response curves for various selective 0 -
agonists are shown for the zfr cells at 48 h in primary
culture in Fig. 5. Isoprenaline, noradrenaline and
dobutamine all acted as full agonists, whilst salbutamol,
a full agonist at 02 receptors, but a partial agonist at
0, receptors (16), produced only 70% of the maximal
response. The compound BRL37344 (Beecham Pharmaceuticals,
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Fig 6: Schild analysis CICI 118551^
Fig. 6A is a representative experiment showing Cortisol
secretion at 48 h (day 3) following stimulation with
isoprenaline alone (o) and in the presence of increasing
concentrations of ICI 118551 10"6-5M (•) , 10"6M (A) and
10*5*5M (■) . Each point is the mean+S.D. for 3 wells. In
Fig. 6B is shown the Schild regression - least squares
fit of log10 (DR-1) versus log10 [ICI 118551], where DR =
dose ratio. Cumulative data from 3 separate cell
preparations.
Epsom, Surrey, U.K.), known to be a full agonist at (J3-
receptors (17), was a poor agonist for the zfr cells.
These results were consistent with the Cortisol secretory
effect of adrenaline occurring through the latter's
binding to a f),- receptor.
To confirm this preliminary characterisation, Schild
plots were obtained using the selective (^-antagonist,
practolol and the selective (^-antagonist, ICI 118,551
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Table 1. Comparison of experimental and published data



























95% CL = 95% confidence limits. Original references are
(18) and (19) .
(ICI pic, Macclesfield, Cheshire, U.K.). Fig. 6
illustrates dose-response curves to isoprenaline in the
presence of increasing concentrations of the (J2
antagonist, ICI 118,551; the inset figure shows the
corresponding Schild plot derived from the linear
portions of these dose-response curves. An identical
approach was used to derive the Schild plot for the
antagonist, practolol (not illustrated).
The calculated pA2 values for practolol and ICI 118,551
from these Schild lots and the pA2 values reported in the
literature are summarised in table 1.
The effects of cholinergic agonists on Cortisol secretion
In contrast to the absent adrenergic response,
freshly collagenase-dispersed bovine zfr cells were
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Fig 7: Cortisol response to AcCh. nicotine and McN-A-343
Cortisol production (1 h incubation) for increasing doses
of the 3 different agonists is shown (•= AcCh; =
nicotine; ■ = McNeil-A-343). The basal Cortisol
production is shown as the single bar (labelled 'Basal').
Each point is the mean+S.D. for triplicate wells in a
single experiment.
significantly stimulated (as compared to basal) by
acetylcholine (12) . As with ACTH and adrenaline (at later
times in culture), cholinergic stimulation peaked by 48
h, declining thereafter. The ED50 with respect to
acetylcholine was 1.2 x 10_6M (range 3.7 x 10"7 to 3.7 x
10"6 M; n=4 experiments) .
Fig. 7 displays dose-response curves to AcCh,
nicotine and the Ml receptor agonist McN-A-343, from
which it is evident that the response is muscarinic,
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although not involving the Ml receptor. The small
nicotinic response was inconsistent (slight stimulation
in 2 out of 5 experiments, only) , and cells showed
morphological evidence of damage at the high doses
necessary to elicit a response.
The effect of cholinergic antagonists on AcCh-stimulated
Cortisol secretion
Fig.8A shows a potent dose-dependent inhibition of
the response to AcCh by the muscarinic receptor
antagonist, atropine. Tubocurarine, a nicotinic
antagonist, had little effect, except for incomplete
inhibition at the highest doses. Also shown is the
failure of propranolol to inhibit the AcCh response,
thereby excluding the possibility that AcCh was releasing
adrenaline from contaminating medullary cells and leading
indirectly to Cortisol secretion.
In Fig. 8B, dose-dependent inhibition of the
response by hexahydro-sila-difenidol is shown. This
antagonist has high anti-muscarinic potency at M3
receptors but low potency at M2 receptors, with
intermediate potency at Ml receptors.
The second messenger response to AcCh
Previous studies have shown that there is no
increase in cyclic AMP in cfr cells in response to AcCh.
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Fig 8: The effects of different antagonists on AcCh-
stimulated Cortisol secretion.
The Cortisol response (1 h incubation) was measured for
each agonist, antagonist or combination, expressing the
secretion as a percentage of the response achieved by
10"4 M AcCh (100%) .
Panel A shows the effect of the muscarinic
antagonist, atropine (A) (A. ) and the nicotinic
antagonist, tubocurarine (T) (IB) . The basal response
alone is shown as the single bar ('Basal') . The effect of
propranolol (P) (at lO"6 M) on -the AcCh-stimulated
response is shown in the last bar of the figure.
Panel B shows the effect of the M3 antagonist,
hexahydro-sila-difenidol (Hex) (•) . The basal response
alone is shown as the single bar ('Basal').
All values are the mean+S.D. for triplicate wells in
a single experiment. In all cases, no effect of the
antagonist alone on basal Cortisol secretion was found.
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Fig 9: The effects of different antagonists on AcCh-
stimulated phosphoinositol formation.
[3H]Inositol-prelabelled cells were incubated, in the
presence of Li" ^10mM), with the antagonists shown and
with or without AcCh (10"4M) for 15 min. The
radioactivity accumulating in the total phosphoinositol
fraction of these cells is shown. Abbreviations and
concentrations used are as follows: Nicotine 10"4M (Nic),
McNeil-A-34 3 10"4M (McN) , Atropine 10'6M (Atr) ,
Tubocurarine 10"6M (Tub) , Hexahydro-sila-difenidol lO"6^
(Hex) , Glycopyrrolate 10_6M (Gly) , Propranolol 10"6!*
(Prop) and Pirenzipine 10'5M (Pir). Results shown are the
mean+S.D. of values from triplicate incubations in a
single experiment.
labelling of membrane phosphoinositides, but no
definitive evidence for an activation of
phosphoinositidase C in bovine zfr cells (11).
Fig. 9 summarises the 3H-inositol labelled head
group response to AcCh (10"4M) and nicotine (10'4M) . The
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effect of a number of muscarinic antagonists and the
nicotinic antagonist, tubocurarine, on the AcCh-
stimulated head group response is also shown. Nicotine
has no effect on the head group response, neither is the
AcCh response blocked by tubocurarine. In contrast, the
non-specific muscarinic antagonists, atropine and
glycopyrrolate, completely antagonise the effects of
AcCh. The relative lack of effect of pirenzipine, an Ml
antagonist, and the antagonistic properties of hexahydro-
sila-difenidol on the head group response are also
illustrated.
Fig. 10 illustrates the time-course of appearance of
3H-labelled phosphoinositol species in response to
stimulation by AcCh (10"4M) from cells pre-labelled with
Fig 10 Time-course of appearance of f3H"l-labelled
phosphoinositol species in response to AcCh.
[3H]Inositol pre-labelled cells were exposed (e) or not
exposed (o) to AcCh (10"4 M) in the presence of Li+ (10
mM), terminating each incubation over the time period 0
to 900s. The water-soluble extracts at each time-point
were subject to HPLC analysis on a partisphere SAX-5
column, and the [3H] counts in the peaks, identified
(using appropriate standards) as InsP, InsP,,
Ins (1, 4 , 5) P3, Ins (1, 3 , 4) P3 and InsP4 and InsP5, separately
measured. The figure shows the time-course of appearance
of 3H-counts in these different phosphoinositols species.
Each point is the mean+S.D. of 3 HPLC analyses from 3
separate wells. The earliest time-point at which the
stimulated cells differ significantly from the
unstimulated cells for each phosphoinositol species is
shown. Changes in labelling of Ins(1,4,5)P3 at 5 s and
15 s are shown in the inset graph with the expanded
scale.
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Fig 11 AcCh-stimulates oscillations in intracellular Ca2*
in single cultured bovine adrenal zona fasciculata/-
reticularis cells.
Cells prepared on coverslips and pre-loaded with Fura 2,
as described in Methods, were perfused with Krebs-
Ringer/Hepes buffer alone and then with the same buffer
containing AcCh (10"5M). Changes in Fura 2 fluorescence
in a single cell, reflecting changes in cytosolic [Ca2+] ,
were monitored as described. AcCh promoted a rapid rise
in [Ca2+] and sustained oscillations with an interspike
interval of 18-120 sec. Individual spikes were of
amplitude 300-550 nM from a resting level of 75 nM.
3H-inositol to steady state. It is evident from this
figure that an increase in labelling of InsP,, InsP2 and
InsP3 species is stimulated by AcCh. More detailed
examination establishes that the earliest labelled
species to show this increase is Ins(1,4,5)P3, consistent
with the activation by AcCh of a phosphoinositidase C
specific for Ptdlns(4,5)P2.
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The effect of AcCh on intracellular rcaz""l
Earlier work on the intracellular Ca2+ response to
AcCh in cell populations of zfr cells (suspension
culture) (12) was extended to a study of the
intracellular Ca2+ response from single fura-2 loaded
cells (in monolayer), using fluorescence enhancement
microscopy. In Fig. 11 it can be seen that, in the case
of the single, representative cell shown, AcCh leads to
an oscillation in intracellular Ca2+, sustained in the
presence of normal extracellular [Ca2*] .
Discussion
Evidence presented here and elsewhere firmly
establishes that cultured bovine zfr cells secrete
Cortisol in response to adrenergic and cholinergic
stimulation (6,7,9,10,12). What is the significance of
these responses in vivo?
In the case of the adrenergic response, a key
question is whether or not the receptor is acquired as
a result of the cell culture process itself (since the
response is absent in freshly isolated cells) . In
contrast, the cholinergic response is clearly present in
freshly isolated cells, arguing strongly for the
potential to respond in vivo.
The demonstration that the adrenergic response is
subject to homologous desensitisation with a tQ5 of
258 WALKER ET AL.
approximately 2 h could provide a possible explanation
for the absent Cortisol response to adrenaline in fresh
cells. Homologous desensitisation of (3-adrenergic
responses are common and often associated with short-term
conformational changes in the receptor, followed by a
longer-term degradation of the receptor (20) . The
possibility arises, therefore, that diffusion of
catecholamines from medulla to cortex after death may
desensitise the receptor in the freshly isolated cells;
certainly evidence exists for the presence of
catecholamines in the adrenal cortex after death (21) . An
absent response might also be the result of receptor
degradation or damage during the isolation procedure
itself.
The results reported here and elsewhere (15)
conclusively establish that the adrenergic response in
the zfr cells occurs through a ^-receptor. This is of
more than passing interest if Ungar's generalisation,
that ^-adrenergic receptors are associated with
adrenergic nerve endings, is correct (22). It implies
that any potential in vivo function for the adrenergic
response depends upon adrenergic nerve stimulation.
Is there any evidence for adrenergic innervation of
the mammalian adrenal cortex? Although there is no
information on this question for the bovine cortex,
evidence for adrenergic innervation of the adrenal cortex
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exists in man (23), mouse (24) and rat (25). Hence,
circumstantial evidence from receptor subclassification
and from morphological studies suggests that any in vivo
adrenergic effects may depend upon nerve stimulation.
Even if this conclusion is correct - and it must still
remain an open question - it begs several important
questions (vide infra).
Several studies now firmly establish that bovine zfr
cells also secrete Cortisol in response to AcCh and that
this depends upon AcCh binding to a muscarinic receptor
(9,10,12). The muscarinic receptor has been shown by both
pharmacological and molecular biological techniques to be
heterogeneous in a variety of tissues. A range of
muscarinic antagonists have established at least 3 types
of muscarinic receptor subtype; the M1 and the M3
receptors are linked through a G-protein to the
activation of phosphoinositidase C, whilst the M2
receptor negatively couples to adenylate cyclase (26).
In this article and elsewhere (12), we establish
that AcCh activates a phosphoinositidase C in bovine zfr
cells, and that the release of Ins(l,4,5)P3 brings about
the expected increase in intracellular [Ca2+]. Similar
observations have been previously reported for the AcCh-
stimulated release of aldosterone from bovine zg cells
(27). The activation of phosphoinositidase C and the
pharmacological evidence', reported here and elsewhere
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(12) , are consistent with AcCh's stimulation of Cortisol
secretion in bovine zfr cells occurring through its
binding to an M3 receptor. The significance of this
classification to any possible in vivo effects is not yet
clear.
That cholinergic stimulation may influence
adrenocortical function in vivo is attested to by the
morphological evidence for cholinergic innervation in
man, cattle (28) and sheep (29).
These observations on the cholinergic response in
bovine zfr cells lead to the same range of, as yet,
unanswered guestions as is the case for the adrenergic
response. Why have a separate innervative control of
steroidogenesis? How do adrenergic or cholinergic
stimulation affect the steroid response of the cells to
humoural factors such as ACTH or All? How do the
adrenergic and cholinergic mechanisms interact?
One possible explanation for separate innervative
control relates to the increasing number of reports that
bovine (and rat) zfr cells also respond to agonists which
stimulate zg cells (e.g. All and vasopressin, as well as
AcCh and adrenaline) (30). Innervative control of
different zones might allow targeting of a response to a
specific zone of the adrenal cortex in a way which cannot
be achieved by a circulating hormone. Adrenergic or
cholinergic innervative stimulation might allow such
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direct control, or a means of altering the relative
proportions of different steroids secreted in response to
other agonists through effects on the steroid pathway
itself. The alternative possibility that such innervative
responses may influence phenomena such as cell growth,
however, must not be overlooked.
Whatever the specific answers to these questions, it
is becoming increasingly clear that the possible
involvement of both adrenergic and cholinergic
innervative control cannot be overlooked in attempting to
understand the control of adrenocortical function in
vivo.
Finally, the observation that adrenaline and AcCh
utilise different second messenger systems allows us to
explore further the link between the second messengers
formed, and the subsequent cellular responses. For AcCh,
in particular, it should be possible to explore
specifically the significance of intracellular,
oscillatory [Ca2+] events in the function of this
neurotransmitter in the adrenal cortex. Evidence that
AcCh and All mobilise a common intracellular pool of
Ca2+, presumably through Ins(l,4,5)P3 formation already
exists for populations of bovine zfr cells (31). This
area can now be explored in more detail in single cells
using fluorescence microscopy techniques.
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abstract
When bovine adrenocortical cells from the zona
fasciculata/reticularis (zfr) are maintained in primary
culture, Cortisol secretion in response to acute stimu¬
lation with ACTH and adrenaline (which activate
adenylate cyclase) is seen to increase steadily over the
first 48 h. while secretion in response to angiotensin II
and acetylcholine (which activate phosphoinositidase
C) shows an initial decline in the first 24 h and a recov¬
ery to maximum after 48 h. We have investigated
whether these discrepant changes in Cortisol secretory
response to the different agonists are due to changes in
formation of the associated second messengers
(cAMP or inositol phosphates), or altered coupling of
these second messenger signals to steroid secretion.
Increases in steroid secretion in response to ACTH
and adrenaline were paralleled by increased cAMP.
Steroid secretion in response to exogenous 8-
bromoadenosine 3':5'-cyclic monophosphate also
increased steadily during this 48-h period. Thus
increased responsiveness was due to both increased
second messenger formation and increased coupling
to the steroid secretory response.
The decreased steroid secretory response to angio¬
tensin and acetylcholine after 24 h, and subsequent
recovery after 48 h in culture, were accompanied by
an increased formation of phosphoinositols after 24 h
and a further increase by 48 h. However, the steroid
secretory response to a combination of calcium iono-
phore and the protein kinase C activator, phorbol 12-
myristate 13-acetate, was reduced after 24 h and
recovered by 48 h of culture. Fura-2-loaded cells also
showed an increase in intracellular [Ca2 + ] after 24 h in
culture. Thus the impaired steroid secretory response
to angiotensin II and acetylcholine after 24 h of
culture was not due to reduced formation of second
messengers but to a failure of Ca2'1" and diacylglycerol
so formed to activate the steroid secretory (process.
Reversible uncoupling of the steroid secretory
response from the Ca2"1"- and diacylglycerol-based but
not the cAMP-based second messengers observed in
bovine zfr cells suggests that differential control
of steroid secretion and other cell functions may be
possible in vivo for activators of phosphoinositidase
C. and may explain apparently discrepant results
from studies on other in-vitro adrenocortical cell
preparations.
Journal of Endocrinology (1992) 133, 21-28
introduction
The ability to maintain homogeneously dispersed cells
from the rat (O'Hare & Neville. 1973) or bovine
(Hornsby & Gill, 1978) adrenal cortex in primary
culture has provided a valuable in-vitro model system
for the study of the mechanisms which maintain
adrenocortical structure and regulate its function.
Thus, fibroblast growth factor has been found to be
important in promoting adrenocortical cell division to
confluence, and adrenocorticotrophin (ACTH) has
been found necessary for maintenance of the steroid
pathway for periods longer than a few days in primary
culture (Hornsby & Gill, 1978).
In recent years, cultured cell preparations have been
increasingly used to investigate the acute second
messenger and steroid secretory responses to steroido¬
genic agonists. When plated at near confluence in a
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basic growth medium of nutrients/10% fetal calf
serum/antibiotics/antifungal agents, bovine adreno¬
cortical cells from the zona fasciculata/reticularis
(zfr) have consistently been reported to show
increased responsiveness to ACTH compared with
freshly isolated cells. Whether considered as steroid
output,;mg protein or as «-fold over basal output,
the response is maintained or higher after 24 h and
increases to a maximum by 48-72 h (Kawamura,
Nakamichi. Imagawa et al. 1984; Williams. Lightly,
Ross et al. 1989; Walker. Lightly, Clyne et al. 1991),
declining thereafter.
We have previously reported that bovine adreno¬
cortical zfr cells also secrete steroids in response to
adrenergic agonists acting via a (3, receptor (Lightly,
Walker. Bird & Williams, 1990) coupled to adenylate
cyclase (Kawamura et al. 1984; Walker, Lightly. Milner
& Williams. 1988; Williams et al. 1989). The poor or
absent steroidogenic response of freshly isolated cells
to adrenergic agonists is followed by a markedly
increased response over the first 48 h ofprimary culture.
The increased steroid secretory response to both
adrenaline and ACTH is paralleled by increased
formation of adenosine 3',5'-cyclic monophosphate
(cAMP) (Kawamura et al. 1984; Walker et al. 1988).
Whilst investigating optimal growth conditions for
studying the cholinergic response in bovine zfr cells,
preliminary evidence was obtained that the Cortisol
response to acetylcholine was reduced at 24 h, com¬
pared with freshly isolated cells (Walker, Strachan,
Lightly et al. 1990). It appeared that this fall in Corti¬
sol secretion at 24 h might also occur with angiotensin
II (All) (Walker et al. 1991). Since previous studies,
discussed above, had suggested that the Cortisol
response to ACTH and adrenaline is increasing at 24 h.
it was decided to undertake a detailed comparison of
the day-by-day Cortisol secretory response to ACTH/
adrenaline, on the one hand, and All/acetylcholine,
on the other.
Since an obvious difference between ACTH and
adrenaline versus All and acetylcholine lies in the dif¬
ferent second messenger responses promoted by these
agonists, it was also decided to investigate changes in
the second messenger responsiveness on a day-by-day
basis. Unlike ACTH and adrenaline, which activate
adenylate cyclase, both All and acetylcholine stimu¬
late a polyphosphoinositide-specific phospholipase C
(phosphoinositidase C) to produce inositol 1.4.5-
tnsphosphate (Ins( 1,4,5)P3) and diacylglycerol (DG),
without increased cAMP formation (Bird, Meikle,
Williams & Walker, 1989; Walker et al. 1990). The
Ins(l,4,5)P3 so formed liberates Ca2+ from intracellu¬
lar stores which, combined with increased Ca2 + influx
across the plasma membrane, leads to a sustained
increase in cytosolic intracellular [Ca2+]. This
response, together with the activation of protein
Journal of Endocrinology (1992) 133, 21-28
kinase C by DG. leads to increased steroid secretion.
The activation of the steroid secretory response by
Ca2+ and DG, independently of cAMP can also be
successfully mimicked in these cells by the combined
action of the Ca2+ ionophore A23187 and the phorbol
ester phorbol 12-myristate 13-acetate (PMA) (Bird,
Walker & Williams,' 19906).
In this paper we demonstrate that bovine zfr cells
show a consistent fall in Cortisol secretion at 24 h in
culture to both All and acetylcholine. This fall is
shown to occur at a time when the membrane phos-
phoinositide turnover is increasing in response to
these agonists. By studying the cellular responses to
Ca2+ ionophore and phorbol ester, alone and in com¬
bination. together with measurements of intracellular
[Ca2+], the probable site of the lesion responsible for
this uncoupling is suggested. The implications of these
findings are also discussed.
MATERIALS AND METHODS
Unless otherwise stated all materials were obtained as
described by Bird, Nicol, Walker & Williams (1990a).
Digitonin, A23187 and PMA were from Sigma
Chemical Company, Poole, Dorset, U.K. Pyruvate
and NADH were from the Boehringer Corporation,
London, U.K. Sequential multi-channel analyser and
computer (SMAC) chemistry calibrator 2 (SETpoint
2) standard (lyophilized bovine serum with added lac¬
tate dehydrogenase from chicken heart) was from
Technicon Diagnostics, Basingstoke, Hants, U.K.
Cell preparation and culture
Cells were isolated and purified from the zfr of the
adrenal gland obtained from 1- to 2-year-old steers, as
described previously by Williams et al. (1989). Cells
were used immediately for studies on freshly isolated
cells, or cultured in 12-well plates (330 000 cells/ml per
2-25 cm well) in a medium of Ham's F10 with 10%
controlled process serum replacement (CPSR 5;
Sigma), penicillin (50 IU/'ml). streptomycin (50 pg/ml)
and amphotericin B (2-5 pg/ml) (F10 growth medium).
After 24 h, medium was removed and replaced with
fresh medium (0-5 ml/well).
Preparation of agonists
All, ACTH, acetylcholine, adrenaline and 8-bromo-
adenosine 3':5'-cyclic monophosphate (8-BrcAMP)
were prepared by dilution in the media described
below as required. A23187 and PMA were initially
dissolved in dimethyl sulphoxide (DMSO) to prepare
a stock solution of 10 mmol/1. This was then diluted
1 :500 with the appropriate medium to give a
20 pmol/1 solution in 0-2% (w/v) DMSO. Addition of
this to cell incubations at 50 pi (25 pi A23187 solution
Phosphoinositidase C agonists in adrenocortical cells i. m. bird and others
and 25 ql PMA solution) per 500 pi final volume gave
a final concentration of 1 qmol/1 in 0-02% DMSO.
Parallel preparations of DMSO alone in medium were
tested in each experiment but no significant effects of
these DMSO controls were seen on steroid production
over controls without DMSO.
Stimulation of Cortisol and cAMP secretion
The basic protocol for experiments on freshly isolated
cells (in suspension) or for plated cells (maintained in
culture) was the same. Medium changes on cells in
suspension were earned out by first pelleting the cells
(centnfugation in a microfuge at 500 g for 3 min) and
then resuspending in fresh medium. For cultured cells,
the well contents were removed by aspiration and
immediately replaced with fresh medium. All incu¬
bations were subsequently earned out in a gassed,
humidified incubator (5% CO, at 37 'C).
Cells were washed twice with 1 ml Earle's balanced
salts (EBS) solution and finally resuspended in EBS
with added bovine serum albumin (BSA) and glucose
(0-2 and 01% (w/v) respectively) (EBSBG; 0-45 ml/
well). After 5 min preincubation at 37 °C, agonists
were added in 50 pi EBSBG and cells incubated for a
further 60 min. At the end of this time cell-free
medium was recovered (by centrifugation of cell
suspensions or aspiration of wells) and stored at
— 20 °C for Cortisol radioimmunoassay, as described
previously (Williams et al. 1989).
Where cAMP secretion into the medium was also
measured, an identical protocol was followed but the
final incubation volume in each well was 1 ml. At the
end of the experiment the medium was recovered and
split into two 0-5 ml volumes. Cortisol content of the
recovered medium was assayed directly as above,
while cAMP content was determined by radioimmu¬
noassay after prior acetylation of 0-5 ml of the
recovered medium (Williams et al. 1989).
Stimulation of phosphoinositidase C response
The activation ofphosphoinositidase C by agonists was
determined by measuring the hormone-stimulated
generation of [3H]inositol phosphates in the presence
of 10 mmol Li + /1.
Labelling of cultured cells with [3H]inositol was first
achieved by supplementing the F10 growth medium in
each well with [3H]inositol to 10 pCi/ml and incubating
for 5 h. Freshly isolated cells were labelled for the
same period of time after resuspension in growth
medium (at 300 000/0-5 ml) with [ H]inositol (10 pCi/
ml), and dispensing to microfuge tubes at 0-5 ml/tube.
Once labelled, the [3H]inositol-containing F10
growth medium was removed and replaced with
EBSBG (0-5 ml/well or tube) and cells were incubated
for 15 min. Medium was replaced with EBSBG-
10 mmol LiCl/1-10 mmol inositol/1 (EBSBG/Li+/Ins;
0-45 ml/well or tube) and cells were incubated for 15
min. Agonists were then added in a total of 50 pi
EBSBG Li Tins and cells incubated for a further 15
min. Cell stimulation was finally terminated by the
addition of ice-cold perchloric acid (PCA; 250 pL
15%). For cultured cells, wells were scraped and the
contents recovered to microfuge tubes with a 0-5 ml
water wash. For ceils in suspension, 0-5 ml water was
added to each tube after addition of the PCA. The
water-soluble [3H]inositol phosphates were then
recovered by pelleting insoluble material (centrifu¬
gation at 3300# for 3 min) and retaining the super¬
natant. These aqueous extracts were neutralized by
thorough mixing with 1-5 ml freon-octylamine (1,1,2-
trichlorotrifluoroethane-tn-n-octylamine; 1:1) and
the resulting three phases separated by brief centrifu¬
gation in a bench centrifuge. Neutral aqueous extracts
(top phase) were recovered and stored frozen at
— 20 C for assay of [3H]inositol phosphates.
Assay of (3H]inositol phosphates
The [3H]inositol phosphates in aqueous extracts were
separated from the [ H]inositol by retention of the
former on columns of anion exchange resin (analytical
grade 1-X8, 100-200 mesh) as described previously
(Bird et al. 1990a). Combined [3H]inositol phosphates
were recovered by elution with 1 mol ammonium
formate/1-0-1 mol formic acid/1 and radioactivity
was determined by liquid scintillation counting in a
Packard 1900CA liquid scintillation counter.
Protein determination
Cellular protein was measured each day by washing
cells three times in EBS (0-5 ml) and solubilizing in
1 % Triton X (0-5 ml/well or tube, incubation at 37 °C
for 15 min followed by scraping of cells with a rubber
spatula). Samples were stored frozen ( — 20 °C) before
dilution at 1 : 10 with water and assay by the Bradford
method, as adapted for the Cobas Fara centrifugal
analyser (see Williams et al. 1989).
Cellular lactate dehydrogenase release and assay
Cells were washed and resuspended in intracellular
buffer (0-45 ml; composition: KC1 (120 mmol/1), NaCl
(10 mmol/1), MgS04 (4-18 mmol/1), EGTA (1 mmol/
1), Hepes (20 mmol/1); pH 7-4) and permeabilized by
addition of digitonin (final concentration 50 qmol/1 in
500 ql final volume). Permeabilization was allowed to
proceed at 37 °C for 15 min. A cell-free supernatant
was then obtained by removal of medium and centri¬
fugation at 3000# (3 min). Samples were stored (as
two x 200 ql volumes) at 4 °C for assay in duplicate.
Journal of Endocrinology (1992) 133, 21-28
i. m. bird and others Phosphoinositidase C agonists in adrenocortical cells
Samples were completely stable at 4 °C for several
days but showed reduced activity when frozen.
The assay procedure used was a modification of the
method of Brydon & Smith (1973), adapted for the
Cobas Fara centrifugal analyser. This assay monitors
the change of NADH to NAD as pyruvate is con¬
verted to lactate. The method described here was car¬
ried out in the absence of urea, so total (i.e. urea stable
and unstable) lactate dehydrogenase was measured.
Stock NADH (0-2 mmol/1) solution and stock
sodium pyruvate (7-7 mmol/1) solutions were prepared
in 0-1 mol KH,P04/1 (buffered to pH 7-4 with NaOH)
and stored at -20°C (stable for several weeks).
For assay of lactate dehydrogenase (LDH) activity,
200 pi NADH solution and 10 pi sample in each
rotor cuvette were prewarmed to 37 C and blank
absorbance values read at 340 nm. Stock pyruvate sol¬
ution (25 pi) was added to start the reaction and. from
6 s after the start, absorbance changes were measured
at 10-s intervals for 100 s. With diluent additions the
total assay volume was 275 pi and final concentrations
of NADH and pyruvate were 0144 and 0-7 mmol/1
respectively. LDH activity was determined from the
initial rate of decrease of absorbance and expressed as
LDH activity units (applying a correction factor of
1600). All assays were carried out with a quality con¬
trol standard of activity 50-60 U/l (SETpoint 2 stan¬
dard diluted ten times with intracellular buffer). For
this quality control standard, the variation of values
obtained in six separate assays on 6 consecutive days
was 58-6 ±31 U/l (mean ± s.d., range 53-62).
Measurement of intracellular calcium
Cells purified as described above were plated onto
22 mm glass coverslips placed in 12 multiwell plates.
After 24 h in culture, cells were loaded with fura-2
AM (5pmol/l) for 30-60 min at 37 °C. A coverslip
with loaded cells was then placed in a thermostated
superfusion chamber attached to the stage of a Nikon
diaphot inverted microscope. Cells were perfused at
37 "C with a modified Krebs-Ringer medium con¬
taining NaCl (134 mmol/1), KC1 (4-5 mmol/1), MgCL
(1 mmol/1), NaH:P04 (1 mmol/1), CaCl, (1-5 mmol/1),
glucose (5-5 mmol/1) and Hepes(10 mmol/l) pH 7-4, and
excited alternately at 340 and 380 nm. Fluorescence
emissions at the two wavelengths were recorded at
506 nm and stored separately on a microcomputer.
The fluorescence ratio (F340/380) was plotted as a func¬
tion of time (after correcting for background counts)
using a dedicated Amstrad 2086 microcomputer.
Statistical analysis
Significance was established by comparison of data
using Student's r-test.
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RESULTS
The changes in Cortisol secretion and cAMP secretion
observed in response to ACTH (0-1 nmol/1, 1 h) or
adrenaline (1 pmol/1. 1 h) on maintenance of bovine
zfr cells in primary culture are shown in Fig. 1. All
data are expressed as «-fold over basal (to allow com¬
parison with data in Fig. 2) but basal values are given
in the figure legend. For comparison, the Cortisol
secretory response to 8BrcAMP (I mmol/1, 1 h) is also
shown.
Freshly isolated cells secreted Cortisol in response to
ACTH but not adrenaline: at 24 h in culture the cells
also responded to adrenaline. An increase in Cortisol
secretory response to both ACTH and adrenaline was
observed over a 48-h period, continuing, in this case,
to a maximum at 72 h of culture (day 4) but declining
thereafter. The Cortisol secretory response to ACTH
and adrenaline was significantly higher on each day
than that on the previous day (P<001 in each case,
from day 1 to day 4). This increased Cortisol secretory
response was paralleled by a corresponding increase
in cAMP formation in each case (Fig. 1).
Freshly isolated cells also secreted Cortisol in
response to 8BrcAMP. and this response increased
steadily to a maximum over the first 48-72 h of
culture, after which it too declined (ACTH: cAMP
secretion significantly increased from days 1 to 2
(P<005) and days 2 to 3 (Z3 < 0 01) but not days 3
to 4; adrenaline: cAMP secretion not significantly
increased from days 1 to 2 but significantly increased
from days 2 to 3 (P<001) and days 3 to 4 (PcOOl)).
The changes in All- and acetylcholine-stimulated
Cortisol secretion and phosphoinositidase C acti¬
vation on each day of primary culture are shown in
Fig. 2. All results are expressed as /i-fold over
basal response (with basal values given in the figure
legend) to allow data to be combined from several
experiments.
While all the results shown are expressed as n-fold,
the raw data also showed similar trends, and the pro¬
tein content of each well, taken as a measure of cell
number, did not vary by more than 20% over the 5-
day period. As an independent check of cell number
on each day. lactate dehydrogenase activity was
released from cells (permeabilized with digitonin) and
assayed as described. The results obtained agreed
closely with the results from protein determinations
(results not shown).
Figure 2 shows that, after 24 h in culture (day 2),
the Cortisol response to All and acetylcholine was
reduced (All: PcOOl in three experiments; acetyl¬
choline: P<005 in two experiments or unchanged
(one experiment)) but rose once more to a maximum
after a total of 48 h in culture (day 3) (Fig. 2). The
response thereafter declined (Cortisol secretion on day
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Dav of culture
figure 1. Cortisol and cAMP secretory responses of bovine
zona fasciculata/reticularis cells stimulated for 1 h with the
agonists (a) ACTH( 1-24) (0-1 nmol/1) or (b) adrenaline
(1 |imol/i)on the day of isolation (day 1) and on successive
days after maintenance in primary culture (from experimen¬
tal days 2 to 5). (c) Cortisol response to 8-bromoadenosine
3':5'-cyclic monophosphate (1 mmol/1). For experimental
details see Materials and Methods. All results are expressed
as n-fold over basal (unstimulated) response and show the
mean + s.D. of triplicate wells from a representative exper¬
iment performed on three different occasions with different
cell preparations. Mean basal values for Cortisol secretion
were 6-80,7-84, 13-10. 11 -76 and 15-12 pmol/well per h per
100 g protein for days 1 to 5 respectively, and mean basal
cAMP secretion was 0-129, 0-234. 0-228.0-176 and
0-190 pmol/well per h per 100 g protein respectively.
4 being less than on day 3; P<001 for All and
/><0-05 for acetylcholine in all three experiments).
Day of culture
figure 2. Cortisol secretory response and phosphoinositi¬
dase C response (generation of [JH]phosphoinositols) of
bovine zona fasciculata/reticulans cells stimulated with (a)
angiotensin II or (b) acetylcholine shown on the day of
isolation (day 1) and on successive days after maintenance
in primary culture (from experimental days 2 to 5). See
Materials and Methods for experimental details. All results
are expressed as n-fold over basal (unstimulated) response
and show the mean ± s.e.m. of mean values from three sep¬
arate experiments, each performed using triplicate wells for
each data point. Mean basal values for Cortisol secretion
were 6-40. 1 -25. 3-25. 5-60 and 2-75 pmol/well per h per 100 g
protein for days 1 to 5 respectively, and mean basal
['H]inositol phosphates labelling were 345, 657, 723, 346 and
321 d.p.m., 100 g protein respectively.
The effect of All and acetylcholine on phospho¬
inositidase C activation in these cells did not parallel
the day-by-day changes in steroid secretory response.
Both agonists promoted a greater formation of
[3H]inositol phosphates after 24 h in culture (day 2,
increase over day 1 significant for All (Z1 < 0-01) in all
three experiments and acetylcholine (/><0-01) in two
out of three experiments) at a time when there is a
marked reduction in the Cortisol secretory response.
The [3H]inositol phosphate responses to All and
acetylcholine then rose to a maximum after 48 h in
culture (day 3), the response on day 4 being signifi¬
cantly (/><0-01) less in two out of three experiments
for both All and acetylcholine.
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Day of culture
figure 3. Cortisol secretory response to A23187 alone (A),
phorbol 12-myristate 13-acetate (PMA) alone (T) or
A23187 and PMA combined (♦) is shown for freshly iso¬
lated bovine zona fasciculata/reticularis cells (day 1) and for
successive days in primary culture (experimental days 2 to
5). For experimental details see Materials and Methods. All
results are expressed as n-foid over basal (unstimulated)
response and show the means ± s.e.m. for triplicate wells in a
representative experiment. Qualitatively identical patterns
were obtained in a total of five experiments with A23187 and
PMA combined, and in two experiments with A23187 and
PMA alone.
Figure 3 shows a representative experiment of the
effects of A23187 alone, PMA alone and A23187 and
PMA combined on the Cortisol secretory response.
The initial changes in Cortisol secretory response
to PMA/A23187 were qualitatively similar to the
changes described for All and acetylcholine. After
24 h in culture (day 2) the response was also much
reduced (/><0-05 in each of five experiments) but
increased once more after 48 h in culture (day 3)
(P<0-05 in all five experiments). In two experiments,
the effects of A23187 and PMA alone were examined.
Figure 3 shows that PMA alone was a much more
effective stimulus to Cortisol secretion than A23187
alone and that the day-by-day secretory pattern was
very similar to the A23187/PMA combination, with a
statistically significant fall in Cortisol secretion at 24 h
(PcO-05 in each of two experiments). Although
A23187 alone was relatively ineffective, the steroid
secretion at 24 h was unchanged, compared with the
freshly isolated cells.
Figure 4 shows the increase in intracellular [Ca2+] in
response to All (0-1 pmol/1) from a single representa¬
tive cell after loading with fura-2 on day 2 of primary
culture. Forty cells from five separate primary cell
isolates were studied on day 2 by this method, with
qualitatively similar responses observed in 68% of the
cells examined, comparable with the findings for cells
on day 3.
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figure 4. Intracellular [Ca; + ] response to angiotensin II
(All) (0-1 pmol/1) from a single fura-2-loaded bovine zona
fasciculata/reticularis cell at 24 h in culture (day 2). The
chamber was continuously perfused with modified Krebs
buffer (see Materials and Methods) at 37 3C, monitoring the
ratio of fluorescence emission at 506 nm following alternate
excitation at 340 and 380 nm (F!40/F,80) versus time (s). All
(0-1 (imol/l) was infused in the same Krebs buffer (arrow). A
representative cell is shown in which the increase in the ratio
(F)40, F,g0) in response to the All infusion is shown. A total
of 40 cells from five different cell preparations was examined
in this way; a rise in intracellular [Ca:+] was observed in
68% cells in response to All.
DISCUSSION
Data in Fig. 1 show that the increase in Cortisol
secretion to ACTH and adrenaline on each of the first
4 days in culture was closely paralleled by changes in
cAMP formation. However, the increased cAMP for¬
mation cannot be the only explanation for the
increased Cortisol secretion since the steroid secretory
response to 8BrcAMP also increased steadily over the
first 72 h of culture. Thus, post-second messenger
factors, such as increased availability of cAMP-
dependent protein kinase or its substrates or increased
steroid synthetic capacity must also be relevant.
In contrast, the Cortisol secretory response to the
agonists which activate phosphoinositidase C, All
and acetylcholine was consistently reduced by 24 h of
culture (day 2) (Fig. 2), thereafter recovering.
Measurement of the protein content of the wells con¬
firmed that this fall was not due to any significant fall
in cell number (results not shown). Accompanying
this fall in Cortisol secretion on day 2, there was
a paradoxical increase in [3H]inositol phosphate
formation. Hence, the decline in Cortisol secretion
could not have been due to reduced activation of the
polyphosphoinositide-specific phosphoinositidase C,
whether through marked reductions in receptor
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numbers or affinity, in G-protein availability or in cell
phosphoinositidase C activity.
There are several explanations which might account
for the dissociation between [3H]inositol phosphate
formation and Cortisol secretion: (1) a requirement for
additional diacylglycerol formed by the breakdown
of phospholipids other than the phosphoinositides
(through activation of an additional phospholipase
C); (2) a failure to elevate intracellular [Ca2+]; (3)
a failure to couple the increased [Ca2 + ] and/or DG
signals to activation of the rate-limiting step of the
steroid pathway cytochrome P450 side-chain cleavage
enzyme: (4) a failure to convert the pregnenolone so
formed into cortisoi.
The first two possibilities appear to be unlikely
when the effects of combined Ca2 + ionophore and
PMA are considered. These agents induce an elev¬
ation of intracellular [Ca2 + ] and activation of protein
kinase C independently of the receptor/G protein/
phosphoinositidase/Ca2 + channel systems, and yet
failed to restore the markedly reduced Cortisol
secretory response in cells on day 2 (Fig. 3). Further¬
more. studies using fura-2-loaded cells on day 2 con¬
firmed that generation of the intracellular Ca:+ signal
was unimpaired (Fig. 4). The fourth possibility can
also be eliminated as no corresponding reduction in
steroid secretion was seen in response to ACTH or
SBrcAMP on day 2. Also, day-by-day changes in cor-
ticosterone secretion paralleled changes in Cortisol
secretion for ACTH and All respectively (E. R. T.
Lightly, unpublished data).
These findings are therefore consistent with a fail¬
ure to couple the Ca2 + and/or DG signals to acti¬
vation of P^O^. In view of the known involvement of
Ca2 + in the Cortisol secretory response to ACTH
(which is maintained on day 2) it is unlikely that the
fault lies in the coupling of the Ca2 + signal to acti¬
vation of PdSO^. This is further supported by the
experiments in which ionophore was studied alone;
A23187 alone achieved a slight but significant stimu¬
lation of Cortisol secretion, with no significant dif¬
ference between days 1 and 2 (Fig. 3). In contrast,
phorbol ester alone was a more potent stimulus to
Cortisol secretion, but was much less effective on
day 2, compared with day 1 (Fig. 3). It seems
most likely, therefore, that there is a failure of DG,
formed by breakdown of the phosphoinositides, to
activate protein kinase C in day-2 cells, either because
of a loss of kinase C itself or the loss of one of its
substrates.
If cells are cultured under the conditions described
for longer than 24 h, a marked recovery of the Cortisol
secretory response to All and acetylcholine is observed,
reaching a maximum on day 3. The response to
A23187/PMA also increases to a maximum on day 3,
as does the phosphoinositidase C response to All and
acetylcholine. Whilst other factors may contribute
to this maximum, it is evident that a recovery of
the coupling of the second messenger responses to
activation of P450iCC must occur.
Stimulation of phosphoinositidase C activity with¬
out an accompanying steroid response has been
observed in vitro in both isolated rat zfr cell prep¬
arations maintained for 3 days in culture before being
stimulated with vasopressin (Gallo-Payet, Guillon.
Balestre & Jard, 1986), and in Y-l cells stimulated
with vasopressin (Langlois, Arroub, Saez & Begeot,
1988) or All (Langlois, Saez & Begeot, 1990). In the
latter case, the cells also failed to respond to PMA,
even though protein kinase C was demonstrated to be
present. The failure in each case to observe a steroid
response is at odds with the reported ability of vaso¬
pressin to stimulate corticosterone secretion by the zfr
of perfused rat adrenal glands and superfused cells
(Hinson. Vinson, Porter and Whitehouse, 1987).
More recently, it has been shown that cultured
ovine adrenal fasciculata cells possess a similar
number of high affinity All receptors as bovine
fasciculata cells. Whilst All activated a phospho¬
inositidase C and increased intracellular [Ca2+] in
both cell types, it led to the stimulation of steroid
secretion only from the bovine cells; ovine cells failed
to secrete glucocorticoids (Viard, Rainey, Capponi
et al. 1990). Clearly, the situation for the bovine
fasciculata cells is more complicated than reported by
Viard et al. (1990), since at 24 h these ceils enter a state
similar to that described for ovine fasciculata cells,
but recover thereafter. Our findings do not rule out
the possibility that ovine cells might also secrete
steroid in response to All, depending upon the time-
after initial plating when experiments are carried out.
An important consequence of our findings is that if
cell cultures are to be used as an experimental model it
is necessary to consider on which day to carry out the
experiments. In the case of bovine zfr cells, exper¬
iments using phosphoinositidase C agonists on day 2
or after day 4 would give poor Cortisol responses. A
further implication is that the secretion of Cortisol by
adrenocortical zfr cells could perhaps be dissociated
from the ability of All and other phosphoinositidase
C agonists to affect other cellular functions such as
the stimulation of mitosis (Gill, 111 & Simonian,
1977). This possibility should be open to experimental
testing in the culture of bovine zfr cells.
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Abstract—The effects of acetylcholine (ACh) and manganese pre-incubation on angiotensin II (AII)-
stimulated incorporation of (3H]inositol into phosphoinositide. phosphoinositol and free inositol fractions
of adrenocortical cells isolated from the bovine zona fasciculata/reticularis (zfr) were investigated. In
cells pre-labelled for 6 hr with [3H]inositol. ACh and All stimulated the incorporation of cytosolic
[3H]inositol into a common hormone-sensitive pool of phosphoinositides, which was distinct from the
non-hormone-sensitive pool labelled in the presence of manganese. Regression analysis of the Cortisol
versus [3H]inositol headgroup responses for both All (10~"-i0"7M) and ACh (10"M0~3 M) showed
that the gradients of these responses were not significantly different. These data provide strong evidence
that in cultured bovine zfr cells, ACh and All stimulate the breakdown and resynthesis of a common
pool of phosphoinositides.
Contrary to the earlier view that adrenocorti-
cotrophin (ACTH§) is the sole stimulus of steroid
secretion from the inner zones of the adrenal cortex,
it is now clear that zona fasciculata/reticularis (zfr)
cells secrete steroids in response to a wide variety
of hormones and neurotransmitters. Studies by
ourselves and others have established that bovine
zfr cells, either freshly isolated or in primary culture,
secrete Cortisol in response to catecholamines [1,2],
angiotensin II (All) [2,3], acetylcholine (ACh)
[2,4,5] and vasopressin [6] in addition to ACTH.
Of these agonists, All and ACh have been shown
to exert this effect through the activation of
a hormone-sensitive phosphoinositidase C [6,7],
Neither agonist has any acute effect on cAMP levels,
whereas both promote the rapid and dose-dependent
formation of water-soluble [3H]phosphoinositols.
The phosphoinositols formed and their time-course
of appearance are consistent with the activation of
a phosphoinositide-specific phosphoinositidase C. In
fura-2-loaded zfr cell suspensions, both All and
ACh stimulate dose-dependent increases in cytosolic
[Ca2+], and both agonists appear to mobilize a
common intracellular Ca2+ pool [8], Furthermore,
in single fura-2-loaded bovine adrenocortical cells,
oscillations in intracellular [Ca2+] have been observed
in response to both agonists [9,10].
* Corresponding author.
§ Abbreviations; zfr, zona fasciculata/reticularis; All,
angiotensin II; ACh. acetylcholine; ACTH, adreno-
corticotrophin; GM. growth medium; EBSBG, Earl's bal¬
anced salt solution containing bovine serum albumin
(0.2%) and glucose (0.1%).
It is also clear that individual cells can respond to
both All and ACh as both agonists mobilize a
common intracellular Ca2+ pool. It is not clear,
however, whether ACh and All receptors are
coupled to phosphoinositidase C which acts on
separate subpools of phosphoinositides, or whether
phosphoinositidase C acts on a common pool of
phosphoinositides. This question is particularly
relevant given the evidence for the existence of
multiple pools of phosphoinositides in these and
other cells [11-13].
In this paper we present evidence that All and
ACh act to stimulate both the breakdown and
resynthesis of a common pool of phosphoinositides.
MATERIALS AND METHODS
Materials. Ham's F10 growth medium, Earl's
balanced salt solution, glutamine and other cell
culture materials were from Northumbria Biologicals
(Cramlington, U.K.). Penicillin, streptomycin and
fungizone were obtained from Flow Laboratories
(Rickmansworth, U.K.) and collagenase from Lome
Diagnostics (Bury St. Edmunds, U.K.). Controlled
Process Serum Replacement No. 5, glucose, ACh,
atropine, inositol and Cortisol were purchased from
the Sigma Chemical Co. (Poole, U.K.) and bovine
serum albumin (fraction V) was obtained from ICN
Biomedical (High Wycombe, U.K.). All (Asp1-
Val5) was the MRC international standard from
the National Institute for Biological Standards
and Control. myo[3H]Inositol and Cortisol tracer
[cortisol-3-(0-carboxymethyl)oximino-(2-[12SI]iodo-
histamine)] were supplied by Amersham Inter-
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national (Amersham. U.K.). 1.1.2-Trichlorotri-
fluoro-ethane and tn-n-octlyamine were purchased
from the Aidrich Chemical Co. (Gillingham. U.K.),
and all other chemicals to Analar grade from BDH
(Thornlibank, Glasgow, U.K.). AG1X8 anion
exchange resin (100-200 mesh, formate form) was
obtained from Bio Rad Laboratories (Watford,
U.K.). Scintillation fluid (299) and scintillation
vials were purchased from Canberra Packard
(Pangbourne. U.K.), and scintillation counting was
earned out on a Canberra Packard 1900CA liquid
scintillation counter.
Cell culture. Bovine adrenal glands were obtained
from freshly slaughtered 1-2-year-old steers at the
local abattoir, and purified zfr cell suspensions
prepared as described previously [3]. Cells were
plated out at a density of 333.000 cells/well in
multiwell plates (12 x 25-mm diameter wells) in
1 mL/well Ham's F10 medium supplemented with
10% Controlled Process Serum Replacement No. 5,
penicillin (50 IU/mL), streptomycin (50 /ig/mL) and
amphotericin B (2.5 trg/mL) (growth medium. GM).
GM was renewed after 24 hr (0.5 mL), and the cells
maintained in primary culture for a further 48 hr
before use. Labelling of the phosphinositides was
achieved by inclusion of [3H]inositol in the GM
(10 ^Ci/mL. 0.5 mL) for the last 6 hr of culture (Figs
1 and 2) or for the entire 48-hr period (Fig. 3) where
steady-state labelling was required [7],
Where manganese-stimulated labelling was inves¬
tigated, MnCL (1 mM) was included in the GM
during the 6-hr labelling period. Where cells were
pre-stimulated with ACh during labelling, 5 pL of
a stock solution of ACh (in GM) was added to
each well to a final concentration of 10~4 M for the
last hour of labelling only. Pre-stimulation was
terminated by addition of 5 uL of the ACh antagonist
atropine (10~6M final concentration) to each well
for 5 min.
Agonist stimulation of phosphoinositidase C. All
agonists were dissolved in Earl's balanced salt
solution containing bovine serum albumin (0.2%)
and glucose (0.1%) (EBSBG). After the labelling
period, GM was replaced with EBSBG (0.5 mL/
well), or EBSBG containing atropine (10"6M) if
cells had been stimulated previously with ACh. Cells
were incubated for 15 min after which medium was
replaced with EBSBG with added LiCl (10 mM) and
inositol (lOmM) (0.45 mL/well). After a further
15 min incubation, agonist solutions (50 /uL) were
added to a final volume of 0.5 mL, and stimulation
allowed to continue for the times indicated before
termination bv addition of ice-cold perchloric acid
(15% v/v, 250 qL/well).
Recovery and measurement of[3H]inositol-labelled
products. Following addition of perchloric acid to
terminate cell stimulation, the base of each well was
scraped using a rubber policeman and the contents
transferred to an Eppendorf tube, with a 0.5 mL water
wash. Following centrifugation (3300 g x 3 min), the
acid supernatant was transferred to a glass tube and
neutralized by mixing with a 1:1 mixture of tri-n-
octylamine and 1,1,2-trichlorotrifluoro-ethane
(1.5 mL). Following a brief centrifugation
(20g x 5 min) to separate the phases, 0.9 mL of the
upper aqueous phase was recovered and stored at
-20° prior to assay.
For assay of [3H]inositol and [3H]phosphoinositols,
samples were thawed. EDTA added to a final
concentration of 1 mM and samples loaded onto
individual columns of AG 1X8 anion exchange resin
(0.25 mL). The columns were washed with water
(2x4 mL), and the combined eluates from loading
and washing (containing free pH|inositol) collected
into a 20 mL scintillation vial. Bound [3H]inositol
phosphates were then eluted directly into a fresh 20-
mL vial with 1 M ammonium formate-0.1 M formic
acid (2 x 2 mL). Following addition of scintillation
fluid (10 mL), radioactivity of the samples was
determined by liquid scintillation counting. All
values shown are volume corrected, and were
counted for 10 min each, or to an error of <1%.
The pelleted material recovered from the
centrifuged perchloric acid extracts was frozen at
-20° under 200 pL water. After thawing, the
loosened pellets were broken up by vortexing and
dissolved bv addition of CHCl3-MeOH-concnHCl
(100:200:1 v/v) (0.75 mL), followed by CHClj and
HC1 (0.1M) (both 250/iL). The resulting aqueous
and organic phases were separated by centrifugation
(20gx5min) and 400 uL of the lower phos-
phoinositide-containing phase recovered to a scin¬
tillation vial. The solvent was removed under air
(Techne sample concentrator), 3 mL scintillation
fluid added, and radioactivity determined by
scintillation counting.
Agonist stimulation of Cortisol secretion. For
studies on Cortisol secretion from unlabelled cells,
cells were washed in EBSBG (2x1 mL) and
incubated in EBSBG for 5 min (0.45 mL). Following
addition of agonists to a final volume of 0.5 mL,
cells were incubated for 1 hr after which the overlying
medium was removed and stored at -20° prior to
Cortisol radioimmunoassay [14].
Statistical analysis. Statistical significance between
results was assessed using Student's r-test. Values
are given as the means ± SD, unless otherwise
stated.
RESULTS
Figure 1 shows the results of studies carried out
on cells pulse-labelled for 6hr (not to steady state)
with [3H]inositol, in the presence or absence of ACh
(10~JM) or Mn:+ (10"3M) as described, and
subsequently challenged with All (10~7M) (in the
presence of lithium) for 15 min. The distribution of
radioactivity between phosphoinositide (a) free
inositol (b) and total phosphoinositol fractions (c) is
shown. Under these labelling conditions the bulk of
the radiolabel is found in the free inositol fraction.
In control cells (no pre-stimulation during
labelling), subsequent acute (15 min) stimulation
with All increased the turnover of the phos-
phoinositides as indicated by increased accumulation
of label in both the phosphoinositides (a) and
phosphoinositols (c), with a corresponding decrease
in free [3H]inositol (b) (all P < 0.01). Although
labelling in the presence of ACh increased the
incorporation of [3H]inositol into the phos¬
phoinositides (P < 0.05), the maximal incorporation
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Fig. 1. Effect of ACh and Mn;" pre-stimulation
on subsequent acute All-stimulated redistribution of
radioactivity between ['H]phosphoinositide. (3H]inositol
and [3H]phosphoinositol fractions of pre-labelled bovine
zfr cells. Cells were pre-labelied for 6 hr with (3H]inositol
in the presence or absence of MnCl (10'3M) or ACh
(10"4 M). as described. Cells were subsequently incubated
for a further 15 min in the presence or absence of All
(10"'M) in fresh medium containing 10 mM Li'.
The distribution of radioactivity between the [3H]-
phosphoinositide (panel a), [3H]inositol (panel b) and (3Hj-
phosphoinositol (panel c) fractions is shown. For further
experimental details see Materials and Methods. Values
shown are the means ± SD of triplicate determinations
from one representative experiment of three similar
experiments.
Fig. 2. Effect of ACh and Mn3* pre-stimulation
on subsequent chronic All-stimulated redistribution of
radioactivity between [3H|phosphoinositide. [3H]inositol
and [3H]phosphoinositol fractions of pre-labelled bovine
zfr cells. Cells were pre-labelled for 6 hr with [3H]inositol
in the presence or absence of Mn3* or ACh, as described.
Cells were subsequently incubated for a further 2 hr in the
presence or absence of All (10"'M) in fresh medium
containing 10 mM Li". The distribution of radioactivity is
shown as in Fig. 1. Values shown are the means ± SD
of triplicate determinations from one representative
experiment of three similar experiments.
achieved by subsequent challenge with All (10~7 M)
was not significantly different to that observed in
control cells. Thus, the same steady state (see
Discussion) was achieved on acute stimulation with
All, whether cells were pre-incubated with ACh or
not. In addition, no significant difference in the
phosphoinositol response to acute All stimulation
was observed between control and ACh pre-treated
cells (c).
Pre-labelling cells with [3H]inositol for 6hr in
the presence of Mn:+ resulted in an increased
incorporation of label into the phosnhoinositides (a)
accompanied by a correspondingly reduced free
inositol lablelling (b) (both P < 0.05). However, on
subsequent acute (15 min) stimulation with All
(10~7M), the incremental increases in the labelling
of the phosphoinositides (a) and phosphoinositols
(c), and the loss of [3H]inositol (b) were not
significantly different from those measured in cells
labelled in the absence of Mn2"".
Figure 2 shows the changes in the distribution of
radioactivity between the three [3H]inositol pools in
cells chronically stimulated with All (2 hr) following
pre-incubation with ACh or Mn2", as above. Chronic
All stimulation resulted in a loss of radioactivity
from the phosphoinositide and free [3H]inositol pools
(a,b), and a correspondingly large phosphoinositol
response (c) (all P<0.05). Although pre-labelling
in the presence of ACh increased incorporation of
[3H]inositolintothephosphoinositides(a)(P < 0.01),
the level to which phosphoinositide labelling and
free [3H]inositol levels dropped in response to
subsequent chronic All stimulation (a) was unaf-
C D. Clyne el al.444
[JH] Inositol in total headgroups (n—fold)
Fig. 3. Correlation between All- and ACh-stimulated
Cortisol secretion and phosphoinositol production in
primary cultures of bovine zfr cells. Cortisol secretion (over
1 hr) and phosphoinositol production (over 15 min) were
measured in response to ACh (ICC-IO"3 M) (A) and All
(10""-1(T?M) (•) as described. Results are expressed as
n-fold stimulation ratios, and show the linear relationship
between Cortisol secretion and phosphoinositidase C
activation (as measured by the accumulation of aqueous-
labelled phosphoinositol headgroups) for both agonists.
Regression analysis of the data gave correlation coefficients
(r) of 0.972 and 0.964 for ACh and All. respectively. The
gradients of the regression lines were not significantly
different (8.38 ± 1.07 and 8.34 ± 1.2. respectively). Values
shown are the means ± SEM of data from 3-6 experiments,
each performed in triplicate.
fected by ACh pre-stimulation, as was the magnitude
of the phosphoinositol response to All (c). In
contrast, when cells pre-labelled in the presence of
Mn2* were subsequently stimulated chronically (2 hr)
with All in the presence of Li+, the elevated level
of phosphoinositide labelling in Mn2* pre-treated
cells (a) was decreased on All stimulation by the
same amount, but not down to the same level, as
cells not pre-treated with Mn2*. In addition, the
magnitude of the phosphoinositol response to
All was reduced following Mn2* pre-stimulation
compared with that seen in both control and ACh
pre-treated cells (P < 0.01).
We have demonstrated previously that both ACh
and All produce dose-dependent increases in Cortisol
secretion in bovine zfr cells, accompanied by a
corresponding activation of phosphoinositidase C
with similar dose dependency [6], Figure 3 illustrates
the correlation between phosphoinositidase C
activation (as measured by the accumulation of
water-soluble [3H]phosphoinositol headgroups over
15 min, in cells pre-labelled to steady state) and the
Cortisol response (over 60 min) for both All
(10-"-I0-'M) and ACh (10~9-10~3 M). A strong
correlation was revealed between these two responses
for each agonist (correlation coeffecients: ACh, r =
0.972 and All. r = 0.964; both P < 0.01). Moreover,
the gradients of the regression lines for All and
ACh were not significantly different (8.32 ± 1.21
and 8.34 ± 1.07. respectively).
DISCUSSION
The effects of All and ACh on phosphoinositide
resynthesis and subsequent breakdown were exam¬
ined in cells pre-labelled with [3H]inositol for 6hr.
We have previously shown that cells labelled for this
length of time contain large reserves of [3H]inositol
in the cytosol but only incorporate small amounts of
label into the phosphoinositides [13], Because cells
are not labelled to steady state, resynthesis of
phosphoinositides (as a consequence of agonist-
stimulated phosphoinositide turnover) increases
labelling of the phosphoinositide pool. If stimulation
is also carried out in the presence of Li* to prevent
recycling of the phosphoinositols into inositol, All
(10~7M) stimulates incorporation to a new steady
state within 15 min. This new steady state is
maintained for up to 30 min of stimulation. After
30 min, cytosolic [3H]inositol becomes depleted so
that newly synthesized lipid is catabolized without
resynthesis. Thus, at stimulation times longer than
30 min, breakdown of this newly labelled lipid can
be observed [13],
Figure 1 shows the effect of ACh and Mn2+ pre-
stimulation on the subsequent redistribution of
[3H]inositol in response to acute All stimulation.
Although ACh preincubation increased phospho¬
inositide labelling, the maximal incorporation of
label into the phosphoinositide pool in response to
All was not significantly different between control
and ACh pre-treated cells. This is consistent with
the stimulation by ACh of incorporation of [3H]-
inositol into the same hormone-sensitive phos¬
phoinositide pool as that utilized by All (i.e. if ACh
had stimulated labelling of a different pool than that
acted upon by All, then the label incorporation into
phosphoinositides would be greater with ACh
preincubation than without). Consistent with this
conclusion, the magnitude of the phosphoinositol
response to acute All stimulation in the presence of
Li2* was unaffected by ACh pre-stimulation during
labelling.
We have also studied the effects of pre-labelling
cells in the presence of 1 mM Mn2*. Treatment with
Mn2* has been shown in other cells to stimulate
labelling by both phosphatidylinositol synthase
activity and inositol headgroup exchange [15-17].
However, this process appears to stimulate the
labelling of a hormone-insensitive pool of inositol
phospholipid [18]. Pre-labelling zfr cells with [3H]-
inositol in the presence of Mn-'* increased the
incorporation of label into the phosphoinositides
and reduced free inositol labelling. However, unlike
ACh pre-stimulation. the subsequent acute All
stimulation resulted in a significant increase in the
maximum phosphoinositide labelling, though the
incremental increase in phosphoinositide and phos¬
phoinositol labelling, and the loss of [3H]inositol
were not significantly different from those measured
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in control cells (labelled in the absence of Mn2+).
Thus, these findings are consistent with Mn2", unlike
ACh, promoting the labelling of a phosphoinositide
pool distinct from that acted on by All.
ACh pre-stimulation had no effect on the level to
which phosphoinositide labelling and free [3H]-
inositol dropped in response to subsequent chronic
All stimulation, and did not alter the magnitude of
the accompanying phosphinositol response (Fig. 2).
Thus, the lipid synthesized in response to the ACh
pre-stimulation was accessible to the phospho-
inositidase C activated by All stimulation and
therefore must have been in the same hormone
sensitive pool. In contrast, when cells pre-labelled
in the presence of Mn2+ were subsequently stimulated
chronically with All in the presence of Li", the pool
of phosphoinositide labelled in response to Mn2"
during the pre-incubation remained inaccessible to
the All-stimulated phosphoinositidase C. Cells pre-
treated with Mn2+ showed the same incremental
decrease in phosphoinositide labelling in response
to chronic All stimulation as did control cells. These
findings also support stimulation by Mn2+ of
the labelling of a hormone-insensitive pool of
phosphoinositide.
It could be argued that the hormone-insensitive
pool of [3H]inositol phospholipid labelled in the
presence of Mn2+ represents labelling of 3-
phosphorylated phospholipids. However, HPLC
analysis of the phosphoinositols formed in response
to All stimulation in bovine zfr cells indicates that
3-phosphate derivatives of the phosphoinositides
are not formed [19]. Even if 3-phosphorylated
phosphoinositides are not substrates for phos¬
phoinositidase activity [20], FPLC and HPLC studies
of the deacylated phosphoinositides from bovine zfr
cells have also failed to detect multiple isomeric
forms of phosphatidylinositol bisphosphate (I.M.B.,
unpublished data).
We have shown previously that ACh and All
activate a hormone-sensitive phosphoinositidase C,
and stimulate the mobilization of a common
intracellular pool of calcium. The data presented
here reveal that both ACh and All also lead to the
breakdown and resynthesis of a common hormone-
sensitive pool of inositol phospholipid. A similar
situation appears to occur in rat zona glomerulosa
cells for vasopressin and All [21], and in WRK-1
cells stimulated with bradykinin and vasopressin
[22],
We also demonstrate (Fig. 3) that the gradients
of the Cortisol versus [3H]inositol headgroup
responses for ACh and All were not significantly
different in cells labelled to steady state. Such a
finding is consistent with both ACh and All acting
through a common mechanism and common pool of
phosphoinositide to promote steroidogenesis. The
coupling of two or more receptors to a common pool
of phosphoinositide in the same cell has implications
with respect to the possible modulation of the effects
ofone agonist by the other. Homologous sensitization
or desensitization to either agonist must occur
through changes at the level of the receptor, whereas
heterologous desensitization would be expected to
result from changes in the phosphoinositidase C-G
protein complex.
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STRACT
Primary cultures of bovine adrenocortical zona fasciculata/reticu-
s (zfrt cells responded to angiotensin II (AID with a dose-dependent
rease in [JH] thymidine incorporation into DNA. The effect was
ximal at 100 nmol/liter All. and was dose dependentlv inhibited bv
rUala^l-AII (saralasin) and DuP753, but not by PD123177. Both
-stimulated Cortisol secretion and phosphoinositidase C activity
e also inhibited by saralasin and DuP753. but not by PD123177.
jrmacological analysis of the antagonism of All-stimulated Cortisol
secretion by saralasin and DuP753 produced pA2 values of 8.79 and
7.02, respectively. Whereas the pA2 for saralasin agreed closely with
previous measurements in other systems. DuP753 was at least one
order of magnitude less potent in inhibiting the action of All in bovine
zfr cells compared to previous measurements in rabbit vascular smooth
muscle. We conclude that the steroidogenic and mitogenic effects of
All in bovine zfr cells are mediated by the ATt receptor. (Endocrinology
132: 2206-2212. 1993)
"'HE octapeptide angiotensin II (All) exerts a wide variety
of physiological responses in many target tissues in-
ding vascular smooth muscle, heart, kidney, brain, and
enal (see Rets. 1, 2 for review). In addition to its well
iracterized steroidogenic effect on adrenal zona glomeru-
a (zg) cells (3), All also stimulates Cortisol secretion from
/ine zona fasciculata/reticularis (zfr) cells through the
ivation of hormone sensitive phosphoinositidase C (PIC)
viewed in Ref. 4).
All is a potent mitogen in several tissues including vascular
i cardiac smooth muscle, and this effect has implicated
in the pathogenesis of hypertension (5). The mitogenic
ect of All in adrenocortical zg cells is well documented;
stimulates growth of rat zg cells (6), and activation of the
iin angiotensin system is accompanied by hypertrophy of
rat zg (7). The trophic effects of All in inner adrenocortical
ies are less well understood. Growth of rat zona fasciculata
) cells has been reported in response to All (8), and
ereas increased (JH]thvmidine incorporation into the DNA
unpurified bovine adrenocortical cells in culture has been
nonstrated (9, 10), the possible mitogenic effects of All in
nfied bovine zfr cells have not been studied,
ncreasing evidence suggests that bovine zfr cells in culture
v be a more relevant model than other species for human
enocortical inner zone cells. Rat (11) and sheep (12) zfr
Received November 4, 1992.
Address correspondence and requests for reprints to: Colin D Clvne.
nburgh University. Department of Clinical Biochemistry, The Roval
rmarv. Edinburgh EH3 9YVV, United Kingdom.
' This work was supported bv a grant from the Sir Stanlev and Ladv
■ ldson Medical Research Fund (University of Edinburgh). C. D. C. is
MRC Scholar.
cells respond to All with increased phosphoinositide turn¬
over and inositol phosphate production, yet neither species
show an accompanying steroidogenic response to AIL even
though ovine and bovine zfr cells possess a similar number
of specific All receptors (12). Human zf cells, by contrast, do
secrete Cortisol in response to All (13), and while the mech¬
anism of this stimulation remains unclear, involvement of
the calcium messenger system is suggested by the steroido¬
genic effects of the calcium ionophore A23187 and the
phorboi ester phorbol 12-myristate 13-acetate in these cells
(14). Furthermore, All stimulates the breakdown of mem¬
brane phosphatidvlinositol-4,5'bisphosphate in cultured hu¬
man zfr cells (authors' unpublished observations).
Whereas previous work has generally failed to support an
involvement of All in stimulating human inner zone cells in
vivo (15, 16), All did produce dose-dependent increases in
plasma Cortisol in normal human subjects when infused
simultaneously over a low constant infusion of ACTH (17),
and mav therefore be important in the regulation of inner
zone function in man.
Using selective nonpeptide antagonists, two subtypes of
All receptors have been identified, termed ATi (sensitive to
DuP753) and AT2 (sensitive to PD123177 and analogs) (18).
Inhibition of 12SI-All binding by these antagonists has shown
the presence of both AT] and AT2 binding sites in many
tissues including adrenal, uterus, brain, and aorta (19, 20),
and marked species differences in the distribution of the
binding sites between tissues has been reported (20).
Whereas both AT, and AT2 binding sites have been iden¬
tified in the adrenal cortex of rat, human (19, 21), rabbit (22),
and monkey (20), unpurified bovine adrenocortical cells in
culture appear to contain only the ATi binding site (23), and
in cultured bovine zg cells, both All-stimulated aldosterone
2206
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cretion and inhibition of ACTH-stimulated cAMP produc-
3n are mediated by the AT, receptor (23).
There have been no studies specifically addressing growth
fects of All in bovine inner zone cells, or attempts to
laractenze the particular receptor subtype present in these
■lis. In the present study, the ability of All to stimulate [3H]
ymidine incorporation into bovine zfr cells in primarv
ilture is reported. The antagonist sensitivity of the rruto-
;nic, steroidogeneic, and second messenger responses to All
ere investigated in this purified zfr cell preparation. Adre-
jcortical All receptors have not previously been character¬
ed by Schild analysis. This analysis provides antagonist
\2 values (—logio antagonist dissociation constant) through
easurement of the potency of an antagonist in inhibiting
e functional response of a tissue to an agonist (24). The
due of pA2 is unique for a given antagonist acting at a
ven receptor subtype, irrespective of the agonist used to
icit the response, and differences in pA2 measurements
;tween tissues can therefore yield valuable information
garding receptor heterogeneity .'Accordingly, we also report
\2 values for both the peptide antagonist (sar',ala8)-AII
aralasin), and for the AT, receptor antagonist DuP753 for
e first time in adrenocortical cells.
Materials and Methods
The source of all cell culture matenals is described in Clyne et al. (25).
mtrolled Process Serum Replacement no. 5 (CPSR5), PBS tablets,
inidet P-40, and (sar',ala8)-angiotensin II (saralasin) were from the
pna Chemical Co. (Poole, Dorset, UK). Dulbecco's Modified Eagle's
;dium (DMEM) was obtained from ICN/Flow (High Wycombe, UK).
/o[3H]inositol. mef/iy/[3H]thvmidine. and Cortisol tracer (cortisol-3-(0-
:boxymethyl)oximino-2(-[1!5I]iodohistamine)] were purchased from
nersham International (Avlesburv, Bucks, UK). Anion exchange resin
is obtained from Bio-Rad Laboratories (Watford, Herts, UK), and
ntillation fluid and vials were from Canberra Packard (Pangbourne,
rkshire UK) All (asp'-val5) was the Medical Research Council standard
/15. Dup753 (also known as losartan potassium and MK 954) (2-ti-
tyl-4-chloro-5-hydroxymethvl-l-[(2'-(lH-tetrazoi-5-vl)bipheny!-4-
methyl)imidazoie, potassium salt) and PD123177 [l-(4-amino-3-
ithvlphenv l)methyl-5-diphenylacetvl-4,5,6,7-tetrahvdro-1H-imi-
zo(4,5-c]pyndine-6-carboxvlic acid-2HCl] were kind gifts from Dr.
land D. Smith (DuPont, Wilmington, DE).
II preparation and culture
Primary cultures of bovine adrenal zfr cells were prepared as de-
ibed previously (26). Cells were dispensed into 12-weli culture dishes
i-mm wells) at a density of 330,000 cells/ml-well (165,000 cells/mi¬
ll for (3H]thymidine uptake studies) in a medium of Ham s F10 with
% (vol/vol) CPSR5, penicillin (50 IU/ml), streptomycin (50 Mg/ml),
i amphotericin B (2.5 Mg/ml). After 24 h, medium was replaced with
rier 0.5 ml identical fresh medium, 0.5 mi fresh medium supplemented
:h 10 iiCi/ml [3H]inositol or, for [3H]thymidine uptake studies, 0.5 ml
,1EM containing antibiotics as above, but without added CPSR5; in
: absence of serum, cells are known to be growth arrested (9).
sasurement of PH] thymidine uptake
Forty eight hours after initial plating, growth arrested cells were
shed twice with 1 ml DMEM and left under 0.5 ml DMEM in the
isence of the agonists and antagonists indicated. After 15 h cells were
lin washed with 2 x 1 ml DMEM, and medium replaced with 0.5 ml
1EM containing fresh agonists/antagonists, supplemented with [3H]
■midine (5 wCi/ml). Stimulation was allowed to proceed for 6 h, after
which ceils were washed with PBS (2x1 ml), and taken up in 1 ml
PBS containing 0.1% (vol/vol) Nonidet P-40 (PBS/N). Well contents
were filtered through Whatman GF/C glass fiber filters with a 1 mi
PBS/N wash, and the filters washed with a further 2 x 5 ml PBS/N.
Filters were then soaked in ethanol and air dried. Finally, (3H]thvmidine
counts were measured using 3 ml scintillation fluid on a Canberra
Packard 1900CA scintillation counter.
Measurement of PIC activation
The activation of PIC in cells prelabeled with [3H]inositol for 48 h
was determined bv measuring the hormone-stimulated generation of
total [3H]inositol phosphates in the presence of 10 mmol/liter LiCl for
15 min as described previously (27). Aqueous (3H]inositol phosphates
were extracted and separated from free [3H]inositol on columns of anion
exchange resin according to Bird et al. (28).
Measurement of Cortisol secretion
Forty eight hours after initial plating, cells were washed twice with 1
ml Earl's Balanced Salt solution (EBS) with added BSA and glucose (0.2
and 0.1% (wt/vol), respectively] (EBSBG) and left under 0.4 ml. After
5-min preincubation at 37 C, antagonists were added in a volume of 50
m1 EBSBG. All (dissolved in EBSBG, 50 ul) was added after a further 5
mm. Stimulation was allowed to proceed for 60 min, after which the
overlving medium was removed and stored at —20 C before Cortisol RIA
(29). '
Data analysis
Unless otherwise indicated, values shown represent the mean ± sem
of triplicate determinations from three separate experiments from dif¬
ferent cell preparations. Significance between values was assessed using
Student's t test. Inhibition curves were fitted to a sigmoid power model
on an IBM computer using Fig P (Biosoft) for calculation of ID*> values,
and those ID50 values reported in the text are the mean of three such
determinations from separate cell preparations. For analysis of dose-
response data, curves were tested for parallelism according to Kenakin
(30). Where the slope of Schild regression lines (24) did not differ
significantly from unity, data were fitted to the best regression line of
slope unity for calculation of pAj values (31).
Results
Effect of All on pH]thymidine incorporation in bovine zfr cells
Figure 1 shows the effect of increasing concentrations of
All on DNA synthesis (as measured by the uptake of [3H]
thymidine over 6 h) in growth arrested bovine zfr cells. All
stimulated [3H]thvmidine incorporation into DNA in a dose-
dependent manner, with half-maximal effect at 0.25 nmol/
liter, and maximal effect at 100 nmol/liter, at which concen¬
tration [3H]thvmidine uptake was stimulated 2.32-fold (n =
3). Significant stimulation (P < 0.05) was observed at AH
concentrations of 10 nmol/liter-1 pmol/liter.
Effect of nonselective and selective All antagonists on All-
stimulated PHJthymidine incorporation
To determine which All receptor subtype is responsible
for the mitogenic action of All in bovine zfr cells, the ability
of the nonselective antagonist saralasin and the selective
nonpeptide antagonists DuP753 and PD123177 to inhibit
All-stimulated [3H]thvmidine incorporation was investi¬
gated. As shown in Fig. 2, saralasin (10 nmol/liter-10 ymol/
liter) completely inhibited the mitogenic effect of All (10
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ig. 1. Effect of increasing concentrations of All on [3H]thymidine
icorporation into DNA in cultured bovine zfr cells. Growth arrested
ovine adrenal zfr cells were challenged with All at the concentrations
idicated for '21 h. [3H]Thymidine (5 MCi/ml) was present for the last
h. adding fresh All at the same concentration, as described. Values
re expressed as a stimulation ratio relative to the basal (unstimulated)
icorporation. and represent the mean ± sem of triplicate determina-
ons from three separate experiments. Mean basal [3H]thvmidine
icorporation was 9330 ± 1552 dpm/well. Significant stimulation at P


















!g. 2. Effects saralasin, DuP753, and PD123177 on All-stimulated
H] thymidine incorporation in cultured bovine zfr cells. Growth ar-
sted cells were challenged with All (10 nmol/liter) in the presence or
isence of <■) DuP753, (A) saralasin or (O) PD123177 at the concen-
ations indicated for 21 h. [3H]thymidine (5 nCi/ml) was present for
e last 6 h of this period. Values are expressed as a percentage of the
ntrol (All. 10 nmol/liter) incorporation. Each point is the mean ±
:m of triplicate determinations from three separate cell preparations,
gnificant inhibition relative to the control All response is indicated
P < 0.05 (*) and P< 0.01 (").
mol/liter), producing significant inhibition at 1 Mmol/liter
' < 0.05). The ID;,, for saralasin was 315 nmol/liter (range,
10-780 nmol/liter).
The AT, receptor antagonist DuP753 also inhibited All (10




dose-dependent manner (Fig. 2), reaching significance at 0.1
Mmol/liter, and producing complete inhibition at 10 Mmol/
liter. Dup753 was slightly more potent than saralasin (ID^o
= 50 nmol/liter, range 12-130 nmol/liter). In contrast, the
AT2-selective antagonist PD123177 did not significantly af¬
fect the magnitude of the mitogenic response to All at
concentrations up to 10 Mmol/liter PD123177.
Saralasin, DuP753 and PD123177 had no intrinsic effect
on [3H]thymidine incorporation at concentrations up to 10
Mmol/liter (data not shown).
Effect of saralasin, DuP753, and PD123177 on All-stimulated
Cortisol secretion and PH] inositol phosphate production
Previous studies have shown that All-stimulated Cortisol
secretion from cultured bovine zfr cells is mediated through
activation of PIC. Cells prelabeled with [3H]inositol for 42 h
(to steady state) secrete Cortisol and produce aqueous [3H]
phosphoinositols (in the presence of Li+) in response to All
with similar dose dependency (28). The effects of saralasin
and DuP753 on All-stimulated Cortisol secretion and [3H]
inositol phosphate production are shown in Fig. 3, a and b,
respectively. Both saralasin and DuP753 completely inhibited
Cortisol secretion in response to a maximal dose of All (10
nmol/liter) with ID50 values of 120 nmol/liter (range 62-150
nmol/liter) and 3.1 ^niol/liter (range 0.2-7.9 Mmol/liter, re¬
spectively (Fig. 3a). Complete inhibition was achieved at 10
Mmol/liter saralasin and 100 Mmol/liter DuP753.
Saralasin and DuP753 also completely inhibited the pro¬
duction of [3H]inositol phosphates in response to All (10
nmol/liter) (Fig. 3b) with 1D5o values of 51 nmol/liter (range
19-69 nmoi/liter) and 0.49 Mmol/liter (range 0.3-1.1 nmolf
liter), respectively.
Neither saralasin nor DuP753 had any effect on either
basal Cortisol secretion or [3H]inositol phosphate production
at concentrations up to 100 Mmol/liter antagonist (data not
shown).
Figure 3c shows the effects of the AT2-selective antagonist
PD 123177 on All-stimulated Cortisol secretion and [^ino¬
sitol phosphate production. PD123177 did not significantly
alter the magnitude of the steroidogenic or second messenger
responses to All (10 nmol/liter) at concentrations up to 0.1
mmol/liter PD 123177. PD 123177 was also without effect on
either basal Cortisol secretion or (3H]inositol phosphate pro¬
duction at concentrations up to 0.1 mmol/liter (data not
shown).
Effect of saralasin and DuP753 on the Cortisol dose response
curve to All
To further characterize the receptor responsible for All-
stimulated Cortisol secretion, dose-response curves to All
were set up in the presence of increasing concentrations of
saralasin and DuP753. Representative experiments are
shown in Fig. 4 a and b, respectively. Both saralasin (10
nmol/liter-0.33 Mmol/liter, Fig. 4a) and DuP753 (0.33 Mmol/
liter-10 Mmoi/liter, Fig. 4b) produced parallel shifts of the All
dose-response curve, without affecting the maximal response
attainable bv All, consistent with competitive antagonism.
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3. Effects of saralasin, DuP753. and PD123177 on All-stimulated
sol secretion and ('H]inositol phosphate production by zfr cells, a,
were incubated for 1 h with All (10 nmol/liter) or All (10 nmol/
the presence of (■) saralasin or (A) DuP753 at the concentrations
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Fig. 4. Representative experiments showing dose response curves for
the secretion of Cortisol stimulated by All alone (■) and by All in the
presence of increasing concentrations of (upper panel) saralasin (lower
panel), DuP753. Values shown are the mean ± SD of triplicate deter¬
minations. Similar results were obtained from four separate cell prep¬
arations for each antagonist.
The dose ratio (DR) for each antagonist concentration was
obtained and Schild analysis [log,0 (DR-1) us. logt0 [antago¬
nist]] performed to calculate antagonist pA2 values (Fig. 5).
The results of this analysis are summarized in Table 1.
Discussion
The observation that All is a potent mitogen in several
tissues including bovine (9, 10) and rat (8) adrenocortical
[3H]Inositol prelabeled cells were challenged with All (10 nmoi/liter)
in the presence or absence of (■) saralasin or IA) DuP753 for 15 min
(in the presence of LiCl, 10 mmol/liter). Total aqueous [JH]inositol
phosphate production is shown vs. antagonist concentration, c, (□)
Cortisol secretion and (O) [:,H]inositol phosphate production in re¬
sponse to All (10 nmol/liter) were determined in the presence or
absence of PD123177 at the concentrations shown. All values are
expressed as a percentage of the control (All, 10 nraol/liter) response,
and each point is the mean ± sem of triplicate determinations from
three separate cell preparations. Mean basal Cortisol secretion was 5.37
± 0.83 pmol/well h. and secretion stimulated by All (10 nmol/liter)
was 491.4 ± 53.1 pmol/well h. Mean basal and mean All (10 nmol/
liter)-stimulated [JH] inositol phosphate production were 4774 ± 286
and 59,581 ± 8,960 dpm/well/15 min, respectively. Significant inhibi¬
tion relative to the control All response is indicated at P < 0.05 (*)
and P < 0.01 (").
■ saralasin
a DuP753
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G. 5. Schild regressions, least squares fit of log10 (DR-1) vs. logl0
ntagonist] where DR = dose ratio. Schiid regressions for saralasin
) and DuP753 (■) are shown. Cumulative data from eight separate
11 preparations.
ABLE 1. Comparison of experimental and published pA2 values
r saralasin and DuP753
Antagonist ExperimentalpA,
95% CL slope 95% CL
Published
PA,
Saralasin 8.79 8.41- 0.81 0.66-0.96 9.01"
9.17
DuP753 7.02 6.89- 0.93 0.85-1.02 S.48"'*7
7.15
95% CL, 95% confidence limits.
:11s led us to investigate the possible mitogenic effects of
II in the bovine zfr, which is known to exhibit mitogenic
sponses to other peptide growth factors (32). Studies of the
Otogenic effect of All in bovine adrenocortical cells have
merallv failed to determine whether the site of action is
stricted to the zg, or also involves the zf. Neither has the
articular All receptor subtype mediating the steroidogenic
id/or mitogenic effects of All in bovine zfr cells been
vestigated.
In the present study, we demonstrate that All stimulates
H]thvmidine incorporation into purified bovine zfr cells
ith a potencv and efficacy comparable to that previously
ported for unpunfied bovine adrenocortical cells in culture
). This response was completely inhibited both by saralasin
id DuP753, but not by PD123177 suggesting that, as in the
onal adrenocortical AC1 cell line (33), the mitogenic action
All in purified bovine zfr cells is mediated by the AT,
ceptor. This receptor subtvpe is known to mediate growth
sponses to All in other cell types, including rat aortic
nooth muscle cells (34).
The mechanism of All-induced mitogenesis in adrenocor-
:ai cells is unknown at present, although a recent report
iplicates both activation of protein kinase C and production
12-lipoxvgenase products in the mitogenic action of All
3), in addition to possible protein-tvrosine phosphorylation
5), and activation of phosphoinositidase C (36).
We have also characterized the receptor subtype respon¬
se for the steroidogenic and second messenger responses
All in bovine zfr cells. Cortisol secretion in response to
II was completely inhibited bv the nonselective All receptor
itagonist saralasin. and by the AT,-selective antagonist
uP753, indicating the involvement of the AT, receptor in
the steroidogenic response to All. This same receptor subtype
is known to mediate aldosterone secretion from cultured
bovine zg cells (23), and dispersed rat adrenal capsular cells
(37). As expected, the AT2-selective antagonist PD123177
was without effect.
All-stimulated Cortisol secretion from bovine zfr cells is
mediated by activation of PIC (28). The formation of [3H]
phosphoinositols in response to All was also inhibited both
by saralasin and DuP753, but not by PD123177, again
consistent with the involvement of the AT, receptor. A
similar inhibition of All-stimulated PIC activity by DuP753
has been reported in clone 9 cells from rat liver (38). In
addition, COS-7 cells transfected with the All-1 receptor
cDNA from bovine adrenal zg or rat aortic smooth muscle
responded to All with an increase in phosphoinositol pro¬
duction (39, 40), whereas no such response was observed in
R3T3 cells, which express AT2 receptors only (41).
It is of interest that saralasm was around one order of
magnitude more potent than DuP753 in inhibiting both All-
stimulated Cortisol secretion and [3H]inositol phosphate pro¬
duction, but was clearly less potent than DuP753 in inhibit¬
ing the mitogenic response to All. Whereas it is tempting to
speculate that the mitogenic and steroidogenic effects of All
may therefore be mediated by different DuP753-sensitive
receptors, this may be a result of the different incubation
conditions used for measurement of these responses. Cortisol
secretion and [3H]inositol phosphate production were meas¬
ured acutely, whereas for measurement of [:>H]thymidine
uptake, cells were exposed to All and/or antagonists for a
total of 21 h. If saralasin were degraded at a faster rate than
the nonpeptide antagonist DuP753 over this time period,
then the relative potency of saralasin would be erroneously
low.
To further characterize the antagonism of All-stimulated
Cortisol secretion by saralasin and DuP753, analysis by Arun-
Iakshana and Schild (24) was performed to calculate antag¬
onist pA2 values. Both antagonists shifted the All concentra¬
tion-response curve to the right, in a parallel manner, without
depressing the maximum response attainable by All, con¬
sistent with competitive antagonism. The extrapolated pA2
for saralasin (8.79) agreed well with previous reports in other
systems (42). Peptide analogs of All have previously been
reported to exhibit partial agonist properties, and saralasin
has also been described as a noncompetitive antagonist of
All-stimulated responses both in vitro (43, 44) and in vivo
(45), as indicated by its nonparailel shifts of the All dose
response curve and depression of the maximum response.
No such activity was observed in the present study for the
antagonism of All-stimulated Cortisol secretion by saralasin.
It is possible that the doses of saralasin employed (10 nmol/
liter-0.33 /umoi/liter) were insufficient for partial agonism to
be detected. However, depression of the maximum response
to All-induced contraction of rabbit aorta by saralasin is
apparent at 3 nmol/liter saralasin (42). As reported by others
(43) the slope of the Schild regression was significantly lower
than unity. This mav be indicative of an agonist uptake
process which would result in underestimation of the dose
ratio and produce a Schild slope less than unity. Indeed
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jptake of All by cultured bovine adrenocortical cells has
?een reported, with All internalization occurring with a half-
ife of 10 min (46). A further possibility is that saralasin acts
n a noncompetitive manner as reported by Wong et al. (43),
n tissues with a large receptor reserve this would result in
parallel shifts of the dose response curve without depression
>f the maximal response at low antagonist concentrations.
Consistent with previous observations (42, 47), DuP753
icted as a classical competitive antagonist of All-stimulated
urtisol secretion, producing parallel shifts of the All dose-
esponse curve with no depression of the maximum response,
"he resultant Schild regression was linear with a slope not
ignificantlv different from unity. However, the observed
)A2 for DuP753 (7.02) was about 30 times lower than that
ireviouslv reported for the antagonism of All-mediated con-
raction of rabbit aorta (pA2 = 8.48). Although differences in
issav conditions might be expected to lead to a difference in
>A2 values for the same receptor, pA2 measurements are
;enerallv in good agreement between laboratories (48). The
nagnitude of the difference in*pA2 values for DuP753 in
iovine zfr cells and smooth muscle was therefore unex-
>ected. One possible explanation is that DuP753 recognizes
wo distinct subtypes of AT, receptor in vascular smooth
nuscle and adrenal cortex, respectively. This hvpothesis
could accord with previous data from both functional and
tructural studies; although All acts via the AT, receptor in
>oth bovine adrenocortical and rat aortic smooth muscle cells
23, 47), (sar)5-AII, and (pro)3-AII were weak agonists/partial
ntagonists of All-stimulated steroidogenesis in bovine adre-
ocortical cells but acted as full agonists of All-stimulated
esponses in rat aortic smooth muscle cells (49). Furthermore,
wo subtypes of the rat AT, receptor (AT1a and AT,S) have
een cloned (50-52). Although no differences in the ligand
mding characteristics between these subtvpes have vet been
etected, AT,a and AT,B receptors appear to be preferentially
xpressed between vascular smooth muscle and adrenal cor-
;x respectively, and their expression subject to differential
sgulation bv steroids (53).
In conclusion, we have demonstrated that All is mitogenic
jr bovine adrenocortical inner zone cells in primary culture,
nd that both the acute steroidogenic and long-term mito-
enic responses to All are mediated by the AT, receptor.
.Ithough the present data are insufficient to explain the
nusuallv low pA2 for DuP753 obtained in bovine adreno-
artical cells, the possibility that distinct subtvpes of AT,
;ceptor are recognized by DuP753 is currently under inves-
gation.
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THE M3 MUSCARINIC RECEPTOR MEDIATES
ACETYLCHOLINE-INDUCED CORTISOL SECRETION
FROM BOVINE ADRENOCORTICAL ZONA
FASCICULATA/RETICULARIS CELLS.
Colin D. Clyne.* Simon W. Walker, t Moira R. NicoLt and Brent C. Williams!
Departments of Pharmacology, 1 George Square, tCIinical Biochemistry. The Royal Infirmary, and
tMedicine. Western General Hospital, Edinburgh University. Edinburgh. UK
(Received 20 August 1993: accepted 30 November 1993)
Abstract—In order to characterize the receptor subtype mediating acetylcholine (ACh)-induced Cortisol
secretion from purified bovine adrenocortical zona/fasciculata/reticularis cells in primary- culture, the
potencies of a range of selective muscarinic antagonists of ACh-induced steroidogenesis were assessed
by Schild analysis. Basal secretion of Cortisol was 10.2 s 1.4 pmoi/well/30 min. ACh stimulated a dose-
dependent increase in Cortisol secretion and was maximally effective at 10"; M. at which concentration
Cortisol secretion was 143.4 ± 12.9 pmol/well/30 min. Hexahvdro-sila-difenidol and para-fluoro-hexa-
hvdro-sila-difenidol were potent competitive antagonists of ACh-stimulated Cortisol secretion, with pA;
values of 8.68 ± 0.28 and 7.96 ± 0.29, respectively. Pirenzepine (pA, = 6.95 - 0.28) and methoctramine
(pA- = 6.06 ± 0.27) were relatively weak competitive antagonists. The pA. values determined in this
study are characteristic of the M, muscarinic receptor, and we conclude that this receptor subtype
mediates ACh-induced Cortisol secretion from bovine zona fasciculata/reticularis cells.
Key words:
Stimulation of adrenocortical steroid secretion in
response to ACh§ was first demonstrated in the
isolated perfused bovine adrenal gland [1], ACh has
since been reported to stimulate steroidogenesis
from the perfused rat and amphibian adrenal [2, 3]
and from cells isolated from both the bovine zg and
zfr [4-6], it is significant that direct cholinergic
innervation of the adrenal cortex has been observed
in several species including sheep [7] and man [8].
Furthermore, a possible role for ACh in regulating
adrenocortical steroidogenesis in man has been
proposed [9],
While no effect of ACh on cAMP levels has been
demonstrated in adrenocortical inner zone cells [5,
6], ACh clearly stimulates Ptdlns turnover. Dose-
dependent increases in 3:P, labelling of Ptdlns occur
in response to ACh [10], and in purified bovine zfr
cells, ACh stimulates the formation of inositol tris-
and bis-phosphates, the time course of appearance
of which is consistent with the activation of a
polyphosphoinositide specific phosphoinositidase C
[6].'
Where studied, stimulation of steroidogenesis and
second messenger formation by ACh have been
sensitive to muscarinic, but not nicotinic antagonists
"
Coiresaonding author, present address: University
College Dublin. Department of Pharmacology, Foster
Avenue. Blackrock. Co. Dublin, Ireland. FAX
353-12692749.
§ Abbreviations: ACh. acetylcholine: zg. zona glo-
merulosa; zfr. zona fasciculata/rcticulans; EBS. Earle's
Balanced Salts solution: HHSD. hexahvdro-sila-difemdol:
p-FHHSD. para-riuoro-hexahvdro-sila-difenidol; Ptdlns.
phosphatidylinositol.
[3. 5. 6. 10. 11]. However, the muscarinic receptor
subtype involved in the steroidogenic response to
ACh has not been established.
Of the five muscarinic receptor subtypes which
have been cloned [12-15], the ml, m2 and m3
receptors appear to correlate with the phar¬
macologically defined M,, M; and M- subtypes [16].
Since none of the muscarinic antagonists currently
available is more than 10-fold selective for a given
receptor subtype, it is necessary to obtain affinity
profiles for a range of antagonists In order to classify
muscarinic receptor subtypes definitively. Such
antagonists include pirenzepine (Mi > M; = Mi),
methoctramine (M- > Mt > M3). HHSD (M, =
M3 > M;) and p-FHHSD (M, > M, = M,) [17-20],
Recently a fourth receptor subtype has been
pharmacologically identified (Ma) exhibiting high
affinity for the Mr and M:-selective antagonists
pirenzepine and AF-DX-116 [21. 22], This putative
M4 receptor subtype can be distinguished from the
M, receptor by its high affinity for himbacine and
methoctramine [21. 23], and appears to correspond
to the muscarinic m4 gene product expressed in
chick heart and brain [24],
Preliminary observations indicated that stimulation
of steroidogenesis from primary cultures of bovine
zfr cells by ACh may occur through the M3 muscarinic
receptor [6]. The present study was undertaken
to definitively characterise the receptor subtype
involved in this response, bv determining the
affinities of a range of selective antagonists of ACh-
stimulated Cortisol secretion bv Schild analysis [25,
26],
MATERIALS AND METHODS
Materials. The source of all cell culture and
1
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Fig. 2. Dose-response curves for the secretion of Cortisol
by cultured bovine zfr cells produced on stimulation with
ACh alone f ■) and in the presence of (upper panel) HHSD
(T) 3.3 x KT'M. (♦) lO-'M; (lower panel) p-FHHSD
(T) 3.3 x 10~"M. (♦) 3.3 x 10"'M. Data points are the
means a: SD of triplicate determinations from one
representative experiment for each antagonist.
[Acetylcholine! (Ml
Fig. 1. Dose-response curves for the secretion of Cortisol
by cultured bovine zfr cells produced on stimulation with
ACh alone (■) and in the presence of (upper panel)
pirenzeptne (T) 3.3 x 10~\W. (♦) (lower panel)
methoctramme (T) 10"!M. (♦) 10_"'M. Data points are
the means 2 SD of triplicate determinations from one
representative experiment for each antagonist.
radioimmunoassay materials is described in Ref. 27.
Controlled Process Serum Replacement No. 5
(CPSR-5), acetylcholine and pirenzepine were from
the Sigma Chemical Co. (Poole. U.K.). HHSD
hydrochloride and p-FHHSD hydrochloride were
kind gifts from Drs G. Lambrecht. E. Mutschier and
R. Tacke of the Johann-Wolfgang-Gothe University
(Frankfurt am Main, Germany). /V.tV'-Bis(6-(2-
methoxybenzly)amino]hexvl - 1.8 - octane - diamine
tetrahvdrochloride (methoctramine) was a generous
gift from Prof. Dr C. Melchiorre. Universita' Degli
Studi di Bologna. (Italy).
Cell culture and stimulation. Bovine adrenal
glands were obtained from freshly slaughtered 1-2
year old steers (Gorgie Abattoir, Edinburgh, U.K.).
Puriried zfr cell suspensions were prepared by the
collagenase digestion and column filtration procedure
described previously [28]. producing a zfr cell
preparation essentially free from glomerulosa and
medullary cell contamination [28], Cells were
cultured at 37" under 5% Co: in 12-well culture
dishes (25 mm diameter wellsLat 333.000 cells/mL.
in 1 mL of Ham's F10 medium containing 10% (v/v)
CPSR-5. penicillin (50 lU/mL), streptomycin (50 tig/
mL) and amphotericin B (2.5,ug/mL) (F10 growth
medium). After 24 hr the overlying medium was
replaced with 0.5 mL of identical fresh medium.
Experiments were performed 48 hr after initial
plating, at which time cells showed peak respon¬
siveness to ACh [29], F10 growth medium was
removed and cells washed twice with 1 mL of EBS
solution with added BSA and glucose (0.2 and 0.1%
(w/'v) respectively] (EBSBG). Cells were pre-
incubated for 5 min -under 0.4 mL EBSBG after
which ACh and/or antagonists, dissolved in EBSBG.
were added to the cells to a final volume of 0.5 mL.
Stimulation was allowed to proceed tor 30 min at
37° after which the overlying medium was removed
and stored at -20°pnortocorttsol radioimmunoassay
as described previously [28],
Data analysts. In order to obtain estimates of
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dose-response curve parameters, data sets were
fitted by iterative non-linear least squares regression
analysis using the software package Fig P (Biosoft)
on an IBM computer, allowing the maximum and
half-maximum responses to be calculated. Dose-
response curves were tested for parallelism according
to Kenakin [30], and antagonist pA2 values estimated
by the method of Arunlakshana and Schiid [26]:
'ogiot'' - 1) = nlog10[B] + pKB
in which r is the dose ratio produced by an antagonist
of concentration [B], n is the Schiid plot slope and
pKb is the antagonist affinity constant. Where n was
found to be not significantly different from unity,
pKB was estimated with n constrained to unity [31].
RESULTS
A series of concentration-response curves to ACh
were set up in the presence of increasing doses of the
muscarinic antagonists pirenzepine. methoctramine,
HHSD and p-FHHSD. Representative experiments
are shown in Figs 1 and 2. Six such experiments
were earned out for each antagonist in order to
determine pA2 values. Basal Cortisol secretion was
10.2 ± 1.4 pmol/well/30 min (mean z: SEM, N = 24
expenments). The dose-response curve for ACh fell
in the concentration range 10~7-10~-M, and the
ED<o for ACh-stimulated Cortisol secretion was
1.1 x 10~6M (range 0.4-7.2 x 10""6M). Maximal
stimulation of Cortisol secretion occurred at
1 x 10~\M ACh. at which concentration Cortisol
secretion was 143.4 ♦ 12.9 pmol/well/30 min
(mean ± SEM. N = 24).
The effect of each of the antagonists studied was
to shift the log dose-response curve to the right.
None of the antagonists had any effect on the
maximal response attainable by ACh or the slope of
the dose-response curve. consistent with competitive
antagonism (Figs 1 and 2). None of the antagonists
had any intrinsic effect on Cortisol secretion at any
of the concentrations emploved (up to 1 x 10~5M
HHSD, 1 x 10"°M p-FHHSD. I x 10"JM pir¬
enzepine and methoctramine) (data not shown).
For estimation of antagonist affinities, the dose
ratio (r) for each concentration of antagonist was
obtained and Schiid plots [26] constructed (Fig. 3).
The estimated antagonist pA2 values and slope of
the Schiid regressions are shown in Table 1.
DISCUSSION
Bovine adrenocortical ACh receptors have previously
been characterized as muscarinic both in the outer
zg and in the inner zfr [4. 5], Walker et al. [6]
reported the effects of a number of cholinergic
agonists and antagonists on Cortisol secretion from
zfr cells, and obtained preliminary evidence for the
presence of an Mi receptor. However, definitive
investigation of the muscarinic receptor subtypes
present in the adrenal cortex has not been carried
out. either by radioligand binding or by functional
analysis, in any species. The present study establishes
that ACh-stimulated Cortisol secretion from bovine
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Fig. 3. Schiid analysis loglu (dose-ratio (/■)-!) vs
log,,(antagonist)) of the antagonism by (A) HHSD, (■)
p-FHHSD. (T) pirenzepine and (♦) methoctramine of
ACh-stimulated Cortisol secretion from bovine zfr cells.
Cumulative data from six separate cell preparations for
each antagonist (two concentrations of antagonist per
experiment).
activation of the M, muscarinic receptor, as discussed
below.
The use of Schiid analysis for calculation of
antagonist pA: values is valid only for competitive
antagonists. The antagonists employed in this study
produced parallel shifts of the log dose-response
curve to ACh without depressing the maximum
response to ACh. and produced linear Schiid
regressions with slopes not significantly different
from unity, consistent with competitive antagonism.
The rank potency order (HHSD > p-
FHHSD > pirenzepine > methoctramine) is charac¬
teristic of that of the M3 muscarinic receptor:the
relatively low potencies of pirenzepine (p<42 = 6.95)
and methoctramine (pA2 = 6.06) indicate that the
steroidogenic response to ACh is not mediated by
M, or M2 receptors respectively (see Ref. 32 for
review), while the high pA2 values for HHSD (pA2 =
8.68) and p-FHHSD (pA2 = 7.96) are characteristic
of M? receptor function [19, 20],
Recently a fourth muscarinic receptor subtype has
been pharmacologically characterized which appears
to correspond to the m4 gene product [21]. While
the bovine adrenal medulla has been shown to
express mRNA transcript exclusively for the m4
receptor, a weak signal for the m4 receptor mRNA
was also detected in the cortex [33]. Although the
putative M4 receptor subtype exhibits high affinity
for the Mrselective compounds HHSD and p-
FHHSD [21], it also has moderate to high affinity
for methoctramine similar to that of pirenzepine in
both ligand binding and functional assays [21. 23],
The low p.4; for methoctramine observed in bovine
zfr cells argues against any significant involvement
of the M4 receptor in ACh—stimulated Cortisol
secretion^
While the observed pA2 values for pirenzepine.
methoctramine and p-FHHSD correlate well with
the known values at M> receptors in other systems
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Table 1. Comparison of experimental pA, values for muscarinic antagonists in bovine zfr cells with previously published
values
Published pA;
Antagonist pA, ± SEM slope i SEM M, M, M} M, Reference
Pizenzepine 6.95 = 0.28 1.06 ± 0.06 8.0-8.3 6.5-6.8 6.7-7.0 7.2-7.7 (21. 23. 38-43]
Methoctramine 6.06 - 0.27 1.01 i: 0.04 6.8-7.6 7.6-8.3* 5.9-6.9 7.6-7.8 [21. 23. 38. 39. 42. 43]
HHSD 8.68 * 0.28 1.02 ± 0.10 7.9-8.7 6.5-6.9 7.6-8.5 7.6-7.9* [21. 38. 40. 44]
p-FHHSD 7.96 = 0.29 0.95 0.05 6.7-7.2 6.0-6.1 7.6-8.0 7.8 [16. 38-40. 42. 43]
' -log.oAT,-
(Table 1), that for HHSD was slightly higher in zfr
cells than would be expected at any muscarinic
receptor. While this value is not inconsistent with
an M3 receptor classification, since HHSD exhibits
highest affinity at M,/M3 receptors, it does require
comment. A similarly high value (8.49) has been
reported previously in ovine detrusser smooth muscle
[34], Although carbachol was used as the agonist,
this would not be expected to affect the apparent
antagonist affinity, since measurements of pA3 are
independent of the agonist used to elicit the
functional response [30]. It seems unlikely that
this discrepancy is due to inadequate antagonist
equilibration time, since the existence of a non-
equilibrium steady-state would be expected to
produce a Schild slope greater than unity [30]: the
Schild slopes for each antagonist in the present study
were not significantly different from unity. It is
possible that the unusually high p/\3 for HHSD
reported in the present study reflects a species-
dependent heterogeneity of M, receptors arising
from differences in receptor or G protein structure.
The precise reasons for this anomaly are unclear at
present, and require further investigation.
The presence of the M3 muscarinic receptor is
consistent with the previously reported effects of
ACh in bovine zfr cells: (i) stimulation of
phosphoinositidase C activity [6, 10], the second
messenger system associated with the cloned ml,
m3 and m5 gene products, and with native M) and
M3 cholinoceptors: (ii) the lack of effect of ACh on
cAMP levels in adrenocortical cells [5, 6]; (iii) the
inability of the Mpselective agonist McN-A-343 to
stimulate Cortisol secretion from bovine zfr cells [6],
Although the significance of ACh in controlling
adrenocortical steroidogenesis remains to be estab¬
lished, a number of observations clearly support an
in vivo function. ACh stimulates Cortisol secretion
from both the isolated perfused bovine adrenal gland
and from freshly isolated bovine zfr cells [1. 6]. In
addition, acetylcholinesterase—positive innervation
of the adrenal cortex has been detected in many
.pedes including sheep [7] and man [8]. While
administration of muscarinic agonists to humans had
no intrinsic effect on plasma steroid concentration,
the plasma aldosterone response to angiotensin II
infusion was inhibited by atropine [9]. Observations
such as these suggest that cholinergic mechanisms
may exert a modulatory effect on the actions of
other adrenocortical agonists. Such modulatory
effects could occur either through interactions
between ACh and other agonists at the level of the
steroidogenic cells, as have been reported to occur
in the amphibian adrenal [35, 36], or through effects
of ACh on adrenocortical blood flow: in conscious
calves, infusion of ACh resulted in a decrease in
adrenocortical vascular resistance and an enhance¬
ment of the steroidogenic effect of adreno-
corticotropin [37], Thus, while data presented here
and elsewhere clearly indicate a direct steroidogenic
action of ACh on purified adrenocortical cells, it
seems likely that ACh may also enhance agonist-
stimulated steroidogenesis in vivo by increasing
adrenal blood flow, thereby increasing the delivery
of such agonists to the steroidogenic tissue.
In conclusion, the antagonist affinity profiles
observed in the present study most closely resemble
those of the M3 muscarinic receptor, and we propose
that this receptor subtype mediates ACh-stimulated
Cortisol secretion from bovine zfrcelis. The functional
significance of this muscarinic cholinergic element
in the regulation of adrenocortical steroidogenesis
in vivo warrants further investigation.
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